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ABSTRACT 
 
NIEN-HSI KO: Investigating Septin-dependent, Actomyosin-ring-independent Cytokinesis 
in Saccharomyces cerevisiae 
(Under the direction of John R. Pringle) 
 In the budding yeast Saccharomyces cerevisiae, a ring of myosin II forms in a septin-
dependent manner at the presumptive budding site in late G1.  This ring remains at the bud 
neck until the onset of cytokinesis, when actin is recruited to it and the resulting actomyosin 
ring contracts.  Concurrently, a septum of cell wall (including a chitinous primary septum 
synthesized by Chs2p) is formed to complete cytokinesis.  Mutants lacking MYO1 (the only 
myosin II gene) have varyingly severe phenotypes that can be suppressed either by deletion 
of a nonessential subunit of the anaphase-promoting complex or cyclosome (APC/C) or by 
overexpression of IQG1 or CYK3.  Iqg1p is the only S. cerevisiae IQGAP and is required for 
both actomyosin-ring formation and primary-septum formation, and hence for normal 
cytokinesis.  Because the actomyosin ring itself is not essential for primary-septum 
formation, Iqg1p must have another cytokinetic function(s), which may involve stimulating 
Cyk3p (a septin-dependent protein involved in cytokinesis) and Hof1p (a possible linker 
between the actomyosin ring and the primary-septum-synthesis machinery) to function in a 
septin-dependent, actomyosin-ring-independent pathway.  Subsequent analyses showed that 
Iqg1p is increased in abundance and persists after cytokinesis in APC/C mutants, that Iqg1p 
is ubiquitinated directly by APC/C in vitro, and that a nondegradable Iqg1p (missing a novel 
recognition motif) can suppress myo1Δ phenotypes.  These data suggest that Iqg1p is a direct 
target of the APC/C.  To identify additional proteins involved in septin-dependent,
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actomyosin-ring-independent cytokinesis, dosage-suppressor screens have been conducted, 
using myo1Δ cyk3Δ and myo1Δ hof1Δ synthetic-sick mutants.  Some of the genes identified 
include EGT2 (encoding a cell-wall endoglucanase), ECM33 (encoding a GPI-anchored 
protein that may regulate cell-wall organization), and a truncated CDC24 (encoding the GEF 
for the Rho-type GTPase Cdc42p) that lacks the C-terminal PB1 domain.  Overexpressing 
Ecm33p or the truncated Cdc24p can also suppress the iqg1Δ and chs2Δ growth defects and 
restore primary-septum formation in iqg1Δ cells.  Furthermore, the suppression by truncated 
Cdc24p appears to be Cdc42p-independent and may involve another Rho-type GTPase(s).  
Finally, the dosage-suppressor screen also uncovered a gene, YJL055W, that when 
overexpressed directly suppresses the inviability of URA3+ cells in the presence of 5-
fluoroorotic acid.
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Cell division is an essential process that partitions the contents of one cell into two cells.  
This process includes a nuclear segregation by mitosis followed by a division of cell surface 
and cytoplasm by cytokinesis.  Of these two stages, mitosis has been shown to be highly 
conserved in plants, animals, and fungi, whereas cytokinesis mechanisms have appeared to 
be variable.  In plant cells, cytokinesis starts when a transient preprophase band marks the 
division site on the plasma membrane in late G2 (Staehelin and Hepler 1996; Assaad, 2001; 
Verma, 2001; Jürgens, 2005a; Jürgens 2005b).  Near the end of mitosis, the phragmoplast, an 
array made of cytoskeletal components, then transports materials via membrane trafficking 
and targeted vesicle fusion to form a cell plate from the center to the periphery of the division 
plane.  The cell plate leads to the formation of plasma membranes that underlie the dividing 
cell wall, which is formed by secretion of cell-wall materials into the lumen of the expanding 
cell plate.  In contrast, cytokinesis in animal cells involves a cleavage furrow containing a 
contractile actomyosin ring, which includes nonmuscle myosin II, F-actin, and other proteins 
(Satterwhite and Pollard, 1992; Rappaport, 1996; Glotzer, 1997; Field et al., 1999; Hales et 
al., 1999; Uyeda et al., 2004).  In anaphase, the mitotic spindle determines the site at which 
the contractile ring and cleavage furrow will form.  A transient structure, the midbody, forms 
as an intercellular bridge when the furrow reaches the remnants of the mitotic spindle.  
Finally, the common membrane that surrounds the two nascent cells is divided so that the
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cells can separate. 
 Although plant and animal cytokinesis appear, at least superficially, quite different, 
recent studies have shown that the two processes actually share some similarities.  For 
example, as in plants, animal cytokinesis also requires membrane trafficking and targeted 
vesicle fusion (Albertson et al., 2005; Matheson et al., 2005).  Specifically, membrane 
delivery is required both for the increased surface area during cleavage furrow ingression and 
for the sealing of divided cells during vesicular abscission of the midbody.  Important goals 
at present are to understand the process of targeted membrane addition during both animal 
and plant cytokinesis, the synthesis of the dividing cell wall via cell plate formation in plant 
cytokinesis, and more broadly the similarities and differences between cytokinesis in various 
cell types. 
To answer these important questions, cytokinesis in various fungi seem like excellent 
study models, because fungal cytokinesis appears to be similar to both animal and plant 
cytokinesis.  For example, in the fission yeast Schizosaccharomyces pombe, cells divide by 
utilizing both a contractile actomyosin ring and formation of a septum made of cell-wall 
materials.  Specifically, the actomyosin ring assembles in the middle of the cell overlying the 
nucleus during early M phase.  At the end of mitosis, the ring contracts as the septum forms 
at the site marked by the ring.  The center layer of the septum is then digested away, leading 
to the separation of the two daughter cells (Chang and Nurse, 1996; Gould and Simanis, 
1997; Field et al., 1999; Hales et al., 1999; Mulvihill and Hyams, 2003). 
Similarly, cytokinesis in the budding yeast Saccharomyces cerevisiae also involves 
an actomyosin ring and a cell-wall septum.  In S. cerevisiae, a myosin ring (made of Myo1p, 
the only type II myosin in this organism) is first formed, in a septin-dependent manner, at the 
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presumptive budding site in late G1 phase (Bi et al., 1998; Lippincott and Li, 1998).  Septins 
are GTP-binding proteins that have been found at the division site in all fungal and animal 
cells examined (Longtine et al., 1996; Hall and Russell, 2004; Gladfelter, 2006) and may 
function as a diffusion barrier and a scaffold for the organization and localization of other 
proteins (Gladfelter et al., 2001; Longtine and Bi, 2003; Dobbelaere and Barral, 2004; 
Versele and Thorner, 2005; Spiliotis and Nelson, 2006).  Remarkably, although the septins 
are required for cytokinesis in some cell types, including S. cerevisiae, they are not required 
in others, including S. pombe (Longtine et al., 1996; Adam et al., 2000; Nguyen et al., 2000; 
Kinoshita and Noda, 2001; An et al., 2004). 
In S. cerevisiae, after its initial septin-dependent formation, the myosin ring then 
remains at the mother-bud neck until the onset of cytokinesis, when actin and other proteins 
are recruited to it to form the mature actomyosin ring, which soon contracts.  Simultaneous 
with or soon after this contraction, the plasma membrane invaginates and the primary cell-
wall septum is synthesized, principally by the chitin synthase Chs2p (Cabib et al., 2001; 
Schmidt et al., 2002).  Secondary septa are then deposited on both sides of the primary 
septum to form the mature trilaminar septum, and the mother and daughter cells are separated 
by the action of a chitinase that partially hydrolyzes the primary septum (Kuranda and 
Robbins, 1991; Colman-Lerner et al., 2001). 
Although the contractile actomyosin ring is involved in cytokinesis of animal cells, S. 
pombe, and S. cerevisiae, one major difference is the essentiality of the ring.  The ring 
appears to be essential for cytokinesis in S. pombe and most animal cells (Rappaport, 1996; 
Gould and Simanis, 1997; Field et al., 1999; Hales et al., 1999; Mulvihill and Hyams, 2003), 
but it is not essential in S. cerevisiae (Rodriguez and Paterson, 1990; Bi et al., 1998; 
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Lippincott and Li, 1998; Schmidt et al., 2002).  The non-essentiality of the actomyosin ring 
is certainly not unique to S. cerevisiae.  For examples, amoebae cells of the slime mold 
Dictyostelium discoideum can carry out cytokinesis on substrates in the absence of the 
actomyosin ring (De Lozanne and Spudich, 1987; Uyeda et al., 2000; Nagasaki et al., 2002), 
and some animal cells, such as chicken embryo, epitheloid kidney, and normal rat kidney 
cells, appear to be able to carry out cytokinesis, albeit less efficiently, even when myosin II 
or actomyosin-ring contraction is inhibited or completely absent (Nunnally et al., 1980; 
Zurek et al., 1990; Uyeda et al., 2004; Kanada et al., 2005). 
In S. cerevisiae, mutant cells lacking Myo1p do not form the actomyosin ring but are 
still viable in most genetic backgrounds, although their septa are typically thick and 
disorganized and often lack well defined primary-septum structures (Schmidt et al., 2002; 
Tolliday et al., 2003; Nishihama et al., 2007).  However, some myo1Δ cells can form 
disorganized primary-septum-like structures made of chitin within the thick septa (Nishihama 
et al., 2007).  The aberrant septa are presumably the reason that myo1Δ cells grow more 
slowly than wild type and fail to separate efficiently, but they also represent a means by 
which S. cerevisiae cells can carry out cytokinesis through a septin-dependent, actomyosin-
ring-independent mechanism(s).  This mechanism(s) may involve pathways and proteins 
functioning in membrane invagination, septum construction, and other related processes.  
Thus, elucidating this mechanism in S. cerevisiae may also shed new light on similar 
pathways in other organisms, including those that may be involved in cell-wall synthesis and 
targeted membrane addition during plant and animal cytokinesis.  In other words, S. 
cerevisiae can serve as an informative model system to study the contractile-ring-
independent process in cytokinesis. 
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To date, some of the septin-dependent proteins that may function independently of 
the actomyosin ring in S. cerevisiae cytokinesis include Iqg1p, Cyk3p, and Hof1p.  Iqg1p is 
the only known IQGAP (Brown and Sacks, 2006) in S. cerevisiae and has been shown to be 
indispensable for actomyosin-ring formation, primary-septum formation, and normal 
cytokinesis (Epp and Chant, 1997; Shannon and Li, 1999; Luo et al., 2004; Nishihama et al., 
2007; see Chapters 2 and 3).  Because the actomyosin ring itself is not essential for 
cytokinesis, Iqg1p must have at least one other cytokinetic function(s) that is independent of 
the actomyosin ring.  To date, the exact function of Cyk3p is unclear, but its overexpression 
suppresses the iqg1Δ growth defect without restoring the actomyosin ring, and the myo1Δ 
cyk3Δ double mutant is synthetically sick, suggesting that Cyk3p also promotes cytokinesis 
through an actomyosin-ring-independent pathway (Korinek et al., 2000; Nishihama et al., 
2007).  Although the exact cellular function of Hof1p remains as a mystery, this protein has 
been shown to be a member of the Pombe-Cdc15-Homology (PCH) family, which also 
includes S. pombe Cdc15p and mammalian proteins PSTPIP1 and PSTPIP2 (Chitu and 
Stanley, 2007).  PCH proteins have been suggested to function at the membrane-cytoskeleton 
interface by coordinating changes in the actin cytoskeleton and membrane morphology.  
Thus, Hof1p may function in cytokinesis as an adapter linking the primary-septum-synthesis 
machinery to the actomyosin ring (Vallen et al., 2000).  Because the myo1Δ hof1Δ double 
mutant is synthetically inviable, Hof1p may also participate in an actomyosin-ring-
independent pathway of cytokinesis. 
In addition to the cytokinetic machineries described above, S. cerevisiae cells also 
have sophisticated regulatory pathways to coordinate cytokinesis with other late-cell-cycle 
events, such as the completion of chromosome segregation and the exit from mitosis.  One 
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such regulatory pathway involves the anaphase-promoting complex or cyclosome (APC/C), 
which is an essential, conserved, and multi-subunit ubiquitin ligase that targets specific cell-
cycle-related proteins for degradation (Peters, 2006).  The APC/C initiates anaphase by 
triggering sister-chromatid separation via degradation of securin (Nasmyth, 2005), which 
unleashes the protease separase and activates the mitotic-exit network (MEN).  The MEN 
further activates Cdc14p, which then activates the APC/C to promote exit from mitosis via 
degradation of mitotic cyclins.  In addition to these major roles, the APC/C also regulates 
other cell-cycle proteins, such as the spindle-associated kinesins Kip1p and Cin8p (Harper et 
al., 2002). 
 To investigate the mechanisms of septin-dependent, actomyosin-ring-independent 
cytokinesis in S. cerevisiae, I have conducted synthetic-lethal and dosage-suppressor screens 
(based on the colony-sectoring assay described by Bender and Pringle, 1991) starting with 
septin and myo1Δ mutants.  From these studies, described in Chapter 2, mutations in the 
nonessential subunits of the APC/C and overexpression of Iqg1p or Cyk3p were found to 
suppress the growth defects of myo1Δ cells.  Furthermore, Iqg1p was found to be a direct 
substrate of the APC/C, and the elevated levels of Iqg1p in APC/C mutants accounted for the 
suppression of the myo1Δ growth defects.  In addition, overexpression of Iqg1p or Cyk3p 
was also found to promote the formation of primary-septum-like structures in the absence of 
the actomyosin ring (Nishihama et al., 2007). 
 To identify additional components of the septin-dependent, actomysin-ring-
independent mechanism of cytokinesis in S. cerevisiae, I have conducted dosage-suppressor 
screens [using the URA3/5-FOA-based lethality described by Boeke et al. (1984), Rothstein 
(1991), and Sikorski and Boeke (1991)] starting with myo1Δ cyk3Δ and myo1Δ hof1Δ double 
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mutants.  In these studies, described in Chapter 3, several known and novel proteins that may 
function in cytokinesis have been identified.  Specifically, overexpression of either Ecm33p 
(which is a GPI-anchored protein that may regulate cell-wall organization) or a truncated 
Cdc24p (which is the GEF for the Rho-type GTPase Cdc42p) lacking its PB1 domain was 
found to promote the formation of primary-septum-like structures and possibly more 
organized thick septa in the absence of the actomyosin ring.  Furthermore, ecm33Δ cells 
displayed minor defects in cytokinesis at 37˚C.  The suppression by the truncated Cdc24p 
appears to be Cdc42p-independent and may involve the action of other Rho-type GTPases, 
such as Rho1p, Rho2p, and/or Rho5p, and/or an unknown factor(s). 
 Taken together, these results suggest that Iqg1p, a novel APC/C target, may stimulate 
Cyk3p and other proteins (such as those involved in targeted membrane addition and/or cell-
wall synthesis/integrity) in a cell-cycle-regulated manner to promote the construction of a 
more normal septum through the contractile-ring-independent mechanism of cytokinesis. 
 A by-product of the dosage-suppressor screens, unrelated to cytokinesis, and 
described in Chapter 4, was the discovery that overexpression of the little-characterized yeast 
gene YJL055W could directly suppress the inviability of URA3+ cells in the presence of 5-
FOA.  This observation appear related to a previous report that the yjl055wΔ mutant has 
increased sensitivity to purine-analog mutagens, and suggests that Yjl055Wp may function in 
the detoxification of nucleotide analogs.  However, the precise mechanism of Yjl055Wp 
action remains unclear.
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CHAPTER 2 
IDENTIFICATION OF YEAST IQGAP (Iqg1p) AS AN ANAPHASE-PROMOTING-




In the yeast Saccharomyces cerevisiae, a ring of myosin II forms in a septin-dependent 
manner at the budding site in late G1.  This ring remains at the bud neck until the onset of 
cytokinesis, when actin is recruited to it.  The actomyosin ring then contracts, septum 
formation occurs concurrently, and cytokinesis is soon completed.  Deletion of MYO1 (the 
only myosin II gene) is lethal on rich medium in the W303 strain background and causes 
slow-growth and delayed-cell-separation phenotypes in the S288C strain background.  These 
phenotypes can be suppressed by deletions of genes encoding nonessential components of the 
anaphase-promoting complex (APC/C).  This suppression does not appear to result simply 
from a delay in mitotic exit, because overexpression of a nondegradable mitotic cyclin does 
not suppress the same phenotypes.  Overexpression of either IQG1 or CYK3 also suppresses 
the myo1Δ phenotypes, and Iqg1p (an IQGAP protein) is increased in abundance and 
abnormally persistent after cytokinesis in APC/C mutants.  In vitro assays showed that Iqg1p 
is ubiquitinated directly by APC/CCdh1 via a novel recognition sequence.  A nondegradable 
Iqg1p (lacking this recognition sequence) can suppress the myo1Δ phenotypes even when 
expressed at relatively low levels.  Taken together, the data suggest that compromise of 
APC/C function allows the accumulation of Iqg1p, which then promotes actomyosin-ring-
independent cytokinesis by activation of Cyk3p. 
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INTRODUCTION 
Cytokinesis is the process that divides the cell surface and cytoplasm of one cell into two 
cells.  Although the list of proteins known to be involved in cytokinesis has expanded 
significantly in recent years, a complete molecular understanding of this process remains 
elusive.  Among the mysteries are the roles of the septins and of the actomyosin contractile 
ring.  The septins are a family of GTP-binding proteins that have been found at the division 
site in all fungal and animal cells examined (Longtine et al., 1996; Hall and Russell, 2004; 
Gladfelter, 2006).  Although their roles are still imperfectly understood, the septins appear to 
function as both a scaffold and a diffusion barrier for the localization and organization of 
other proteins (Gladfelter et al., 2001; Longtine and Bi, 2003; Dobbelaere and Barral, 2004; 
Versele and Thorner, 2005; Spiliotis and Nelson, 2006).  Surprisingly, although the septins 
are indispensable for cytokinesis in some cell types, they are dispensable in others (Longtine 
et al., 1996; Adam et al., 2000; Nguyen et al., 2000; Kinoshita and Noda, 2001; An et al., 
2004).  Similarly, it has recently become clear that the actomyosin ring at the division site is 
also dispensable for cytokinesis in a variety of cell types (Bi et al., 1998; Nagasaki et al., 
2002; Kanada et al., 2005).  In the budding yeast Saccharomyces cerevisiae, the septins are 
essential for formation of the actomyosin ring.  However, this cannot be their only role, 
because they are essential for cytokinesis in this organism, whereas the actomyosin ring is 
not essential in most strain backgrounds (Bi et al., 1998; Schmidt et al., 2002; Nishihama et 
al., 2007).  A major challenge at present is to elucidate the actomyosin-ring-independent 
role(s) of the septins in cytokinesis in yeast and (presumably) in other cell types.  
In S. cerevisiae, Myo1p (the only type II myosin in this organism) forms a ring at the 
presumptive budding site in late G1 (Bi et al., 1998; Lippincott and Li, 1998).  This ring 
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remains at the mother-bud neck until the onset of cytokinesis, when actin and other proteins 
are recruited to it to form the mature actomyosin ring, which soon contracts.  Concurrent 
with this contraction, the plasma membrane invaginates and the primary cell-wall septum is 
synthesized, principally by the chitin synthase Chs2p (Cabib et al., 2001; Schmidt et al., 
2002).  Secondary septa are then deposited on both sides of the primary septum to form the 
mature trilaminar septum, and the mother and daughter cells are separated by the action of a 
chitinase that partially hydrolyzes the primary septum (Kuranda and Robbins, 1991; Colman-
Lerner et al., 2001).  In viable myo1Δ cells, no actomyosin ring forms, and the septa that 
form are typically disorganized and often lack well defined primary-septum-like structures 
(Schmidt et al., 2002; Tolliday et al., 2003; Nishihama et al., 2007).  These disorganized 
septa are presumably the reason that myo1Δ cells grow more slowly than wild type and fail to 
separate efficiently, resulting in the formation of multi-cell clusters. 
Among the proteins recruited to the division site in a septin-dependent manner just 
before cytokinesis are Iqg1p and Cyk3p.  Iqg1p is the only member of the IQGAP family 
(Brown and Sacks, 2006) in S. cerevisiae, and it has been reported to be essential both for 
formation of the actomyosin ring and for cytokinesis (Epp and Chant, 1997; Shannon and Li, 
1999; Luo et al., 2004).  Because the actomyosin ring itself is not essential for cytokinesis, 
Iqg1p must have at least one cytokinetic function that is actomyosin-ring independent.  The 
function of Cyk3p is not known, but its overexpression suppresses the iqg1Δ lethality without 
restoring the actomyosin ring, suggesting that Cyk3p also promotes cytokinesis through an 
actomyosin-ring-independent pathway (Korinek et al., 2000; Nishihama et al., 2007). 
For successful cellular reproduction, cytokinesis must be coordinated with other late-
cell-cycle events such as the completion of chromosome segregation and the exit from 
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mitosis.  Not surprisingly, cells have sophisticated regulatory pathways to ensure this 
coordination. Regulation of late mitotic events depends largely on the anaphase-promoting 
complex or cyclosome (APC/C), an essential multi-subunit ubiquitin ligase that targets 
specific cell-cycle-related proteins for degradation (Peters, 2006).  The APC/C, with its 
activating subunit Cdc20p, initiates anaphase by triggering sister-chromatid separation via 
degradation of the securin Pds1p (Nasmyth, 2005), which unleashes the protease separase.  In 
S. cerevisiae, separase activation also initiates release of the protein phosphatase Cdc14p 
from its nucleolar inhibitor Net1p.  Activation of the mitotic-exit network (MEN) further 
activates Cdc14p, which then activates Cdh1p, a second APC/C-activating subunit that 
targets Clb2p and other mitotic cyclins for degradation in late mitosis.  In addition to these 
major roles, the APC/C also regulates other cell-cycle proteins, such as the spindle-associated 
kinesins Kip1p and Cin8p (Harper et al., 2002).   
13 subunits of the APC/C have been identified in S. cerevisiae.  Many of the core 
subunits are essential for APC/C function and thus for viability.  However, some subunits, 
including Cdc26p, Apc9p, Doc1p, Swm1p, and Mnd2p, are not essential. Cdc26p and Apc9p 
appear to be involved in the assembly of the APC/C (Passmore, 2004), Doc1p is involved in 
promoting the association between the APC/C and its substrates (Carroll and Morgan, 2002; 
Passmore et al., 2003; Carroll et al., 2005), Swm1p is required for full catalytic activity of 
the APC/C (Schwickart et al., 2004; Page et al., 2005), and Mnd2p appears to have little role 
in mitotic control but is important in regulating the APC/C during meiosis (Oelschlaegel et 
al., 2005; Page et al., 2005) 
 To investigate the mechanisms of septin-dependent, actomyosin-ring-independent 
cytokinesis in S. cerevisiae, we have been conducting synthetic-lethal and dosage-
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suppression screens starting with septin and myo1Δ mutants.  During these studies, we 
unexpectedly observed that mutations in nonessential subunits of the APC/C could suppress 
the phenotypes of myo1Δ mutants.  We present evidence that Iqg1p is a direct substrate of the 
APC/C and that the elevation of Iqg1p levels in APC/C mutants accounts for the suppression 
of myo1Δ phenotypes. 
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MATERIALS AND METHODS 
Strains, Plasmids, Growth Conditions, and Genetic Methods 
The strains and plasmids used in this study are listed in Tables 2.1 and 2.2; their construction 
is described below or in the tables.  Yeast were grown on liquid or solid synthetic complete 
(SC) medium lacking specific nutrients as needed to select plasmids or transformants, YP 
rich liquid or solid medium, or YM-P rich, buffered liquid medium (Lillie and Pringle, 1980; 
Guthrie and Fink, 1991).  2% glucose was used as carbon source except for experiments 
involving induction of gene expression under GAL promoter control, for which 1% or 2% 
raffinose plus 0.5% or 2% galactose was used, as indicated.  Yeast strains were grown at 
23˚C except as noted.  The antibiotic geneticin (G418; Cambrex, Walkersville, MD) was 
used to select for cells containing the kanR marker, and 5-fluoroorotic acid (5-FOA; Research 
Products International, Mt. Prospect, IL) was used to select for ura3-mutant cells.  To arrest 
cells in G1, α-factor (Sigma-Aldrich, St. Louis, MO) was used at the concentration indicated.  
The microtubule-depolymerizing drug benomyl (DuPont, Wilmington, DE) was used at 50 
µg/ml to arrest cells in M phase.  To block translation, cycloheximide [MP Biomedicals, 
Solon, OH (Figure 2.6) or Sigma-Aldrich (Figure 2.9)] was added to the growth medium at 
the concentration indicated.  Standard procedures were used for growth of Escherichia coli, 
genetic manipulations, polymerase chain reaction (PCR), and other molecular biological 
procedures (Sambrook et al., 1989; Guthrie and Fink, 1991; Ausubel et al., 1995). 
Strain and Plasmid Constructions 
Genes were deleted using the PCR method (Baudin et al., 1993; Longtine et al., 1998) and 
the primers indicated in Table 2.3; in each case, the entire coding region was deleted.  The 
success of each deletion was confirmed by two PCR tests that used check primers that were 
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upstream and downstream, respectively, of the deleted region together with primers internal 
to the selectable markers (Longtine et al., 1998; Table 2.3).  C-terminal tagging with 
sequences encoding the 3HA epitope or GFP(F64L,S65T,V163A) was also done using the 
PCR method with plasmid pFA6a-3HA-His3MX6 (Longtine et al., 1998) or pFA6a-
GFP(F64L,S65T,V163A)-His3MX6 (see below) as template.  The success of the tagging was 
confirmed by two PCR tests, essentially as described above.  To construct strains DOY138-
141, an IQG1-TAP:His3MX6 C-terminal fragment was PCR-amplified using genomic DNA 
from strain IQG1-TAP as template and the primers indicated in Table 2.3.  This cassette was 
then transformed into appropriate parental strains as indicated in Table 2.1. 
 Plasmid pFA6a-GFP(F64L,S65T,V163A)-His3MX6 was constructed by subcloning 
an MscI-BstBI fragment containing the three mutations from YEpGFP*-BUD8F (Schenkman 
et al., 2002) into MscI/BstBI-cut pFA6a-GFP(S65T)-HIS3MX6 (Wach et al., 1997).  Plasmid 
pTSV31A-MYO1 was constructed by subcloning the 7.0-kb SalI-BamHI MYO1 fragment 
from pBS-MYO1 (a gift from E. Bi, University of Pennsylvania, Philadelphia, PA) into 
SalI/BamHI-cut pTSV31A (a 2µ URA3 ADE3 plasmid; M. Tibbetts and J.R. Pringle, 
unpublished results).  Plasmid pGT04 was constructed using two steps of PCR.  In the first 
step, a fragment of IQG1 (nucleotides -262 to +3 relative to the A of the start codon) was 
amplified from genomic DNA with a BamHI site incorporated into the 5' primer and a 3' 
primer that included nucleotides corresponding to positions +127 to +141 of IQG1.  A 
second fragment (nucleotides +127 to +277) was also amplified from genomic DNA using a 
5' primer that included nucleotides corresponding to positions -15 to +3 of IQG1 and a 3' 
primer that included an XbaI site.  In the second step, the PCR products from the first step 
were purified and used as template with the BamHI-site-containing 5' primer and the XbaI-
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site-containing 3' primer.  The resulting product, which contained 262 nucleotides of the 
IQG1 promoter, a start codon, and 151 nucleotides (from +127 to +277) of open-reading-
frame sequence, was cut with BamHI and XbaI, gel-purified, and inserted into BamHI/XbaI-
cut pRS305 (Sikorski and Hieter, 1989).  Plasmids pGAL-IQG1-TAP and pGAL-iqg1Δ42-
TAP were constructed by transforming yeast cells with BamHI/HindIII-cut pRSAB1234 (see 
Supplemental Materials and Methods of Gelperin et al., 2005) with PCR-amplified full-
length or truncated (lacking codons 2-42) IQG1; the amplified fragment contained 22 (5') and 
21 (3') base pairs of flanking vector sequences to allow the in vivo recombination.     
Growth Rates, Cell-Cluster Indices, Colony-Sectoring Assays, and FACS Analysis 
To determine growth rates, exponential-phase cultures (OD600 ≈ 0.4) in YM-P medium were 
diluted two-fold with fresh YM-P, and incubation was continued.  The times needed to return 
to the original OD600 were recorded as the doubling times. 
To determine cell-cluster indices, strains were streaked onto the indicated media, 
grown overnight, scraped from the plates, washed once with water by centrifugation, 
resuspended, sonicated briefly, and observed by DIC microscopy.  Each unbudded (one cell 
body) or budded (two cell bodies) cell was scored as one nonclustered unit, and entities with 
three, four, five, or six-or-more cell bodies were scored as one, two, three, or four clusters, 
respectively.  Each count was continued until the number of clusters plus nonclustered units 
was 100, and the number of clusters was recorded as the cluster index.  To minimize the 
possibility that the cell-cluster index determined for the myo1Δ single mutant would be 
influenced by spontaneously arising suppressors, we examined nine different myo1Δ strains 
that were obtained as segregants from RNY112 and its double-mutant derivatives. 
The colony-sectoring assay was based on that described by Bender and Pringle 
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(1991).  ade2-1 ade3Δ ura3-3 myo1Δ strains carrying a URA3 ADE3 MYO1 plasmid were 
grown on SC-Ura plates, then streaked onto YP or YPGalRaf plates to observe sectoring or 
nonsectoring single colonies.  In some experiments, a LEU2-marked plasmid (empty or 
carrying IQG1 or CYK3) was also present.  In these cases, the strains were first grown on SC-
Ura-Leu plates, then streaked onto SC-Leu plates to observe sectoring or nonsectoring single 
colonies. 
To assess the extent of G2 delay using the fluorescence-activated cell sorter (FACS), 
cells were grown to exponential phase (OD600 ≈ 0.4) in YM-P medium, then collected, fixed, 
stained with SYTOX Green (Invitrogen, Carlsbad, CA), and examined using standard 
procedures (Haase and Reed, 2002). 
Screen for Dosage Suppressors of myo1Δ  
A W303-background myo1Δ haploid strain, RNY798, which contained an ADE3 MYO1 
plasmid and could only form nonsectored viable colonies (see above), was transformed with 
a genomic-DNA library in the low-copy plasmid YCp50-LEU2 (Bi and Pringle, 1996; the 
library was constructed using DNA from an S288C-background strain and was kindly 
provided by F. Spencer and P. Hieter, Johns Hopkins University, Baltimore, MD).  From 
~20,000 transformants screened on SC-Leu plates, 85 reproducibly sectoring transformants 
were identified.  Isolation of plasmids and retransformation of strain RNY798 yielded 14 
plasmids that rescued the lethality of the myo1Δ strain.  Sequencing and subcloning of the 
inserts revealed that nine plasmids contained full-length MYO1 or C-terminal MYO1 
fragments, and that in three other plasmids, the gene responsible for suppression was either 
IQG1 (two cases) or CYK3 (one case).  The suppressing genes in the final two plasmids have 
not yet been identified. 
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Protein Analysis and Ubiquitination Assays 
Iqg1p-3HA levels were determined by Western blotting in both asynchronous and 
synchronous cultures.  For synchronous cultures, the supersensitive bar1Δ (Sprague, 1991) 
strains were grown to exponential phase in SC-His medium, treated for 3 h with 70 ng/ml α-
factor to arrest cells in G1, released from arrest by centrifugation and resuspension in SC-His 
medium, and sampled at 20-min intervals.  At each time point, one sample was taken for 
protein extraction, and a second sample was fixed for 10 min in 70% ethanol at 0˚C, 
resuspended in PBS, stained with DAPI (Sigma-Aldrich), and used to evaluate cell-cycle 
progression by scoring the percentages of large-budded cells with two well separated 
chromosome sets.  To extract proteins, cells were collected by centrifugation, resuspended in 
1.85 M NaOH containing 2% β-mercaptoethanol, and incubated for 10 min at 0˚C.  
Trichloroacetic acid was then added to 50%, and incubation was continued for 15-25 min at 
0˚C.  Insoluble material was collected by centrifugation, mixed with SDS-sample buffer, 
boiled for 5 min, and analyzed on 7% SDS-polyacrylamide gels.  After blotting proteins 
electrophoretically to nitrocellulose transfer membrane (GE Healthcare, Piscataway, NJ), 
Iqg1p-3HA was detected using the rat monoclonal anti-HA antibody 3F10 (Roche Molecular 
Biochemicals, Indianapolis, IN) as primary antibody.  Protein bands were then visualized 
using either mouse anti-rat-IgG secondary antibody (Jackson ImmunoResearch, West Grove, 
PA), alkaline-phosphatase-conjugated goat anti-mouse-IgG tertiary antibody (Sigma-
Aldrich), and the AttoPhos AP fluorescent-substrate system (Promega, Madison, WI) (Figure 
2.6D), or HRP-conjugated goat anti-rat-IgG secondary antibody (GE Healthcare), and the 
ECL chemiluminescence system (GE Healthcare) (Figure 2.7).  Actin was detected using 
either a goat polyclonal anti-actin antibody (Karpova et al., 1993) (Figures 2.6D and 2.7B) or 
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the mouse monoclonal anti-actin antibody MAB1501 (Chemicon, Temecula, CA) (Figure 
2.7A) as primary antibody.  Protein bands were then visualized using alkaline-phosphatase-
conjugated rabbit anti-goat-IgG secondary antibody (Sigma-Aldrich) and the AttoPhos AP 
system (Figure 2.6D), HRP-conjugated donkey anti-goat-IgG secondary antibody (Santa 
Cruz Biotechnology, Santa Cruz, CA) and the ECL system (Figure 2.7B), or alkaline-
phosphatase-conjugated goat anti-mouse-IgG secondary antibody and the AttoPhos AP 
system (Figure 2.7A).  In Figure 6D, the intensities of the protein bands were measured using 
the Storm Scanner Model 840 (GE Healthcare), and the values for Iqg1p-3HA were 
normalized using the actin bands from the same samples. 
Iqg1p-TAP levels were determined by Western blotting using the peroxidase anti-
peroxidase soluble complex produced in rabbit (Sigma-Aldrich, Cat. No. P1291) and the 
SuperSignal West Pico chemiluminescence system (Pierce Biotechnology, Rockford, IL).  
For the experiments of Figure 2.6B and C, cell lysates were prepared as described previously 
(Ostapenko and Solomon, 2005), and Iqg1p-TAP was precipitated from equal amounts of 
lysate by incubation for 90 min at 4°C with IgG-Sepharose (GE Healthcare) in 10 mM Tris-
Cl, pH 7.5, 150 mM NaCl, containing 1% NP-40 and protease inhibitors (10 mg/ml each of 
leupeptin, chymostatin, and pepstatin; all from Chemicon).  Precipitated proteins were 
separated on 10% SDS-PAGE, transferred to Immobilon-P membranes (Millipore, Billerica, 
MA), and detected as described above using an overnight incubation at 4°C in 10 mM Tris-
Cl, pH 7.5, 150 mM NaCl, containing 0.1% Tween-20 and 5% dry milk.  For the experiments 
of Figure 2.9C and D, protein extracts were prepared and analyzed by 10% SDS-PAGE and 
Western blotting as described previously (Ubersax et al., 2003).  Iqg1p-TAP and Iqg1∆42p-
TAP were detected as described above, and Clb2p was detected using a rabbit polyclonal 
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anti-Clb2p primary antibody (Kellogg and Murray, 1995), an HRP-conjugated donkey anti-
rabbit-IgG secondary antibody (GE Healthcare), and the SuperSignal West Pico system.  
To perform ubiquitination assays, reaction components were expressed and purified 
as described previously (Charles et al., 1998; Carroll and Morgan, 2002, 2005).  Substrates 
were produced in rabbit-reticulocyte lysates by coupled transcription and translation in the 
presence of 35S-methionine, following the manufacturer’s instructions (Promega).  Truncated 
IQG1 constructs with a T7 promoter sequence and Kozak site added upstream were made 
using two steps of PCR.  In the first step, the desired IQG1 fragment was PCR-amplified 
using a 5' primer containing a sequence of 23 nucleotides that overlapped the 5' primer used 
in the second step plus 30-37 nucleotides of IQG1 coding sequence beginning with a start 
codon.  The 3' primer contained ~20 nucleotides of coding sequence ending with a stop 
codon.  In the second step, the product from the first step was used as template with the same 
3' primer and a 5' primer of 119 nucleotides that included a T7 promoter and a Kozak site.  
Point mutations were introduced by incorporation into the 5' primer used in the first step.  
Similarly, full-length PDS1 and CYK3 constructs were generated with the T7 promoter 
sequence and Kozak site upstream of the start codons.  Ubiquitination reactions were 
performed and monitored using a Molecular Dynamics PhosphorImager (GE Healthcare) as 
described previously (Carroll and Morgan, 2002, 2005; Carroll et al., 2005). 
Microscopy and Quantitation of GFP Fluorescence 
DIC and fluorescence microscopy were performed using a Nikon (Tokyo, Japan) Eclipse 
E600-FN microscope and an ORCA-2 cooled CCD camera (Hamamatsu Photonic Systems, 
Bridgewater, NJ).  To quantitate Iqg1p-GFP signal intensities, cells were grown to 
exponential phase in SC-His medium, collected by centrifugation, and resuspended in water 
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before observation by DIC and fluorescence microscopy.  The average intensities of the GFP 
signals at the mother-bud neck were determined for each strain using MetaMorph version 5.0 
(Universal Imaging Corporation, Downington, PA); a box of fixed size was drawn to contain 
the neck of each large-budded cell with a detectable signal, and the total fluorescence of the 
boxed area was measured and recorded using the regional-measurement function of 
MetaMorph.
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RESULTS 
Suppression of myo1Δ Phenotypes by APC/C Mutations 
We performed a screen for mutations synthetically lethal with myo1Δ in the S288C strain 
background at 23˚C.  The first several mutants analyzed proved to be temperature sensitive 
for growth (i.e., unable to grow at 37˚C even when the MYO1 plasmid was present), which 
seemed to offer an easy method to clone the genes harboring the synthetic-lethal mutations.  
Using a genomic-DNA library to rescue the temperature sensitivity of one mutant, we 
recovered CDC26, which encodes a subunit of the APC/C that is nonessential at 23˚C but 
essential at 37˚C.  Further investigation revealed that the parental myo1Δ strain used in the 
screen was itself temperature sensitive and harbored a cdc26 mutation [a YJRWdelta11 or 
YJRWdelta13 sequence (338 nucleotides; Saccharomyces Genome Database) inserted at 
nucleotide -7 relative to the start site of the CDC26 ORF] that accounted for the temperature-
sensitive phenotype.  Because myo1Δ strains grow less well than wild type (Rodriguez and 
Paterson, 1990; Bi et al., 1998; Lippincott and Li, 1998) and can accumulate spontaneous 
suppressor mutations (Tolliday et al., 2003), this suggested that the cdc26 mutation might 
have been selected because it alleviated the phenotype of the original myo1 mutant.  Indeed, 
when we intentionally introduced mutations of CDC26 or other nonessential APC/C subunits 
into freshly prepared myo1Δ strains, we found that these mutations could suppress both the 
clustering and slow-growth phenotypes in the S288C background (Figure 2.1) and the lethal 
phenotype (Tolliday et al., 2003; Nishihama et al., 2007) in the W303 background (Figure 
2.2).  Similar results were obtained with mutations of CDH1, the APC/C activator for exit 
from mitosis (Figures 2.1B and C; Figure 2A).  In contrast, mutation of PDS1, which 
encodes securin, the APC/C target whose degradation triggers anaphase onset, did not alter 
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the phenotypes in either background (Figures 2.1B and C; Figure 2.2A).  Taken together, 
these results suggested that APC/C mutations do not suppress myo1Δ phenotypes by 
affecting the timing of anaphase. 
Lack of myo1Δ Suppression by Delayed Mitotic Exit 
It also seemed possible that APC/C mutations might suppress myo1Δ phenotypes by delaying 
mitotic exit and thus allowing more time for an inefficient process of cytokinesis to be 
completed successfully.  To explore this possibility, we first introduced a deletion of NET1 
into an S288C-background strain that was heterozygous for a myo1Δ mutation.  Because 
NET1 encodes an inhibitor of Cdc14p, which activates the APC/C for mitotic exit, it seemed 
possible that a net1 mutation might exacerbate the myo1Δ phenotypes by accelerating mitotic 
exit.  Indeed, the doubly heterozygous diploid yielded only synthetic-lethal or synthetic-sick 
myo1Δ net1Δ double-mutant segregants (Figure 2.3A), and the poor viability was suppressed 
by deletion of a nonessential APC/C subunit (Figure 2.3B).  These data were consistent with 
the hypothesis that APC/C mutations might suppress the myo1Δ phenotypes by delaying 
mitotic exit.  However, this hypothesis was difficult to reconcile with the observation that 
mutation of MND2, which appears to have little effect on mitotic exit (Oelschlaegel et al., 
2005; Page et al., 2005), suppressed the myo1Δ phenotypes as effectively as did mutations of 
other APC/C subunits (Figure 2.1B and C; Figure 2.2A). 
To explore this matter further, we wanted to delay mitotic exit by means independent 
of effects on the APC/C.  To this end, we constructed strains in both backgrounds in which 
the nondegradable mitotic cyclin Clb2pΔDB (Amon et al., 1994) is expressed from the 
inducible GAL1 promoter.  FACS analysis on asynchronous cultures showed that in glucose 
medium, APC/C-mutant strains showed a higher ratio of G2/M cells to G1 cells than did 
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wild-type strains (Figure 2.4A and B, panels 1 and 4), indicating a delay in mitotic exit in the 
APC/C mutants.  A shift to galactose medium produced a modest decrease in the G2/M-to-
G1 ratio in these strains (Figure 2.4A and B, panels 2, 3, 5, and 6), presumably reflecting a 
delay in cell-cycle initiation on the poorer carbon source (Pringle and Hartwell, 1981).  In 
contrast, the PGAL-clb2ΔDB strains showed no accumulation of G2/M cells on glucose 
medium (Figure 2.4A and B, panels 7) but, as expected, showed a significant accumulation 
of such cells when production of Clb2pΔDB was induced by growth in galactose medium 
(Figure 2.4A and B, panels 8 and 9).  The apparent delay in mitotic exit was similar to 
(W303 background) or greater than (S288C background) the delay produced by APC/C 
mutations.  However, in contrast to APC/C mutations, induction of Clb2pΔDB produced 
little or no suppression of either the myo1Δ clustering phenotype in the S288C background 
(Figure 2.4C) or the myo1Δ lethal phenotype in the W303 background (Figure 2.4D and E).  
Thus, neither reduced degradation of the APC/CCdh1 target Clb2p nor the resulting delay in 
mitotic exit appears to suppress myo1Δ phenotypes.  These results suggested that some other 
APC/C target(s) and/or pathway(s) might be involved in the suppression. 
Suppression of myo1Δ  Phenotypes by Overexpression of Iqg1p or Cyk3p 
In parallel with the synthetic-lethal screen, we also screened for dosage suppressors of 
myo1Δ lethality in the W303 background (see Materials and Methods).  From this screen, 
low-copy plasmids carrying IQG1 and CYK3 were isolated.  Further investigation showed 
that both low-copy and high-copy IQG1 and CYK3 plasmids could indeed suppress myo1Δ 
inviability in the W303 background, as judged by tests either of spore viability (Figure 2.5A) 
or of the ability of vegetative myo1Δ cells to lose a MYO1 plasmid (Figure 2.5B).  
Sequencing of both genes in the W303 background revealed no mutations (Nishihama et al., 
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2007), suggesting that the suppression of myo1Δ lethality was due simply to increased 
amounts of one or the other wild-type protein.  In further support of this hypothesis, either 
low-copy or high-copy plasmids containing either IQG1 or CYK3 could also suppress the 
clustering phenotype of the myo1Δ mutant in the S288C background (Figure 2.5C).  These 
results suggested that Iqg1p, Cyk3p, or both might be a previously unrecognized target(s) of 
the APC/C, so that APC/C mutations would suppress myo1Δ phenotypes by increasing the 
amount of that protein(s). 
Role of APC/C in the Post-Mitotic Degradation of Iqg1p 
To ask if Iqg1p or Cyk3p might be a target of the APC/C, we first searched their sequences 
for the known APC/C-recognition motifs called the destruction box (DB) (King et al., 1995; 
Burton and Solomon, 2001; Burton et al., 2005), KEN box (Pfleger and Kirschner, 2000), A 
box (Littlepage and Ruderman, 2002), and GxEN motif (Castro et al., 2003).  No such 
sequences were found in Cyk3p, but two possible DBs, a possible KEN box, and a GKEN 
sequence (a possible KEN box or GxEN motif) were found in Iqg1p (Figure 2.6A).  Thus, we 
focused on this protein.  Wild-type cells arrested in G1 phase had significantly lower levels 
of Iqg1p and a significantly higher rate of Iqg1p turnover than cells arrested in M phase 
(Figure 2.6B; Figure 2.6C, top two panels), suggesting that the APC/C might target Iqg1p for 
degradation at the end of mitosis, as it does other proteins.  Consistent with this hypothesis, 
we found that Iqg1p levels were significantly elevated in asynchronous populations of 
APC/C-mutant cells (Figure 2.6D) and that the rapid rate of Iqg1p degradation in G1 cells 
was eliminated in APC/C mutants (Figure 2.6C, bottom two panels).  Moreover, in 
synchronous cultures, Iqg1p levels were found to increase before mitosis and drop 
precipitously after mitosis in wild-type cells (Figure 2.7A and B, left panels), and the post-
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mitotic decrease was largely eliminated in an APC/C mutant (Figure 2.7A and B, right 
panels). 
 Finally, we also examined cells expressing Iqg1p-GFP from the chromosomal IQG1 
promoter.  As reported previously (Epp and Chant, 1997; Shannon and Li, 1999), Iqg1p 
localized to a ring at the mother-bud neck in medium-budded and large-budded wild-type 
cells.  However, the neck signal was rather weak (Figure 2.8A) and was observed in only 
~50% of the medium-budded and large-budded cells.  Moreover, the Iqg1p-GFP did not 
appear to persist through cell division, because signal was never observed in unbudded cells 
(Figure 2.8B, left panel).  In contrast, in APC/C mutants, Iqg1p-GFP signal was observed at 
the neck in a higher percentage (~80%) of medium-budded and large-budded cells and was 
significantly brighter there (Figure 2.8A).  Moreover, Iqg1p-GFP appeared to persist through 
cell division in at least some cells, because patches of signal were sometimes observed in 
unbudded cells (Figure 2.8B, right panel). 
 Taken together, the results strongly suggest that Iqg1p is degraded in a cell-cycle-
dependent manner that depends, directly or indirectly, on the APC/C.   
Ubiquitination of Iqg1p by the APC/C and Identification of a Novel APC/C-Recognition 
Motif 
To ask if Iqg1p is a direct target of the APC/C, in vitro ubiquitination assays were performed 
using various fragments of Iqg1p and wild-type APC/C with its activator Cdh1p.  Under 
conditions in which the well characterized APC/C substrate Pds1p was ubiquitinated 
effectively (Figure 2.9A, lanes 1 and 2), Iqg1p(1-750) and Iqg1p(33-250) were ubiquitinated 
in an APC/C-dependent manner (Figure 2.9A, lanes 3 and 4; Figure 2.9B, lanes 1 and 2), 
whereas Iqg1p(43-750), Iqg1p(400-1100), and Iqg1p(741-1495) were not (Figure 2.9A, lanes 
5-10).  These data indicated that Iqg1p is indeed a direct target of the APC/C and that a 
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recognition sequence between amino acids 1 and 42 is required for this ubiquitination.  
Although this region contains no clear DB or other known APC/C-recognition sequence (see 
above), amino acids 34-42 have some resemblance (RxxxxxxxN) to previously characterized 
DBs (RxxLxxxxN/D/E), and mutating residues within this sequence reduced (single 
substitutions:  Figure 2.9B, lanes 3-10) or eliminated (multiple substitutions:  Figure 2.9B, 
lanes 11-14) APC/CCdh1-dependent ubiquitination. 
 We also performed similar experiments using full-length Cyk3p.  However, 
consistent with the lack of recognizable APC/C-recognition sequences in this protein, no 
ubiquitination was detected (data not shown). 
 To ask if the apparent APC/CCdh1-recognition sequence in Iqg1p is also important for 
its turnover in vivo, we compared the stabilities of full-length Iqg1p and Iqg1p(43-1495) in 
both the W303 and S288C strain backgrounds.  As expected, the truncated protein was 
substantially more stable both during prolonged arrest in G1 (Figure 2.9C) and at the end of 
mitosis in a synchronized population (Figure 2.9D). 
Suppression of myo1Δ Phenotypes by Nondegradable Iqg1p 
The data presented above suggest that the elevated levels of Iqg1p resulting from APC/C 
mutations might explain the suppression of myo1Δ phenotypes by such mutations.  In this 
case, synthesis at normal levels of a nondegradable Iqg1p should also be able to suppress 
myo1Δ phenotypes.  In agreement with this prediction, we found that expression of Iqg1p(43-
1495) from the chromosomal IQG1 promoter could suppress both the myo1Δ lethality in the 
W303 background (Figure 2.10A) and the myo1Δ clustering phenotype in the S288C 
background (Figure 2.10B).  Somewhat surprisingly, segregants expressing the 
nondegradable Iqg1p in an otherwise wild-type background showed little or no defect in 
  31 
growth rate (Figure 2.10A).  However, overexpression of the nondegradable Iqg1p from a 
GAL promoter did cause severe growth defects (data not shown). 
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DISCUSSION 
Suppression of Actomyosin-ring Defects by APC/C Mutations 
The actomyosin contractile ring is involved in cytokinesis in most if not all animal and 
fungal cells.  Nonetheless, it has recently become clear that this structure is dispensable for 
cytokinesis in a variety of cell types (see Introduction), indicating that actomyosin-ring-
independent mechanisms are critical, and in some cases sufficient, for cytokinesis.  In an 
attempt to elucidate these mechanisms, we are performing genetic studies in S. cerevisiae.  In 
this organism, the phenotypes associated with loss of the actomyosin ring (due to deletion of 
the myosin II gene MYO1) vary greatly in severity depending on the strain background, 
presumably due to differences among the strains in the efficiency of the actomyosin-ring-
independent mechanisms, as discussed in more detail elsewhere (Nishihama et al., 2007).   
 During our studies, we made the surprising observation that mutations in genes 
encoding nonessential subunits of the APC/C could suppress both the lethal phenotype of 
myo1Δ in the W303 strain background and the slow-growth and delayed-cell-separation 
phenotypes of myo1Δ in the S288C strain background.  Initially it seemed likely that this 
suppression might result simply from changes in the timing of late-cell-cycle events; for 
example, a delay in mitotic exit due to APC/C malfunction might allow more time for an 
inefficient process of cytokinesis to be completed successfully.  However, several lines of 
evidence (the suppression by cdh1 and mnd2 mutations; the lack of effect of a pds1 mutation 
or of expression of a nondegradable Clb2p; see Results for details) suggested strongly that 
the suppression is not due to changes in the timing of either anaphase or mitotic exit, and 
hence that it is likely to involve some novel APC/C target(s) and/or pathway(s).  Indeed, 
there is now good evidence that suppression occurs because the APC/C defects result in an 
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increased abundance of Iqg1p, a novel APC/CCdh1 target that is important in actomyosin-ring-
independent cytokinesis, as discussed further below. 
 This model provides a plausible explanation for why a net1 mutation exacerbates the 
phenotype of myo1Δ in the S288C strain background.  We initially interpreted this 
observation in terms of effects on the timing of late-cell-cycle events, reasoning that an 
acceleration of mitotic exit could provide insufficient time for an inefficient cytokinesis 
process to be completed.  However, it now seems more likely that premature activation of 
Cdc14p resulting from the absence of Net1p leads to premature activation of Cdh1p, and thus 
targeting of Iqg1p for destruction by APC/CCdh1 before its role in cytokinesis can be 
completed.  Of course, the effects of net1 mutations could also be more complex. 
Identification of Iqg1p as an APC/C target 
In a dosage-suppressor screen, we observed that even low-copy plasmids containing IQG1 or 
CYK3 could suppress the myo1Δ phenotypes in both the S288C and W303 genetic 
backgrounds.  These observations suggested that Iqg1p, Cyk3p, or both might be previously 
unidentified targets of APC/C.  Thus, mutations that compromised APC/C function might 
allow the intracellular concentrations of Iqg1p, Cyk3p, or both to rise to levels that could 
suppress the myo1Δ phenotypes [by mechanisms that we consider in more detail elsewhere 
(Nishihama et al. (2007)].  Although it remains possible that Cyk3p is an APC/C target, there 
is as yet no evidence to support this possibility: Cyk3p contains no recognizable APC/C 
recognition sequences, and we failed to detect ubiquitination in vitro by APC/CCdh1.  In 
contrast, a variety of in vivo and in vitro experiments indicate that Iqg1p is a target of 
APC/CCdh1.  First, in wild-type cells, both the levels of Iqg1p and the rates of Iqg1p 
degradation fluctuate during the cell cycle in a manner consistent with APC/C-triggered 
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degradation at the end of mitosis.  Second, in APC/C (including cdh1) mutants, the rates of 
Iqg1p degradation are drastically reduced; correspondingly, Iqg1p is present at higher levels 
and persists abnormally through cell division.  Finally, in vitro assays showed that Iqg1p can 
be ubiquitinated directly by APC/CCdh1.  The observation that the myo1Δ phenotypes can be 
suppressed by expression of a stabilized Iqg1p (lacking the APC/CCdh1 recognition site) from 
the chromosomal IQG1 promoter provides strong support for the hypothesis that the 
suppression by APC/C mutations indeed results from the elevated and more persistent levels 
of Iqg1p in the mutant strains. 
 Interestingly, recognition of Iqg1p by APC/CCdh1 does not appear to depend on any of 
the sequences that correspond to previously characterized APC/C-recognition motifs.  
Instead, the ubiquitination of Iqg1p depends on a novel sequence (33-LRPQSSSKIN-42) 
near the N-terminus that is similar but not identical to the consensus DB [RxxLxxxxN/D/E: 
Burton and Solomon, 2001] and KEN-box (KENxxxN/D: Pfleger and Kirschner, 2000) 
motifs.  Further dissection of the amino acids important for recognition of this site by the 
APC/C should shed light on the mechanisms of APC/C-target interaction.  In the meantime, 
the results highlight the dangers of attempting to identify APC/C targets solely on the basis 
of the known recognition motifs. 
 Another interesting conclusion from this study concerns the role of Mnd2p.  Although 
this APC/C subunit appears to have little or no role in mitotic control (Oelschlaegel et al., 
2005; Page et al., 2005), we found that an mnd2 mutation suppressed the myo1Δ phenotypes 
as strongly as did other APC/C mutations.  This apparent discrepancy might be explained if 
there are specific roles of particular APC/C subunits in the interactions with different specific 
APC/C targets.  However, it also seems possible that the explanation simply involves 
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differential strengths of the interactions of the APC/C with different targets.  In particular, 
because the APC/C roles in anaphase promotion and mitotic exit are essential for cell 
survival, the interactions with the relevant targets might be stronger than the interactions with 
a target like Iqg1p whose APC/C-mediated degradation is not essential for cell survival.  
Thus, the loss of an accessory subunit like Mnd2p might have little effect on the strong 
interactions but a major effect on the weak interactions.  An attraction of this model is that it 
may also explain why mutating any of the nonessential APC/C subunits has essentially the 
same effect on suppression of the myo1Δ phenotypes, even though each subunit appears to 
have a distinct role in APC/C function (Carroll and Morgan, 2002; Passmore et al., 2003; 
Schwickart et al., 2004; Carroll et al., 2005; Page et al., 2005). 
Significance of Timely APC/C-mediated Degradation of Iqg1p 
An interesting and unresolved question is the role of the APC/C-dependent proteolysis of 
Iqg1p, a question that is highlighted by the observation that expression at endogenous levels 
of a nondegradable Iqg1p has little effect on cell growth.  One possible answer involves the 
multiple roles of the myosin light chain Mlc1p.  Recent studies have shown that S. cerevisiae 
cells are highly sensitive to the cellular levels of this protein, which is a light chain for Iqg1p, 
Myo1p, and the type V myosin Myo2p, and that the Mlc1p-Myo2p interaction is critical for 
septum formation, cell separation, and new bud formation (Luo et al., 2004).  Thus, 
heterozygous mlc1Δ diploid cells display haploinsufficiency that can be suppressed by 
reduced the copy number of MYO2 (Stevens and Davis, 1998), and overexpression of a 
Myo1p C-terminal tail (containing the Mlc1p-binding IQ motifs) leads to cytokinetic defects 
that can be alleviated by overexpression of Mlc1p (Tolliday et al., 2003).  In addition, our 
own recent studies have shown that overexpression of Iqg1p from a high-copy plasmid with 
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its normal promoter in wild-type cells can cause multi-cellular clustering (Nishihama et al., 
2007).  Finally, high levels of overexpression of the nondegradable Iqg1p from a high-copy 
plasmid with the GAL promoter appear to cause severe cytokinetic defects.  Taken together, 
these results suggest that the association of Mlc1p with each binding partner may need to be 
fine-tuned temporally and that the timely APC/C-mediated degradation of Iqg1p may be 
important to release Mlc1p particularly for interaction with Myo2p. 
Possible Conserved Regulation of IQGAPs by the APC/C 
Iqg1p is the only known member of the conserved IQGAP family in S. cerevisiae (Brown 
and Sacks, 2006), and because IQGAPs and the APC/C are both conserved, it is possible that 
other IQGAPs are also regulated by the APC/C.  This hypothesis is particularly attractive for 
Rng2p in S. pombe and IQGAP1 in mammalian cells, because these proteins are also 
involved in cytokinesis (Eng et al., 1998; Wu et al., 2003; Skop et al., 2004).  However, 
although each protein has a single DB consensus sequence, neither Rng2p nor IQGAP1 has a 
sequence corresponding to the novel APC/C-recognition motif identified in Iqg1p.  Thus, the 
possible regulation of these proteins by the APC/C will require further investigation. 
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Figure 2.3.  Figure 3 of Chapter 2 
 
 
  40 
Figure 2.4.  Figure 4 of Chapter 2 
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Figure 2.5.  Figure 5 of Chapter 2 
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Figure 2.6.  Figure 6 of Chapter 2 
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Figure 2.7.  Figure 7 of Chapter 2 
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FIGURE LEGENDS (1 to 10) 
Figure 2.1.  Suppression of myo1Δ clustering and slow-growth phenotypes by APC/C 
mutations in the S288C strain background.  (A) Presence of multi-cell clusters in a myo1Δ 
strain but not in a congenic wild type (WT).  Strains YEF473A and KO608 were grown 
overnight on YP plates and observed by DIC microscopy as described in Materials and 
Methods.  (B) Suppression of clustering phenotype.  Strains were grown as in A, and 
clustering was scored as described in Materials and Methods.  Strains were YEF473A, 
KO608 and related strains (for myo1Δ; see Materials and Methods), KO397, KO421, KO401, 
KO405, KO415, KO257, and KO139.  Values shown are the means of three to nine counts 
except for myo1Δ (mean of 25 counts); standard deviations are also indicated. (C) 
Suppression of slow-growth phenotype.  Strains were the same as in B.  The doubling times 
shown are the averages of two measurements made as described in Materials and Methods. 
 
Figure 2.2.  Suppression of myo1Δ lethality by APC/C mutations in the W303 strain 
background.  (A) Suppression of spore lethality.  Tetrads were dissected from strains 
heterozygous for myo1Δ::kanMX6 or for both myo1Δ::kanMX6 and an APC/C or pds1 
mutation marked by TRP1.  All viable myo1Δ segregants (scored by growth on YP+G418) 
also carried an APC/C mutation (scored by growth on SC-Trp).  The strains analyzed were 
RNY509, KO213, KO216, KO346, KO351, KO354, and KO246.  (B) Demonstration of 
suppression by a colony-sectoring assay.  Strain RNY798 (myo1Δ ade2 ade3; MYO1 ADE3 
plasmid) and its apc9Δ derivative KO313 were streaked onto YP plates.  Only strain KO313 
could form viable subclones (sectors) that had lost the plasmid and thus were white due to the 
loss of Ade3p activity.  
 
Figure 2.3.  Synthetic lethality between myo1Δ and net1Δ in the S288C background and its 
suppression by an APC/C mutation.  (A) Tetrads were dissected from a strain (KO199) 
heterozygous for the unlinked mutations myo1Δ::kanMX6 and net1Δ::TRP1.  Most tetrads, 
like the six shown here, yielded no viable double-mutant spores.  In 18 additional tetrads, 
only two viable spores were recovered that carried both mutations and thus grew, albeit very 
slowly, on both YP+G418 and SC-Trp plates.  (B) Tetrads were dissected from a strain 
(KO275) heterozygous for myo1Δ::kanMX6, net1Δ::TRP1, and apc9Δ::His3MX6.  In 54 
tetrads dissected, 24 viable segregants were recovered that carried both myo1Δ and net1Δ 
(see examples in circles); 20 of these also carried apc9Δ (as shown by growth on SC-His 
plates), and the other four grew very slowly. 
 
Figure 2.4.  Lack of myo1Δ suppression by expression of a nondegradable mitotic cyclin.  
All galactose media also contained 1% raffinose.  (A and B) Delayed mitotic exit produced 
by APC/C mutations or by expression of a nondegradable cyclin.  (A) S288C-background 
strains KO492, KO399, and KO494 were grown to exponential phase in YM-P medium 
containing glucose or galactose, as indicated, and FACS analysis was performed as described 
in Materials and Methods.  (B) W303-background strains KO372, KO529, and KO369 were 
grown and analyzed as described for panel A.  (C-E) Lack of suppression of myo1Δ 
phenotypes.  (C) Clustering phenotype in the S288C background.  Strains YEF473A, KO608, 
and KO570 were grown overnight on YP plates containing the indicated sugars, and 
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clustering was scored as described in Materials and Methods.  Values shown are the means of 
three to five counts; standard deviations are also indicated.  (D and E) Lethal phenotype in 
the W303 background.  (D) Three sets of tetrads from strain KO336 [myo1Δ::kanMX6/+ and 
heterozygous for PGAL-clb2ΔDB:LEU2 (see Table 2.1)] were dissected (top panel) on YP + 
2% glucose (tetrads 1-5), YP + 0.5% galactose (tetrads 6-10), or YP + 2.0% galactose 
(tetrads 11-15).  Tetrads were then replica-plated to YP plates containing the indicated sugars 
plus G418 (to identify any segregants carrying myo1Δ) and to SC-Leu plates containing the 
indicated sugars (to identify segregants carrying PGAL-clb2ΔDB).  No viable myo1Δ 
segregants were observed in 24 tetrads dissected on 0.5% galactose and 18 tetrads dissected 
on 2% galactose.  (E) Strain KO360 was streaked onto YP plates containing the indicated 
sugars.  The absence of white sectors (none were observed in >300 colonies observed) 
indicates an inability to form viable subclones that have lost the MYO1 ADE3 plasmid even 
when Clb2pΔDB is expressed. 
 
Figure 2.5.  Suppression of myo1Δ phenotypes by overexpression of IQG1 or CYK3.  The 
genes were carried on LEU2-marked low-copy (pRS315-based) or high-copy (pRS425- or 
YEplac181-based) plasmids.  (A and B) Suppression of myo1Δ lethality in the W303 
background.  (A) Suppression of spore inviability.  Tetrads were dissected from strain 
RNY509 (myo1Δ::kanMX6/+) carrying either an empty vector (top two rows) or an IQG1 or 
CYK3 plasmid (bottom four rows).  With the empty vectors, no viable myo1Δ segregants 
were observed in 43 tetrads dissected (or in 67 tetrads of strain RNY509 dissected in the 
absence of a plasmid).  With the IQG1 and CYK3 plasmids, 34 viable myo1Δ segregants 
(scored by growth on YP+G418) were observed in 168 tetrads dissected; all such segregants 
also carried an IQG1 or CYK3 plasmid (scored by growth on SC-Leu).  (B) Suppression 
demonstrated by a colony-sectoring assay.  Strain RNY798 (myo1Δ ade2 ade3; MYO1 ADE3 
plasmid) was transformed with the indicated plasmids and streaked onto SC-Leu plates.  
Only transformants carrying an IQG1 or CYK3 plasmid could form viable subclones (sectors) 
that had lost the MYO1 ADE3 plasmid and thus were white due to the loss of Ade3p activity.  
(C) Suppression of clustering phenotype in the S288C background.  Strains RNY1006, 
RNY1007, RNY1001, RNY1002, RNY1003, and RNY1004 were grown overnight on SC-
Leu plates, and clustering was scored as described in Materials and Methods.  Values shown 
are the means of three counts; standard deviations are also indicated. 
 
Figure 2.6.  Increased Iqg1p levels in M-phase cells and in APC/C mutants.  All strains 
expressed either Iqg1p-TAP or Iqg1p-3HA from the chromosomal IQG1 promoter.  (A) 
Domain structure of Iqg1p.  CH, calponin-homology domain; DB1 (191RFELQDLYN199) 
and DB2 (276RSGLIKDFN284) (black lines), putative destruction-box sequences; KEN 
(600-602) (black line), putative KEN-box; GKEN (627-630) (black line), putative KEN-box 
or GxEN motif; IQ, IQ repeats; GRD, GAP-related domain.  (B) Cell-cycle dependence of 
Iqg1p levels.  Strains BY4741 (lane 1; untagged control) and IQG1-TAP (lanes 2 and 3) were 
grown to exponential phase in YP medium at 30˚C, and strain IQG1-TAP was then treated 
for 2 h either with 100 ng/ml α-factor or with 50 µg/ml benomyl to arrest cells in G1 or M 
phase.  Proteins were then extracted, precipitated, and analyzed by SDS-PAGE and Western 
blotting as described in Materials and Methods.  (C) Regulation of Iqg1p degradation by 
APC/CCdh1.  Strains DOY138, DOY139, DOY140, and DOY141 were grown to exponential 
phase in YP medium.  Strains DOY138 (top panel) and DOY139 (third panel) were then 
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treated for 2 h with 100 ng/ml α-factor to arrest cells in G1 phase; the last 30 min of this 
incubation was at 37˚C in order to inactivate the temperature-sensitive APC/C subunit 
Cdc23-1p in DOY139 while providing an appropriate control.  Strain DOY140 (second 
panel) was arrested in M phase by shifting to YP medium containing 2% galactose + 2% 
raffinose for 2 h at 30˚C to induce expression of the nondegradable Pds1pmdb.  Strain 
DOY141 (bottom panel) was arrested in G1 phase by shifting to 37˚C for 2 h to inactivate 
Cdc28-13p.  After these incubations, translation in all four strains was blocked by addition of 
50 µg/ml cycloheximide.  Samples were taken at the time of cycloheximide addition and at 
10-min intervals thereafter, and proteins were extracted and analyzed as described in panel B.  
The blot in the top panel was exposed ~10 times longer than the others in order to allow 
visualization of the much lower amount (cf. panel B) of Iqg1p-TAP in the wild-type G1 cells 
at time 0.  (D) Increased Iqg1p levels in APC/C-mutant strains.  Strains KO474, KO470, 
KO460, and KO465 (left four lanes) are in the S288C background; strains KO490, KO486, 
KO477, and KO482 (right four lanes) are in the W303 background.  Each strain was grown 
to exponential phase in SC-His medium, and proteins were extracted and analyzed by SDS-
PAGE, Western blotting, and quantitation as described in Materials and Methods.  Iqg1p-
3HA levels are expressed relative to those in the appropriate wild type, using the actin band 
for normalization. 
 
Figure 2.7.  Cell-cycle regulation of Iqg1p levels and the effect of APC/C mutations on this 
regulation.  All strains expressed Iqg1p-3HA from the chromosomal IQG1 promoter.  Strains 
were grown, synchronized in G1 by treating with α-factor, and sampled as described in 
Materials and Methods.  Iqg1p-3HA levels were assessed as described in Figure 2.6D (but 
without quantitation in this case), and the percentages of anaphase cells were assessed by 
DAPI staining as described in Materials and Methods.  (A) S288C-background strains 
KO672 and KO671. (B) W303-background strains KO589 and KO588.  
 
Figure 2.8.  Stronger (A) and more persistent (B) Iqg1p-GFP signal in APC/C mutants.  
Strains KO566 (wild type), KO563 (doc1Δ), and KO625 (swm1Δ) are in the S288C 
background and express Iqg1p-GFP from the chromosomal IQG1 promoter.  Cells were 
grown and observed as described in Materials and Methods.  (A) For each strain, all medium- 
and large-budded cells with detectable Iqg1p-GFP signal at the mother-bud neck were 
imaged using identical exposure times (4 sec) and scaling factors.  Representative images are 
shown together with a histogram of average signal intensities (determined as described in 
Materials and Methods) for 80-100 of the imaged cells of each strain; standard errors of the 
mean are also indicated.  (B) Unbudded cells of strains KO566 and KO563 were imaged 
using identical exposure times (4 sec) and scaling factors.  Representative fluorescence 
images are shown. 
 
Figure 2.9.  Ubiquitination of Iqg1p by APC/CCdh1 and identification of a novel APC/CCdh1-
recognition motif.  (A and B) Ubiquitination of Iqg1p in vitro and its dependence on Iqg1p 
residues 33-42.  Full-length Pds1p and various Iqg1p fragments (as indicated) were 
synthesized in vitro and incubated with E2-methyl-ubiquitin and purified APC/CCdh1 as 
described in Materials and Methods.  Proteins were then separated by SDS-PAGE and 
visualized using a PhosphorImager.  The slower-migrating proteins seen in the presence of 
APC/CCdh1 (lanes A2, A4, B2, B4, B6, B8, and B10) are Pds1p or Iqg1p ubiquitination 
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products.  In B, the point mutations introduced into Iqg1p(33-250) are indicated (see 
Materials and Methods); 3A denotes the triple mutation R34A,S37A,N42A, and 4A denotes 
the quadruple mutation R34A,S37A,K40A,N42A.  (C and D) Dependence of Iqg1p turnover 
in vivo on the N-terminal APC/CCdh1-recognition sequence.  (C) Strains GT24 (pGAL-IQG1-
TAP) and GT70 (pGAL-iqg1Δ42-TAP) were grown to exponential phase in YP medium 
containing 2% raffinose as sole carbon source and arrested in G1 phase by treatment with 1 
µg/ml  α-factor for 4 h.  Galactose (2%) was then added to induce Iqg1p-TAP or Iqg1Δ42p-
TAP for 1 h, after which glucose (2%) and cycloheximide (100 µg/ml) were added to block 
both transcription and translation of the IQG1 constructs.  Samples were taken at the time of 
glucose and cycloheximide addition and at intervals thereafter, and Iqg1p-TAP was extracted 
and analyzed by Western blotting as described in Materials and Methods.  (D) Strains IQG1-
TAP (IQG1-TAP) and GT124 (iqg1Δ42-TAP) were grown to exponential phase in YP 
medium at 30°C, arrested in G1 phase by treatment with 10 µg/ml α-factor for 4 h, and 
released from the arrest by washing once and resuspending in fresh YP medium.  When 90% 
of the cells had budded, 10 µg/ml α-factor was added again to prevent the initiation of new 
cell cycles.  Samples were taken at the time of release from α-factor arrest and at intervals 
thereafter, and proteins (including Clb2p as a control) were analyzed by Western blotting as 
described in Materials and Methods. 
 
Figure 2.10.  Suppression of myo1Δ phenotypes by expression of a nondegradable Iqg1p at 
endogenous levels.  (A) Suppression of myo1Δ lethality in the W303 background.  Tetrads 
were dissected from two strains (KO1228 and KO1229) that are heterozygous for both 
myo1Δ::kanMX6 and iqg1Δ42:LEU2.  From 44 tetrads dissected, 34 viable myo1Δ 
segregants were recovered, as shown by growth on YP+G418; each of these also carried 
iqg1Δ42, as shown by growth on SC-Leu.  (B) Suppression of clustering phenotype in the 
S288C background.  Strains YEF473A, KO1248, and KO1249 were grown overnight on YP 
plates and clustering was scored as described in Materials and Methods. 
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Table 2.1.  Strain List of Chapter 2 
 
 
Strain a,b Genotype       Source 
 
 
YEF473 a a/α his3-Δ200/his3-Δ200 leu2-Δ1/leu2-Δ1 lys2-801/ Bi and 
lys2-801 trp1-Δ63/trp1-Δ63 ura3-52/ura3-52  Pringle, 1996 
YEF473A a a his3-Δ200 leu2-Δ1 lys2-801 trp1-Δ63 ura3-52  Segregant 
          from YEF473  
YEF473B a α his3-Δ200 leu2-Δ1 lys2-801 trp1-Δ63 ura3-52  Segregant 
          from YEF473 
BY4741 a,c a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0    Brachmann et  
          al., 1998 
IQG1-TAP a as BY4741 except IQG1-TAP:His3MX6   Ghaemmaghami
          et al., 2003 
W1588-4C b a ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 Zhao et al.,  
          1998 
JMY314.1 α ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 T. Petes  
     -4b b 
AFS92 b as W1588-4C except bar1Δ     Jaspersen et  
          al., 1998 
DOY138 b as W1588-4C except bar1Δ IQG1-TAP:His3MX6  This study d 
DOY139 b as W1588-4C except bar1Δ cdc23-1:URA3    This study d 
  IQG1-TAP:His3MX6 
DOY140 b as W1588-4C except bar1Δ IQG1-TAP:His3MX6  This study d 
  leu2-3,112:PGAL-pds1-mdb:LEU2   
DOY141 b as W1588-4C except cdc28-13:TRP1 cdh1Δ::LEU2  This study d 
  IQG1-TAP:His3MX6 
GT24 b  as W1588-4C except bar1Δ [pGAL-IQG1-TAP]  This study e 
GT70 b as W1588-4C except bar1Δ [pGAL-iqg1Δ42-TAP]  This study e 
GT112 b as W1588-4C except bar1Δ MYO1-GFP:His3MX6  This study f 
  iqg1Δ42:LEU2 
GT124 a as BY4741 except iqg1Δ42-TAP:His3MX6:LEU2  This study g 
RNY112 a as YEF473 except myo1Δ::kanMX6/+   Nishihama et 
al., 2007  
RNY501 b a/α ade2-1/ade2-1 can1-100/can1-100 his3-11,15/  W1588-4C X 
his3-11,15 leu2-3,112/leu2-3,112 trp1-1/trp1-1  JMY314.1-4b 
  ura3-1/ura3-1       
RNY509 b as RNY501 except myo1Δ::kanMX6/+   Nishihama et 
al., 2007 
RNY798 b as W1588-4C except myo1Δ::kanMX6 ade3Δ::His3MX6 This study h 
  [pTSV31A-MYO1] 
RNY1001 a as YEF473B except myo1Δ::kanMX6 [pRS315-IQG1] This study i 
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RNY1002 a as YEF473B except myo1Δ::kanMX6 [YEp181-IQG1] This study i 
RNY1003 a as YEF473B except myo1Δ::kanMX6 [pRS315-CYK3] This study i 
RNY1004 a as YEF473B except myo1Δ::kanMX6 [pRS425-CYK3] This study i 
RNY1006 a as YEF473B except myo1Δ::kanMX6 [pRS315]  This study i 
RNY1007 a as YEF473B except myo1Δ::kanMX6 [pRS425]  This study i 
KO139 a as YEF473A except myo1Δ::kanMX6 pds1Δ::TRP1  This study j 
KO199 a as YEF473 except myo1Δ::kanMX6/+ net1Δ::TRP1/+ This study j 
KO213 b as RNY501 except myo1Δ::kanMX6/+ cdc26Δ::TRP1/+ This study j  
KO216 b as RNY501 except myo1Δ::kanMX6/+ apc9Δ::TRP1/+ This study j  
KO246 b as RNY501 except myo1Δ::kanMX6/+ pds1Δ::TRP1/+ This study j 
KO257 a as YEF473A except myo1Δ::kanMX6 cdh1Δ::TRP1  This study j 
KO275 a as YEF473 except myo1Δ::kanMX6/+ net1Δ::TRP1/+ This study k 
  apc9Δ::His3MX6/+ 
KO296 b  as W1588-4C       Segregant 
          from RNY509 
KO313 b as W1588-4C except myo1Δ::kanMX6 ade3Δ::His3MX6 This study l 
  apc9Δ::TRP1 [pTSV31A-MYO1]  
KO336 b as RNY501 except myo1Δ::kanMX6/+   This study m 
  PGAL-clb2ΔDB:LEU2 
KO342 b as RNY501 except PGAL-clb2ΔDB:LEU2   This study m 
KO346 b as RNY501 except myo1Δ::kanMX6/+ swm1Δ::TRP1/+ This study j  
KO351 b as RNY501 except myo1Δ::kanMX6/+ mnd2Δ::TRP1/+ This study j  
KO354 b as RNY501 except myo1Δ::kanMX6/+ cdh1Δ::TRP1/+ This study j  
KO360 b as W1588-4C except myo1Δ::kanMX6 ade3Δ::His3MX6 This study m 
  PGAL-clb2ΔDB:LEU2 [pTSV31A-MYO1] 
KO369 b as W1588-4C except PGAL-clb2ΔDB:LEU2   Segregant 
from KO342 
KO372 b as W1588-4C       Segregant 
from KO342 
KO388 a as YEF473 except PGAL-clb2ΔDB:LEU2   This study m 
KO397 a as YEF473A except myo1Δ::kanMX6 cdc26Δ::TRP1 This study j 
KO399 a as YEF473A except doc1Δ::TRP1    This study j 
KO401 a as YEF473A except myo1Δ::kanMX6 doc1Δ::TRP1  This study j 
KO405 a as YEF473A except myo1Δ::kanMX6 swm1Δ::TRP1 This study j 
KO415 a as YEF473A except myo1Δ::kanMX6 mnd2Δ::TRP1 This study j 
KO421 a as YEF473A except myo1Δ::kanMX6 apc9Δ::TRP1  This study j 
KO460 a as YEF473B except IQG1-3HA:His3MX6 doc1Δ::TRP1 This study n 
KO463 a as YEF473A except IQG1-3HA:His3MX6 swm1Δ::TRP1 This study n 
KO465 a as YEF473B except IQG1-3HA:His3MX6 swm1Δ::TRP1 This study n 
KO470 a as YEF473B except IQG1-3HA:His3MX6 cdc26Δ::TRP1 This study n 
KO471 a as YEF473A except IQG1-3HA:His3MX6   This study n 
KO474 a as YEF473B except IQG1-3HA:His3MX6   This study n 
KO477 b as JMY314.1-4b except IQG1-3HA:His3MX6  This study n 
  apc9Δ::TRP1 
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KO481 b as W1588-4C except IQG1-3HA:His3MX6 swm1Δ::TRP1 This study n 
KO482 b as JMY314.1-4b except IQG1-3HA:His3MX6  This study n 
  swm1Δ::TRP1 
KO486 b as JMY314.1-4b except IQG1-3HA:His3MX6  This study n 
  cdc26Δ::TRP1 
KO487 b as W1588-4C except IQG1-3HA:His3MX6   This study n 
KO490 b as JMY314.1-4b except IQG1-3HA:His3MX6  This study n 
KO492 a as YEF473A       Segregant 
from KO388 
KO494 a as YEF473A except PGAL-clb2ΔDB:LEU2   Segregrant 
from KO388 
KO529 b as W1588-4C except cdh1Δ::TRP1    Segregant 
from KO354 
KO561 a as YEF473 except myo1Δ::kanMX6/+   This study m 
  PGAL-clb2ΔDB:LEU2  
KO563 a as YEF473A except IQG1-GFP:His3MX6 doc1Δ::TRP1 This study o 
KO566 a as YEF473A except IQG1-GFP:His3MX6   This study o 
KO570 a as YEF473A except myo1Δ::kanMX6   Segregant 
  PGAL-clb2ΔDB:LEU2      from KO561 
KO588 b as W1588-4C except IQG1-3HA:His3MX6 swm1Δ::TRP1 This study p 
  bar1Δ::kanMX6 
KO589 b as W1588-4C except IQG1-3HA:His3MX6   This study p 
  bar1Δ::kanMX6 
KO608 a as YEF473A except myo1Δ::kanMX6   Segregant 
from RNY112 
KO625 a as YEF473A except IQG1-GFP:His3MX6 swm1Δ::TRP1 This study o 
KO671 a as YEF473A except IQG1-3HA:His3MX6 swm1Δ::TRP1 This study p 
  bar1Δ::kanMX6 
KO672 a as YEF473A except IQG1-3HA:His3MX6   This study p 
  bar1Δ::kanMX6  
KO1226 a a/α his3-Δ200/his3Δ1 leu2-Δ1/leu2Δ0 lys2-801/+  This study q 
  met15Δ0/+ trp1-Δ63/+ ura3-52/ura3Δ0 
myo1Δ::kanMX6/+ iqg1Δ42-TAP:His3MX6:LEU2/+ 
KO1228 b as RNY501 except bar1Δ/+ iqg1Δ42:LEU2/+  This study q 
  myo1Δ::kanMX6/MYO1-GFP:His3MX6 
KO1229 b as RNY501 except bar1Δ/+ iqg1Δ42:LEU2/+  This study q 
  myo1Δ::kanMX6/MYO1-GFP:His3MX6 
KO1248 a as YEF473A except myo1Δ::kanMX6   Segregant 
          from KO1226 
KO1249 a as YEF473A except myo1Δ::kanMX6   Segregant 
  iqg1Δ42-TAP:His3MX6:LEU2    from KO1226 
___________________________________________________________________________ 
a Denotes strains of the S288C genetic background (Mortimer and Johnston, 1986). 
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b Denotes strains of the W303 genetic background (Thomas and Rothstein, 1989).  Note that 
although the original W303 contained a rad5 mutation, all of the W303-family strains used 
here are RAD5+ like W1588-4C (Zhao et al., 1998). 
c American Type Culture Collection (Manassas, VA) strain ATCC201388 or ATCC4040002. 
d Strains YJB14 and YJB115 (Burton and Solomon, 2000), OCF1517.2 (Cohen-Fix et al., 
1996), and YJB368 (Burton and Solomon, 2001) were transformed with an IQG1-
TAP:His3MX6 C-terminal-tagging cassette (see Materials and Methods).  
e Strain AFS92 was transformed with the indicated plasmids (Table 2.2). 
f Strain AFS92 was transformed with a MYO1-GFP:His3MX6 C-terminal-tagging cassette 
and then with pGT04 (Table 2.2) after cutting with NheI to target integration to the IQG1 
coding sequence.  The site of integration was confirmed by PCR. 
g Strain IQG1-TAP was transformed with pGT04 after cutting with NheI, and the site of 
integration was confirmed by PCR. 
h Strain RNY509 was transformed with pTSV31A-MYO1 (Table 2.2).  A myo1Δ::kanMX6 
segregant carrying the plasmid was isolated by tetrad dissection and transformed with an 
ade3Δ::His3MX6 deletion cassette. 
i Strain RNY112 was transformed with pRS316-MYO1.  A myo1Δ::kanMX6 segregant 
carrying the plasmid was then isolated by tetrad dissection and transformed with the 
indicated plasmids (Table 2.2); pRS316-MYO1 was then eliminated by growth on 5-FOA. 
j Strains RNY112 and RNY509 were transformed with various TRP1-marked deletion 
cassettes (see Materials and Methods).  Single-mutant and double-mutant segregants from the 
RNY112 derivatives were isolated by tetrad dissection. 
k Strain KO199 was transformed with an apc9Δ::His3MX6 deletion cassette. 
l Strain RNY798 was transformed with an apc9Δ::TRP1 deletion cassette 
m Strains YEF473, RNY112, RNY501, RNY509, and RNY798 were transformed with 
plasmid YIp-GAL-clb2ΔDB (Table 2.2) after cutting with KpnI to target integration to the 
LEU2 locus.  Although the actual sites of integration were not checked, each diploid 
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transformant was heterozygous for a single copy of the PGAL-clb2ΔDB:LEU2 allele, as shown 
by subsequent tetrad analysis. 
n Strains YEF473A and KO296 were transformed with an IQG1-3HA:His3MX6 C-terminal-
tagging cassette (see Materials and Methods).  The resulting strains were crossed to various 
APC/C mutant strains, and segregants were isolated by tetrad dissection. 
o Strain YEF473A was transformed with an IQG1-GFP:His3MX6 C-terminal-tagging 
cassette (see Materials and Methods).  The resulting strain was crossed to doc1Δ and swm1Δ 
strains (from the same tetrads that yielded KO401 and KO405), and single-mutant and 
double-mutant segregants were isolated by tetrad dissection. 
p Strains KO463, KO471, KO481, and KO487 were transformed with a bar1Δ::kanMX6 
deletion cassette (see Materials and Methods). 
q Strains RNY112 and RNY509 were transformed with plasmids pRS316-MYO1 and 
pTSV31A-MYO1, respectively.  A myo1Δ::kanMX6 segregant carrying the plasmid was then 
isolated from each strain by tetrad dissection and mated to strain GT124 or GT112, as 
appropriate to maintain the S288C or W303 genetic background.  pRS316-MYO1 or 
pTSV31A-MYO1 was then eliminated by growth on 5-FOA. 
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Table 2.2.  Plasmid List of Chapter 2 
 
 
Plasmid  Description     Source 
 
 
pRS315  CEN6 ARS4 LEU2 (low copy) Sikorski and Hieter, 1989 
pRS425  2µ, LEU2 (high copy)   Christianson et al., 1992 
YEp181-IQG1 2µ, LEU2 IQG1 (high copy)  Nishihama et al., 2007 
pRS315-IQG1  IQG1 in pRS315   Nishihama et al., 2007 
pRS315-CYK3 CYK3 in pRS315   Nishihama et al., 2007 
pRS425-CYK3 CYK3 in pRS425   Nishihama et al., 2007 
pRS316-MYO1 CEN6 ARS4 URA3 MYO1  Nishihama et al., 2007 
pTSV31A-MYO1 2µ, URA3 ADE3 MYO1  See text  
YIp-GAL-clb2ΔDB LEU2 PGAL-clb2ΔDB (integrating) S. Reed 
pGT04   LEU2 iqg1Δ42 (integrating)  See text 
pGAL-IQG1-TAP 2µ, URA3 PGAL-IQG1-TAP  See text 
pGAL-iqg1Δ42-TAP 2µ, URA3 PGAL-iqg1Δ42-TAP See text 
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Table 2.3.  Primer List of Chapter 2 
 
 
Primer  Purpose   Primer sequence 
 
 
5'TTEF Internal check primer  5'-TATTTTTTTTCGCCTCGACATCATC 
for the His3MX6 or  TGCCC-3' 
kanMX6 marker 
 
3'PTEF Internal check primer  5'-GTATGGGCTAAATGTACGGGCGAC 
for the His3MX6 or   AGTCAC-3' 
kanMX6 marker 
 
5'TRP1 Internal check primer  5'-TAAAAGACTCTAACAAAATAGCAA 
  for the TRP1 marker  ATTTCG-3' 
 
3'TRP1 Internal check primer  5'-GTGCTTAATCACGTATACTCACGTG 
  for the TRP1 marker   CTCAA-3' 
 
APC9dF 5' primer to construct  5'-CAAATTCAGGAAGGAAAGAAATA 
  apc9Δ    GCTGTGACAAAGTAAGCGGATCCCCG 
      GGTTAATTA-3' 
 
APC9dR 3' primer to construct  5'-GATATATATACACGTGAAGCAAAA 
  apc9Δ     AAGGCATTGCCTCTGGAATTCGAGCT 
CGTTTAAAC-3' 
 
APC9dK Upstream check primer 5'-TAAACCGTGGCATTCAACTAGCAC 
  for apc9Δ   AAGACT-3' 
 
APC9dC Downstream check primer 5'-GATTTCGAGTATTATGTCCGATCC 
  for apc9Δ   TAAGTA-3' 
 
CDC26dF 5' primer to construct  5'-GAAGAGAAAAAAAAAACAGCAAC 
  cdc26Δ   AATAACATCGCACTTGCGGATCCCCG 
      GGTTAATTA-3' 
 
CDC26dR 3' primer to construct  5'-TGCGCGTGTGCGTGTGCGTGTGCG 
  cdc26Δ   TATGCGGATATGCTAGAATTCGAGCT 
CGTTTAAAC-3' 
 
CDC26dK Upstream check primer 5'-CCAACAAACATTTGAACATACCTG 
  for cdc26Δ   ATTTGAGG-3' 
 
CDC26dC Downstream check primer 5'-GCGTGAATGATGCTGTCCAGACGC 
  for cdc26Δ   TACTGCAA-3' 
 
CDH1dF 5' primer to construct  5'-GTCACCCTTCCTTCTAGTCTTCATC 
  cdh1Δ    CTAAATTTAGTTGCCGGATCCCCGGG 
      TTAATTA-3' 
 
CDH1dR 3' primer to construct  5'-GAATTTTTGAGATGATATTACTAC 
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  cdh1Δ    TATGAAAACCCTTTAGAATTCGAGCT 
CGTTTAAAC-3' 
 
CDH1dK Upstream check primer 5'-TTTTGGTTTTCCCTACCCAGTTATT 
  for cdh1Δ   TACCC-3' 
 
CDH1dC Downstream check primer 5'-TCATTTAGGTTTTTGTCAACATTGA 
  for cdh1Δ   TGTAA-3' 
 
DOC1dF 5' primer to construct  5'-CGTGGAGATATCAGATGTAAAGTA 
  doc1Δ    GTTAGAGTAGAAAAACGGATCCCCG 
      GGTTAATTA-3' 
 
DOC1dR 3' primer to construct  5'-GGTAATAGCAAGGAAGAAAATAT 
  doc1Δ    CATAAACGGCATATTAGAATTCGAG 
      CTCGTTTAAAC-3' 
 
DOC1dK Upstream check primer 5'-AACGGTGGATTTTTTGTCTAGTTTC 
  for doc1Δ   CAAAT-3' 
 
DOC1dC Downstream check primer 5'-ATGTGCCACTGTAAGGACACCTTT 
  for doc1Δ   ATTCGT-3' 
 
MND2dF 5' primer to construct  5'-ACCGACAACCATAAACAGCGGCG 
  mnd2Δ    AAGAGAAGACAAAGCACGGATCCCC 
      GGGTTAATTA-3' 
 
MND2dR 3' primer to construct  5'-AATAGATAGATGAATTTTGGTGCT 
  mnd2Δ    GAGGAGAGCATTTTTGAATTCGAGCT 
CGTTTAAAC-3' 
 
MND2dK Upstream check primer 5'-TTTTCTAAATCTTTTAGAACATTCA 
  for mnd2Δ   AATCA-3' 
 
MND2dC Downstream check primer 5'-CAAGTTAGATCCATCGGGCAGCGA 
  for mnd2Δ   ATTGGT-3' 
 
NET1dF 5' primer to construct  5'-ACAGAGAGAAGTCGATTACTGTAC 
  net1Δ    ACCGTGCCTCCTTCTCGGATCCCCGG 
GTTAATTA-3' 
 
NET1dR 3' primer to construct  5'-AGCTTTCTGTGACGTGTATTCTACT 
  net1Δ    GAGACTTTCTGGTAGAATTCGAGCTC 
      GTTTAAAC-3' 
 
NETdK Upstream check primer 5'-CCTCTCTTCAAGTTTCCTATACCCG 
  for net1Δ   AGCTT-3' 
 
NETdC Downstream check primer 5'-ATTGCTTTGATTCTGGCAATCCAA 
  for net1Δ   ATGGTT-3' 
 
PDS1dF 5' primer to construct  5'-CGGTACCAAGCTAGATTAAGTGCT 
  pds1Δ    AGATAATAAACCTTTCGGATCCCCGG 
GTTAATTA-3' 
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PDS1dR 3' primer to construct  5'-CGTGTATATATGTTGTGTGTATGT 
  pds1Δ    GAATGAGCAGTGGATGAATTCGAGCT 
CGTTTAAAC-3' 
 
PDS1dK Upstream check primer 5'-GGTGTGAAGGACGGAGTCTTCAAT 
  for pds1Δ   GGTGAA-3' 
 
PDS1dC Downstream check primer 5'-TATTGGGGTATTTACTGAATGAGA 
  for pds1Δ   AAAGGA-3' 
 
SWM1dF 5' primer to construct  5'-TCAGAGAAGTGGGGTGAGCAAAG 
  swm1Δ   TATAACAACCACGATTCGGATCCCCG 
      GGTTAATTA-3' 
 
SWM1dR 3' primer to construct  5'-AATTTCTGACTAATGATCAGCATA 
  swm1Δ   TACGTCACGTTCTGCGAATTCGAGCT 
      CGTTTAAAC-3' 
 
SWM1dK Upstream check primer 5'-TTACCGTGACCGTGTGAGACAATT 
  for swm1Δ   CATTGA-3' 
 
SWM1dC Downstream check primer 5'-CAAGAAATACTTAATTAGCGTTTC 
  for swm1Δ   AAATGC-3' 
 
IQG1tF 5' primer to construct  5'-CATTTGATTGTCAGTTTTTTCTATA 
  IQG1-3HA or IQG1-GFP AAAGGAACGCTTTGCGGATCCCCGG 
GTTAATTA-3' 
 
IQG1-R1 3' primer to construct  5'-TAACAGCTTTTGCCCAATATGCTC 
  IQG1-3HA or IQG1-GFP AAAACCGAGTTATCTAGAATTCGAG 
      CTCGTTTAAAC-3' 
 
IQG1tK Upstream check primer 5'-AGAGGAGTGCTTAAAACCATCAG 
  for C-terminal tags of IQG1 GGGTGAA-3' 
 
IQG1-6000R Downstream check primer 5'-CCAAAAATGCTGCCCATTCCTAGT- 
  for C-terminal tags of IQG1 3' 
 
MSO1855 5' primer to amplify  5'-GTTGAACCAAAAATCGAGACGTG-3' 
  IQG1-TAP:His3MX6 
 
MSO1856 3' primer to amplify  5'-TATCGCCAAATTACAGCACATGC-3' 
  IQG1-TAP:His3MX6 
 
pGT04- 5' primer for fragment (-262 5'-GAGACGGATCCCGCTTTATATTGA 
BamHI to +3) of pGT04  GCTACGCATCGC-3' 
 
pGT04- 3' primer for fragment (-262 5'-TATGTTTAACGAAGACATTGTTTTT 
linker3  to +3) of pGT04  GCACCACCTTGTTACATATAATTG-3' 
 
pGT04- 5' primer for fragment (+127 5'-GGTGGTGCAAAAACAATGTCTTCG 
linker5  to +277) of pGT04  TTAAACATAGCGTCGCC-3' 
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pGT04- 3' primer for fragment (+127 5'-GTCTCTCTAGACTACGGTATATTTT 
XbaI  to +277) of pGT04  CCTACGAGTTTGTTAG-3' 
 
Gal-5'-IQG1 5' primer to construct pGAL 5'-GGAATTCCAGCTGACCACCATGAC 
  -IQG1-TAP   AGCATATTCAGGCTCTCCTTCGAAAC 
      CAGGCAATAA-3' 
 
Gal-5'-iqg1 5' primer to construct pGAL 5'-GGAATTCCAGCTGACCACCATGTCT 
42  -iqg1Δ42-TAP  TCGTTAAACATAGCGTCGCCAAGTCA 
      TTTAAAGAC-3' 
 
Gal-3'-IQG1 3' primer to construct pGAL 5'-CGATCCCCGGGAATTGCCATGCAA 
  -IQG1-TAP or pGAL-iqg1Δ AGCGTTCCTTTTATAGAAAAAACTGA 
  42-TAP   CAATCAAATG-3' 
 
IVT5'-T7- 5' primer to add T7  5'-GGGGGCCCCCGGGGGCCCCCTAATAC 
Kozak  promoter sequences and a GACTCACTATAGGGAATTGTGAGCGGAT 
  Kozak site to each fragment AACAATTCCTCTAGAAATAATTTTGTTTA 
  for ubiquitination assay ACTTTAAGAAGGAGATATATCGCCGCCG 
      CCATGGGG-3' 
 
IVT5'-1aa 5' primer to make fragment 5'-GATATATCGCCGCCGCCATGGGGA 
  that starts at amino acid 1 TGACAGCATATTCAGGCTCTCCTTCG 
  for ubiquitination assay AAACCAGGC-3' 
 
IVT3'-750aa 3' primer to make fragments 5'-TTAAGCCCAAAGACTTGGATTTGG 
  that end at amino acid 750 ACAGTC-3' 
  for ubiquitination assay 
 
IVT5'-43aa 5' primer to make fragment 5'-GATATATCGCCGCCGCCATGGGGA 
  that starts at amino acid 43 TGTCTTCGTTAAACATAGCGTCGCCA 
  for ubiquitination assay AGTC-3' 
 
IVT5'-400aa 5' primer to make fragment 5'-GATATATCGCCGCCGCCATGGGGA 
  that starts at amino acid 400 TGTCTCATTATTCTCCCATGAGAAGA 
  for ubiquitination assay GAAAGGATGA-3' 
 
IVT3'-1100aa 3' primer to make fragment 5'-TTACACATTATAAAGGACATCTTTG 
  that ends at amino acid ATATGAGGC-3' 
  1100 for ubiquitination assay 
 
IVT5'-741aa 5' primer to make fragment 5'-GATATATCGCCGCCGCCATGGGGA 
  that starts at amino acid 741 TGCTAGACTGTCCAAATCCAAGTCTT 
  for ubiquitination assay TGGGCTGTCA-3' 
 
IVT3'-1495aa 3' primer to make fragment 5'-GCAAGAGCCCTCAGCTTCTC-3' 
  that ends at amino acid 1495 
  for ubiquitination assay a 
 
IVT3'-250aa 3' primer to make fragments 5'-TTAAGGCCATGCTTTTTTACAAGCT 
  that end at amino acid 250 GCG-3' 
  for ubiquitination assay 
 
IVT5'-33aa 5' primer to make fragment 5'-GATATATCGCCGCCGCCATGGGGA 
  61 
  that starts at amino acid 33 TGCTGAGACCGCAGTCAAGTTCCAAA 
  (no mutation) for  ATC-3' 
  ubiquitination assay 
 
IVT5'-33aa 5' primer to make fragment 5'-GATATATCGCCGCCGCCATGGGGA 
-R34A  that starts at amino acid 33 TGCTGGCACCGCAGTCAAGTTCCAAA 
  (mutation R34A) for  ATC-3' 
  ubiquitination assay 
 
IVT5'-33aa 5' primer to make fragment 5'-GATATATCGCCGCCGCCATGGGGA 
-S37A  that starts at amino acid 33 TGCTGAGACCGCAGGCAAGTTCCAAA 
  (mutation S37A) for  ATC-3' 
  ubiquitination assay 
 
IVT5'-33aa 5' primer to make fragment 5'-GATATATCGCCGCCGCCATGGGGA 
-S37L  that starts at amino acid 33 TGCTGAGACCGCAGCTAAGTTCCAAA 
  (mutation S37L) for  ATC-3' 
  ubiquitination assay 
 
IVT5'-33aa 5' primer to make fragment 5'-GATATATCGCCGCCGCCATGGGGA 
-K40A  that starts at amino acid 33 TGCTGAGACCGCAGTCAAGTTCCGCA 
  (mutation K40A) for  ATC-3' 
  ubiquitination assay 
 
IVT5'-33aa 5' primer to make fragment 5'-GATATATCGCCGCCGCCATGGGGA 
-3A  that starts at amino acid 33 TGCTGGCACCGCAGGCAAGTTCCAAA 
  (triple mutation) for  ATCGCCTCTT-3' 
  ubiquitination assay 
 
IVT5'-33aa 5' primer to make fragment 5'-GATATATCGCCGCCGCCATGGGGA 
-4A  that starts at amino acid 33 TGCTGGCACCGCAGGCAAGTTCCGCA 
  (quadruple mutation) for ATCGCCTCTT -3' 
  ubiquitination assay 
 
 
a No stop codon is needed in the primer because the natural IQG1 stop codon is included in 
the amplified fragment. 
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CHAPTER 3 
IDENTIFICATION OF ADDITIONAL PROTEINS INVOLVED IN SEPTIN-




In the budding yeast Saccharomyces cerevisiae, a ring of myosin II (Myo1p) forms in a 
septin-dependent manner at the presumptive budding site in late G1.  At the onset of 
cytokinesis, actin is recruited to the Myo1p ring to form an actomyosin ring, which soon 
contracts, and a septum of cell wall (including a chitinous primary septum synthesized by 
Chs2p) forms concurrently to complete cytokinesis.  Three other proteins involved in 
cytokinesis are Iqg1p, Cyk3p, and Hof1p.  Iqg1p is the only S. cerevisiae IQGAP and is 
required for actomyosin-ring formation, primary-septum formation, and hence normal 
cytokinesis.  Because the actomyosin ring itself is not essential for primary-septum 
formation, Iqg1p must have at least one other cytokinetic function(s), which may involve 
stimulating Cyk3p and Hof1p to function in a septin-dependent and actomyosin-ring-
independent pathway.  To identify additional proteins involved in this pathway, we have 
conducted screens for dosage suppressors of the myo1Δ cyk3Δ and myo1Δ hof1Δ synthetic 
growth defects.  We have identified several genes including EGT2 (which encodes a cell-wall 
endoglucanase that may be involved in cell separation), ECM33 (which encodes a GPI-
anchored protein that may regulate cell-wall organization), and a truncated CDC24 (which 
encodes the GEF for the Rho-type GTPase Cdc42p) that lacks the C-terminal PB1 domain.
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Overexpression of Ecm33p or the truncated Cdc24p can also suppress the iqg1Δ and chs2Δ 
growth defects and restore the formation of primary septum in iqg1Δ cells.  Further studies 
showed that deletion of ECM33 causes minor cytokinetic defects at 37˚C, and that the 
suppression by the truncated Cdc42p is likely to be Cdc42p-independent and may involve 
targeting Rho1p, Rho2p, Rho5p, and/or an unknown factor(s).
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INTRODUCTION 
Cytokinesis is a late stage of cell division whereby the cell surface and cytoplasm of one cell 
is divided into two cells.  Although the molecular understanding of cytokinesis has improved 
recently, only some of the participating proteins have been identified so far.  Among them 
are the septins, which are GTP-binding proteins that have been found at the division site in 
all fungal and animal cells examined (Longtine et al., 1996; Hall and Russell, 2004; 
Gladfelter, 2006).  Surprisingly, although the septins are required for cytokinesis in some cell 
types, they are not in others (Longtine et al., 1996; Adam et al., 2000; Nguyen et al., 2000; 
Kinoshita and Noda, 2001; An et al., 2004).  Functionally, the septins have been proposed as 
both a diffusion barrier and a scaffold for the organization and localization of other 
components (Gladfelter et al., 2001; Longtine and Bi, 2003; Dobbelaere and Barral, 2004; 
Versele and Thorner, 2005; Spiliotis and Nelson, 2006).  One such septin-dependent 
component in the budding yeast Saccharomyces cerevisiae is the contractile actomyosin ring.  
Whereas the septins are essential for cytokinesis in this organism, the actomyosin ring is not 
in most strain backgrounds (Bi et al., 1998; Schmidt et al., 2002; Nishihama et al., 2007).  
Thus, the septins must have other roles in cytokinesis that are independent of the actomyosin 
ring.  One current objective is to assess these roles and identify the involved proteins in yeast 
and perhaps in other cell types where the actomyosin ring may be dispensable (Uyeda et al., 
2000; Nagasaki et al., 2002; Kanada et al., 2005).  
 In S. cerevisiae, the initial recruitment of the septins to the presumptive budding site 
has been indicated to depend on the activation of Rho-type GTPase Cdc42p by its guanine-
nucleotide-exchange factor (GEF) Cdc24p (Gladfelter et al., 2001; Iwase et al., 2006), which 
appears to require its Dbl-homology (DH) domain for the GEF activity (Shimada et al., 
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2004) and an interaction with Bem1p (Chenevert et al., 1992) through its Phox-Bem1-
homology (PB1) domain (Butty et al., 2002; Shimada et al., 2004).  Cdc42p and other Rho-
type GTPases (Rho1p-Rho5p) have been shown to be involved in pathways regulating cell 
polarization and integrity (Pringle et al., 1995; Drgonova et al., 1996; Qadota et al., 1996; 
Madden and Snyder, 1998; Pruyne and Bretscher, 2000; Guo et al., 2001; Schmitz et al., 
2002; Fernandes et al., 2006).  After the initial recruitment, the septins appear to assemble 
into a ring structure (Iwase et al., 2006), and Myo1p (the only type II myosin in S. 
cerevisiae) then forms a ring within the septin ring in late G1 (Bi et al., 1998; Lippincott and 
Li, 1998).  This ring remains at the mother-bud neck until the onset of cytokinesis, when 
actin and other proteins are recruited to it to form the mature actomyosin ring, which soon 
contracts.  Around the same time, the plasma membrane invaginates and the primary septum 
(composed of chitin) is synthesized, principally by the chitin synthase Chs2p (Cabib et al., 
2001; Schmidt et al., 2002).  Secondary septa (composed mainly of other cell-wall materials, 
such glucans and mannoproteins) are then deposited on both sides of the primary septum to 
form the mature trilaminar septum.  Thus, for a normal septum to be formed, mechanisms 
that are required for normal cell-wall synthesis, such as the glycosylation and anchoring of 
mannoproteins, may need to be fully functional (Schmidt et al., 2005).  A GPI-anchored 
protein Ecm33p and its homolog Pst1p have recently been shown to participate in such 
mechanisms (Pardo et al., 2004).  Finally, to complete cell separation, chitin in the primary 
septum is hydrolyzed by a chitinase (Kuranda and Robbins, 1991; Colman-Lerner et al., 
2001) and some glucans are removed by glucanases, such as Egt2p (Kovacech et al., 1996).  
In addition to the actomyosin ring, some of the other septin-dependent components of 
cytokinesis in S. cerevisiae include Iqg1p, Cyk3p, and Hof1p.  Iqg1p is the only known 
  73 
IQGAP (Brown and Sacks, 2006) in S. cerevisiae and has been shown to be indispensable for 
actomyosin-ring formation, primary-septum formation, and normal cytokinesis (Epp and 
Chant, 1997; Shannon and Li, 1999; Luo et al., 2004; Nishihama et al., 2007; see Chapter 2).  
Because the actomyosin ring itself is not essential for cytokinesis, Iqg1p must have at least 
one other cytokinetic function(s) that is independent of the actomyosin ring.  To date, the 
exact function of Cyk3p is unclear, but its overexpression suppresses the iqg1Δ growth defect 
without restoring the actomyosin ring, and myo1Δ cyk3Δ double mutant is synthetically sick, 
suggesting that Cyk3p also promotes cytokinesis through an actomyosin-ring-independent 
pathway (Korinek et al., 2000; Nishihama et al., 2007). Although the exact cellular function 
of Hof1p remains as a mystery, this protein has been shown to be a member of the Pombe-
Cdc15-Homology (PCH) family, which includes S. pombe Cdc15p and mammalian proteins 
PSTPIP1 and PSTPIP2 (Chitu and Stanley, 2007).  PCH proteins have been suggested to 
function at the membrane-cytoskeleton interface by coordinating changes in actin 
cytoskeleton and membrane morphology.  Thus, Hof1p may function in cytokinesis as an 
adapter linking the primary-septum-synthesis machinery to the actomyosin ring (Vallen et 
al., 2000).  Because the myo1Δ hof1Δ double mutant is synthetically inviable, Hof1p may 
also participate in an actomyosin-ring-independent pathway of cytokinesis. 
To investigate the mechanisms and to identify additional components of septin-
dependent, actomyosin-ring-independent cytokinesis in S. cerevisiae, we have been 
conducting dosage-suppressor screens starting with myo1Δ cyk3Δ and myo1Δ hof1Δ double 
mutants.  From these studies, we have identified several known and novel proteins, including 
Ecm33p and a truncated Cdc24p without its PB1 domain.  Our analysis suggests that both 
Ecm33p and the truncated Cdc24p can promote the formation of primary-septum-like 
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structures in the absence of the actomyosin ring.  We also present evidence that this novel 
function of the truncated Cdc24p may be GEF-dependent but Cdc42p-independent and 
involve targeting Rho1p, Rho2p, Rho5p, and/or an unknown factor(s).
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MATERIALS AND METHODS 
Strains, Plasmids, Growth Conditions, and Genetic Methods 
The strains and plasmids used in this study are listed in Tables 3.1 and 3.2; their construction 
is described below or in the tables.  Except as noted, yeast were grown at 23˚C on liquid or 
solid synthetic complete (SC) medium lacking specific nutrients as needed to select 
transformants or to maintain plasmids, YP rich solid medium, or YM-P rich, buffered liquid 
medium (Lillie and Pringle, 1980; Guthrie and Fink, 1991).  2% glucose was used as carbon 
source except for experiments involving induction of gene expression under GAL promoter 
control (for which 1% raffinose plus 2% galactose was used) and recovery of viable iqg1Δ or 
chs2Δ spore colonies on rich medium without dosage-suppressor plasmids (for which 2% 
glycerol was used).  The antibiotic geneticin (G418; Cambrex, Walkersville, MD) was used 
to select for cells containing the kanR marker, and 5-fluoroorotic acid (5-FOA; Research 
Products International, Mt. Prospect, IL) was used to select for ura3-mutant cells.  Standard 
procedures were used for growth of Escherichia coli, genetic manipulations, polymerase 
chain reaction (PCR), and other molecular biological procedures (Sambrook et al., 1989; 
Guthrie and Fink, 1991; Ausubel et al., 1995). 
Strain and Plasmid Constructions 
Genes were deleted using the PCR method (Baudin et al., 1993; Longtine et al., 1998) and 
the primers indicated in Table 3.4; in each case, the entire coding region was deleted.  The 
success of each deletion was confirmed by two PCR tests that used check primers that were 
upstream and downstream of the deleted region together with primers internal to the 
selectable markers (Longtine et al., 1998; Table 3.4). 
 Plasmids YEp13-ECM33, YEp13-EGT2, YEp13-cdc24-PB1Δ, YEp13-RHO1, 
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YEp13-RGD2, YEp13-RPL30, YEp13-NAB6, YEp13-MNN9, and YEp13-YJL055W were 
isolated in two dosage-suppressor screens using a myo1Δ cyk3Δ or myo1Δ hof1Δ double-
mutant strain and a genomic-DNA library (DeMarini et al., 1997) constructed by cloning 
Sau3A fragments into the BamHI site of plasmid YEp13 (high-copy, LEU2; Broach et al., 
1979).  Plasmid pRS315-CDC24 (kindly provided by E. Bi, University of Pennsylvania, 
Philadelphia, PA) was constructed in two steps.  First, an XbaI-HpaI-cut fragment, 
containing CDC24, from plasmid YEp352-CDC24 (Bi et al., 2000) was cloned into XbaI-
SmaI-cut plasmid YIplac211 (Gietz and Sugino, 1988).  In the second step, an XbaI-SacI-cut 
fragment, containing nucleotides from -1961 relative to the start site of CDC24 to +313 
relative to its stop codon, from the resulting plasmid of the first step, was cloned into XbaI-
SmaI-cut plasmid pRS315 (Sikorski and Hieter, 1989).  Plasmid YEp13-CDC24 was 
constructed in two steps.  First, a fragment containing nucleotides from +2296 to +2859 
relative to the start site of CDC24 plus +1 to +40 relative to the SphI of YEp13 was PCR-
amplified using pRS315-CDC24 as template and primers CDC24P3 and CDC24P4 (Table 
3.4).  In the second step, the PCR product from the first step was purified and transformed 
together with SphI-cut YEp13-cdc24-PB1Δ into wild-type cells, and transformants 
containing plasmids resulting from homologous recombination were selected on SC-Leu 
plates.  Plasmid YEp13-cdc24-DH8 was constructed in two steps.  First, a fragment 
containing nucleotides from +764 to +1659 relative to the start site of CDC24 and two 
mutations (N452G and E453G) within the DH domain was PCR-amplified using plasmid 
pRS414-3xmycCdc24-DH8 (kindly provided by R. Arkowitz, Universite De Nice, France) as 
template and primers CDC24P7 and CDC24P8 (Table 3.4).  In the second step, the PCR 
product from the first step was purified and transformed together with BbvCI-cut YEp13-
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cdc24-PB1Δ into wild-type cells, and transformants containing plasmids resulting from 
homologous recombination were selected on SC-Leu plates.  Plasmid pGAL-6xHIS-CDC42 
was constructed in two steps.  First, a fragment containing CDC42 was PCR-amplified using 
plasmid pQE-6xHIS-CDC42 (see below) as template and primers pQErev and SalI-HIS 
(Table 3.4).  In the second step, the PCR product from the first step was purified, cut with 
SalI and XbaI, and cloned into the corresponding sites of plasmid YCpIF2 (Foreman and 
Davis, 1994).  pQE-6xHIS-CDC42 was constructed in three steps.  First, a fragment 
containing CDC42 was PCR-amplified using plasmid pRS314-CDC42 (Zhang et al., 2001) 
as template and primers T3 and BamHI-CDC42 (Table 3.4).  Second, the PCR product from 
the first step was purified, cut with BamHI and SalI, and cloned into the corresponding sites 
of plasmid YCplac33 (Gietz and Sugino, 1988).  Third, a BamHI-SalI-cut fragment from the 
resulting plasmid of the second step was then cloned into the corresponding sites of plasmid 
pQE-30 (QIAGEN Sciences, Valencia, CA).  Plasmids pGAL-RHO1, pGAL-RHO2, pGAL-
RHO3, pGAL-RHO4, and pGAL-RHO5 were all constructed by similar methods.  First, a 
fragment containing the RHO1, RHO2, RHO3, RHO4, or RHO5 gene was PCR-amplified 
using either a high-copy plasmid containing the gene (kindly provided by D. Lew, Duke 
University, Durham, NC) or genomic DNA from a His3MX6:PGAL-RHO5 strain as template 
and primers set GAL-RHO1 plus 3'IF-RHO1, GAL-RHO2 plus 3'IF-RHO2, GAL-RHO3 
plus 3'IF-RHO3, GAL-RHO4 plus 3'IF-RHO4, or GAL1-seq plus 3'IF-RHO5 (Table 3.4).  
Second, the PCR product from the first step was purified and transformed together with SalI-
cut YCpIF2 into wild-type cells, and transformants containing plasmids resulting from 
homologous recombination were selected on SC-Leu plates. 
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Growth Rates, Microscopy, and WGA Labeling 
To determine growth rates, exponential-phase cultures (OD600 ≈ 0.4) in the indicated medium 
were diluted two-fold with fresh medium, and incubation was continued at 23˚C or 37˚C, as 
indicated.  The times needed to return to the original OD600 were recorded as the doubling 
times. 
 DIC microscopy was performed using a Nikon (Tokyo, Japan) Eclipse E600-FN 
microscope and an ORCA-2 cooled CCD camera (Hamamatsu Photonic Systems, 
Bridgewater, NJ).  Electron microscopy (EM) was performed using a JEOL (Tokyo, Japan) 
JEM-1230 microscope and a Gatan Peltier-cooled Bioscan (Gatan Inc., Pleasanton, CA).  
Cells were grown to exponential phase in either YM-P (for wild-type), SC-His (for iqg1Δ 
and chs2Δ mutants), or SC-Leu (to select for plasmids) medium (50 ml).  Cells were 
collected on a 0.2 µm filter, resuspended in 10 ml of primary fixative buffer [3% 
glutaraldehyde (Sigma-Aldrich, St. Louis, MO) in 0.1 M sodium cacodylate, pH6.8 (Electron 
Microscopy Sciences, Hatfield, PA)], and incubated at 23˚C for 15 min.  Cells were 
recollected by centrifugation, resuspended again in 10 ml of primary fixative buffer, 
incubated at 23˚C for 45 min, and then at 4˚C overnight.  After washing three times with 
water by centrifugation, cells were further fixed with 1 ml of 4% potassium permanganate 
(Electron Microscopy Sciences) at 4˚C for 2 h with shaking, followed by five washes with 
water.  Fixed cells were stained with 1 ml of 2% uranyl acetate solution (Electron 
Microscopy Sciences) at 23˚C for 1 hr, followed by two washes with water.  At 23˚C, cells 
were then dehydrated through a graded series (50%, 70%, 85%, 90%, 95%, and 100%) of 
ethanol for 5 min each and infiltrated with increasing concentrations (1:1 dilution of LR 
White:100% ethanol, overnight; 3:1 dilution, 2 h) of LR White (Sigma-Aldrich), followed by 
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two suspensions in pure LR White (3 h for each).  Cell suspension was transferred to gelatin 
capsules, which were then cured in incubator at 55˚C for 3 days to polymerize the resin.  
Thin sections for EM were cut with a Leica Ultracut S (Leica Microsystems, Bannockburn, 
IL).  Sections were placed on EM grids and stained with aqueous uranyl acetate and lead 
citrate (Sigma-Aldrich) for 5 min each before observation. 
 For WGA labeling, sections on grids were pre-incubated in PBS for 5 min, incubated 
in 1:50 to 1:5 dilutions of WGA-gold (15 nm; EY Laboratories, Inc., San Mateo, CA) in PBS 
for 15 min, jet-rinsed with water, and stained with aqueous uranyl acetate and lead citrate for 
5 min each before observation.
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RESULTS 
Dosage Suppressors of the myo1Δ cyk3Δ  and myo1Δ  hof1Δ Synthetic Growth Defects 
To identify additional proteins involved in cytokinesis in S. cerevisiae, particularly those that 
may participate in a septin-dependent and actomyosin-ring-independent pathway, we have 
used a high-copy, LEU2-marked genomic library to screen for dosage suppressors of the 5-
FOA-induced synthetic growth defect of a myo1Δ cyk3Δ [URA3 MYO1 plasmid] or myo1Δ 
hof1Δ [URA3 MYO1 plasmid] strain (Vallen et al., 2000; Nishihama et al., 2007; see 
Materials and Methods).  To date, 25,000 colonies have been screened in each of the two 
screens.  17 (myo1Δ cyk3Δ) and 11 (myo1Δ hof1Δ) plasmids that could suppress the growth 
defects have been isolated, five and two of the 17 plasmids contained CYK3 and MYO1, and 
four and one of the 11 contained HOF1 and MYO1, indicating that the screens could 
successfully identify bona fide suppressors.  The remaining plasmids were sequenced and 
subcloned (data not shown) to determine the responsible suppressor genes.  The identified 
dosage suppressors from each screen are shown in Figure 3.1.  A plasmid containing ECM33 
was pulled out twice and four times in the myo1Δ cyk3Δ and myo1Δ hof1Δ screens, a plasmid 
containing RPL30 was pulled out twice, and all other plasmids were pulled out once each.   
Besides Ecm33p or Egt2p, overexpressing Nab6p or Yjl055Wp could also suppress the 5-
FOA-induced growth defects of both strains (data not shown).  The strong suppression by 
Yjl055Wp was shown to be independent of cytokinesis and has been indicated to directly 
suppress the inviability of URA3+ cells in the presence of 5-FOA (see Chapter 4). 
Suppression of the iqg1Δ  and chs2Δ  Growth Defects 
Because Myo1p, Cyk3p, and Hof1p might all function downstream of Iqg1p, and Chs2p is 
required for the synthesis of a normal septum, it seemed possible that the isolated dosage 
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suppressors could also suppress the iqg1Δ and/or chs2Δ growth defects.  Indeed, 
overexpression of Cdc24-PB1Δp (without the C-terminal PB1 domain) or Ecm33p could 
suppress the iqg1Δ and chs2Δ spore inviability on YPD (Figure 3.2A; Table 3.3) and the 
inability of vegetative iqg1Δ and chs2Δ cells to lose an IQG1 or CHS2 plasmid (Figure 
3.2B).  Overexpressing Egt2p could do the same, except it could not suppress the 
chs2Δ spore inviability (Figure 3.2, A and B; Table 3.3).  Finally, all the other isolated 
suppressors could not suppress the iqg1Δ spore inviability (Table 3.3), but were not tested for 
the chs2Δ growth defects. 
 In addition to the suppressions described above, we wanted to test if overexpression 
of Cdc24-PB1Δp, Ecm33p, or Egt2p could also suppress the slow-growth phenotype (Epp 
and Chant, 1997; Schmidt et al., 2002; Nishihama et al., 2007) of iqg1Δ and chs2Δ cells.  To 
explore this possibility, we first needed to isolate viable iqg1Δ and chs2Δ strains without 
using any dosage suppressors.  Previous studies (Bulawa and Osmond, 1990) have indicated 
that chs2Δ spores are sometimes viable, but grow very poorly, on YP+glycerol plate.  We 
wanted to confirm this result and test whether the same would be true for iqg1Δ spores.  
Indeed, viable but very slow-growing iqg1Δ and chs2Δ spore colonies could be recovered on 
YP+glycerol (Figure 3.3A).  Similar spore colonies carrying empty vector YEp13 (Table 3.2) 
were also isolated using this method (data not shown).  Finally, compared to these very slow-
growing mutant cells, iqg1Δ and chs2Δ cells overexpressing Cdc24-PB1Δp, Ecm33p, or 
Egt2p grew significantly faster (Figure 3.3B).  
Primary-Septum-Like Structures Induced by Dosage Suppressors 
To understand how exactly could the overexpression of Cdc24-PB1Δp, Ecm33p, or Egt2p 
suppress the iqg1Δ and chs2Δ growth defects, we examined the septum structures of the 
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suppressed cells with electron microscopy (EM).  As reported previously (Schmidt et al., 
2002), wild-type cells formed trilaminar septa (Figure 3.4, panels A1-A4).  Using the strains 
recovered from YP+glycerol, we found that both iqg1Δ (Figure 3.4, panels B1-B4) and 
chs2Δ cells (Figure 3.5, panels A1-A4) contained no primary septa, and instead of a 
trilaminar-septum structure, mutant cells could only synthesize thick secondary septa.  
Similarly, chs2Δ cells overexpressing Cdc24-PB1Δp (Figure 3.5, panels B1-B4) and iqg1Δ 
and chs2Δ cells overexpressing Egt2p (Figure 3.4, panels E1-E4; Figure 3.5, panels C1-C4) 
could only form thick septa.  In contrast, we found that in addition to forming thick septa 
(Figure 3.4, panels C1 and D1; Figure 3.5, panel D1), iqg1Δ cells overexpressing Cdc24-
PB1Δp (Figure 3.4, panels C2-C4) or Ecm33p (Figure 3.4, panels D2-D4) and chs2Δ cells 
overexpressing Ecm33p (Figure 3.5, panels D2-E3) could occasionally form primary-
septum-like structures (represented by a sharp-white stripe(s) within a thick septum).  In the 
case of chs2Δ cells overexpressing Ecm33p, the sharp-white stripes appeared to be lesser 
sharp and sometimes revolved around a block of darker stained materials (probably made of 
cell wall) within the thick septum (Figure 3.5, panel E3) and seemed to be directly involved 
in cell separation (Figure 3.5, panel E4). 
 The apparent existence of primary-septum-like structures in some chs2Δ cells 
overexpressing Ecm33p was especially surprising because chs2Δ cells should lack the chitin 
to build the primary septum.  To test whether the observed primary-septum-like structures 
were made of chitin, we labeled them with Wheat-Germ-Agglutinin (WGA).  Indeed, the 
sharp-white stripes of iqg1Δ cells overexpressing Cdc24-PB1Δp or Ecm33p were composed 
at least partially of chitin (Figure 3.6, panels A1-B2), but those (including the lesser-sharp 
ones that revolved around a block of darker stained materials) of chs2Δ cells overexpressing 
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Ecm33p seemed not to be composed of chitin (Figure 3.6, panels C1 and C2).  This means 
that cells overexpressing Ecm33p can form primary-septum-like structures, even in the 
absence of the actomyosin ring or chitin synthase II, suggesting that Ecm33p may have a role 
in the construction of primary septum during cytokinesis. 
Involvement of Ecm33p and Pst1p in Cytokinesis 
To address whether Ecm33p and its only known homolog Pst1p may be involved in 
cytokinesis, we constructed ecm33Δ, pst1Δ, and ecm33Δ pst1Δ strains.  At 23˚C, cells of all 
three mutants seemed to grow as well as wild-type cells (Figure 3.7A, four left lanes); and at 
37˚C, ecm33Δ and ecm33Δ pst1Δ, but not pst1Δ, cells seemed to grow slightly slower than 
wild-type cells (Figure 3.7A, four right lanes) and form multi-cell clusters (Figure 3.7B) at a 
very low frequency (data not shown), suggesting that Ecm33p may have a minor role in 
cytokinesis at 37˚C.  Consistent with this result, at 37˚C, ecm33Δ hof1Δ, ecm33Δ pst1Δ 
hof1Δ, and ecm33Δ pst1Δ myo1Δ cells grew more poorly than hof1Δ and myo1Δ cells (Figure 
3.7C, right panel).  Interestingly, even at 23˚C, ecm33Δ pst1Δ hof1Δ cells grew more poorly 
than hof1Δ and ecm33Δ hof1Δ cells (Figure 3.7C, left panel), suggesting perhaps Pst1p can 
sometimes substitute for Ecm33p in cytokinesis. 
The Cdc42p-Independent, GEF-Dependent Suppression by Cdc24-PB1Δp May Involve 
Other Rho-GTPase(s) and/or Unknown Factor(s) 
Based on sequencing, Cdc24-PB1Δp should contain amino acids 1-780 of Cdc24p plus 299 
amino acids of YEp13-vector sequence (Figure 3.8A).  Without a PB1 domain to interact 
with Bem1p, Cdc24-PB1Δp might not be a fully functional GEF for the Cdc42p-GTPase.  
Indeed, unlike wild-type Cdc24p, expressing Cdc24-PB1Δp could not rescue the 
temperature-sensitive lethality of cdc24-4 (Toenjes et al., 1999) (Figure 3.8B).  Consistent 
with this result, overexpression of Cdc42p could not suppress the iqg1Δ spore inviability on 
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YPD (Table 3.3).  Thus, the suppression of cytokinetic growth defects by overexpressing 
Cdc24-PB1Δp is probably independent of Cdc42p and may involve other factor(s).  We also 
constructed a plasmid overexpressing Cdc24-DH8p, which is Cdc24-PB1Δp plus two 
mutations within the DH domain that should deactivate the GEF activity.  Overexpressing 
Cdc24-DH8p could not suppress the iqg1Δ spore inviability (Table 3.3), indicating that the 
suppression by Cdc24-PB1Δp still requires its GEF activity. 
 Because the suppression by Cdc24-PB1Δp is GEF-dependent, we wanted to see if 
other known Rho-type GTPases could be involved.  Indeed, overexpression of Rho1p, 
Rho2p, or Rho5p, but not Rho3p nor Rho4p, could suppress the iqg1Δ spore inviability 
(Table 3.3), suggesting that Cdc24-PB1Δp, at least when overexpressed, may function as a 
GEF for Rho1p, Rho2p, and/or Rho5p.  However, overexpression of Cdc24-PB1Δp could 
still suppress the iqg1Δ spore inviability even in the absence of Rho2p and/or Rho5p (Figure 
3.8C), indicating that although Rho2p and Rho5p may be targets of Cdc24-PB1Δp, they are 
not required for the described suppression.  Furthermore, we found that overexpressing 
Cdc24-PB1Δp could not suppress the synthetic lethality of deletions of TUS1 (Schmelzle et 
al., 2002) and ROM2 (Ozaki et al., 1996), which encode two known GEFs of Rho1p (Figure 
3.8D), indicating that although Cdc24-PB1Δp may function as a GEF for Rho1p, it cannot 
adequately function as the main one. 
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DISCUSSION 
To identify additional proteins involved in septin-dependent, actomyosin-ring-independent 
cytokinesis, we have been conducting dosage-suppressor screens starting with myo1Δ cyk3Δ 
and myo1Δ hof1Δ double mutants.  We have isolated ECM33, EGT2, cdc24-PB1Δ, RHO1, 
RGD2, RPL30, NAB6, and MNN9.  Subsequent analyses indicated that overexpression of 
Ecm33p, Egt2p, or Cdc24-PB1Δp could also suppress the iqg1Δ and chs2Δ growth defects.  
Furthermore, overexpressing Ecm33p in iqg1Δ and chs2Δ cells or overexpressing Cdc24-
PB1Δp in iqg1Δ cells could induce the formation of primary-septum-like structures.  
Deletions of ECM33 and its homolog PST1 seemed to cause minor defects in cytokinesis, 
particularly at 37˚C.  Finally, the suppression by Cdc24-PB1Δp was found to be Cdc42p-
independent and GEF-dependent and might involve Rho1p, Rho2p, Rho5p, and/or an 
unknown factor(s). 
Suppressions by Overexpressing Ecm33p 
The primary-septum-like structures in iqg1Δ and chs2Δ cells overexpressing Ecm33p 
probably help mutant cells to grow better by providing a more efficient method of cell 
separation.  However, the formation of these structures in chs2Δ cells was rather surprising 
because Chs2p synthesizes the chitin for primary septum, but the lack of proper WGA 
labeling on these structures suggests that they are composed mainly of cell-wall materials 
other than chitin, perhaps of glucans and mannoproteins.  This is consistent with a previous 
report (Pardo et al., 2004) that Ecm33p is involved in the N-linked glycosylation and cell-
wall anchoring of mannoproteins.  Perhaps Ecm33p participates in an actomyosin-ring-
independent and Iqg1-Cyk3-involved pathway of primary-septum construction by regulating 
mannoproteins and other cell-wall materials.  Among the remaining mysteries is that the 
  86 
observed primary-septum-like structures often revolve around a block of darker stained cell-
wall material, and that cell separation seems to occur via the hydrolysis of these structures.  
To date, this phenotype has not been observed in other mutant cells and seems to be unique 
to the overexpression of Ecm33p.  Understanding the molecular basis of these structures may 
help us to understand the role of Ecm33p in primary-septum formation. 
 Because the observed primary-septum-like structures did not appear very frequently 
(approximately one in every 20 cytokinetic cells observed; data not shown), the 
overexpression of Ecm33p probably can also suppress the iqg1Δ and chs2Δ growth defects 
via another mechanism(s).  One possibility is that overexpressing Ecm33p may help mutant 
cells with cytokinetic defects to construct better thick secondary septa.  After germinating on 
YPD, iqg1Δ and chs2Δ spores often go through several rounds of cell division before a whole 
colony is lysed (data not shown).  Consistent with this observation, iqg1Δ and chs2Δ cells 
sometimes appear to be lysed (EM analysis; data not shown), and the source of the lysis often 
appears to be near the thick septa.  Thus, the thick septa may often be poorly constructed and 
can easily cause cell lysis, especially during cell separation when parts of the thick septa are 
dissolved.  Overexpressing Ecm33p can anchor more mannoproteins and other cell-wall 
materials to construct a more stable and stronger thick septum.    
 Regardless of the exact mechanism of suppression by Ecm33p, it is likely that 
Ecm33p only plays a minor role in normal cytokinesis, because the deletion of ECM33 did 
not cause any detectable cytokinetic defect at 23˚C and only caused minimal multi-cell 
clustering at 37˚C, which probably led to the slightly slower growth rate.  In addition, all 
observed ecm33Δ cells, including those in clusters at 37˚C, could synthesize the trilaminar 
septum with a normal primary septum (data not shown).  One interesting observation of 
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ecm33Δ cells was the existence of small sharp-white stripes in the secondary septa, running 
perpendicularly and connected to the primary septum (data not shown) at both 23˚C and 
37˚C.  Furthermore, these small sharp-white stripes were sometimes present throughout the 
entire cell wall of ecm33Δ cells (data not shown).  It is possible that these structures could 
have interfered with proper cell separation, thus at 37˚C, where cell cycle would progress 
faster, ecm33Δ cells could occasionally form clusters.  It will be interesting to test if these 
small sharp-white stripes are made of chitin and/or other cell-wall materials.  Understanding 
the molecular basis of these structures may help us to understand the role of Ecm33p in 
primary-septum formation and cell-wall organization. 
 Initial analysis of Pst1p, a homolog of Ecm33p, has shown that it appears to play no 
direct role in cytokinesis, because pst1Δ cells did not form clusters and had normal looking 
septum at both 23˚C or 37˚C (data not shown).  However, although ecm33Δ single and 
ecm33Δ pst1Δ double mutant cells looked similar under EM, the small sharp-white stripes in 
the double mutant seemed to be more abundant (data not shown).  Furthermore, ecm33Δ 
pst1Δ double mutations, but not ecm33Δ or pst1Δ single mutation, are synthetic lethal in 
combination with myo1Δ at 37˚C.  Taken together, these results suggest that in the absence of 
Ecm33p, Pst1p may partially substitute for its function, which is consistent with a previous 
report (Pardo et al., 2004). 
 In summary, Ecm33p appears to play a role in cytokinesis, especially at 37˚C or when 
normal cytokinesis is compromised.  It will be interesting to test if Cyk3p promotes primary-
septum synthesis partly through Ecm33p.  One experiment is to test if overexpressing Cyk3p 
can restore primary-septum formation in iqg1Δ ecm33Δ cells.  Also, it will be interesting to 
determine if Ecm33p localizes more intensely to the bud necks in iqg1Δ and chs2Δ cells. 
  88 
Suppressions by Overexpressing Cdc24-PB1Δp 
The formation of primary-septum-like structures in iqg1Δ cells, but not in chs2Δ cells, 
overexpressing Cdc24-PB1Δp suggests that the suppressions by Cdc24-PB1Δp may involve 
more than one mechanism.  Perhaps the overexpression of Cdc24-PB1Δp can help mutant 
cells to produce primary-septum-like structures (only in the presence of chitin made by 
Chs2p), build better thick septa (by over-activating the cell-integrity pathways), and/or 
conduct more efficient hydrolysis of cell-wall materials during cell separation.  Regardless of 
the exact mechanism, the suppressions are likely to be independent of Cdc42p but dependent 
of the GEF activity and functioning through Rho1p, Rho2p, Rho5p, and/or an unknown 
factor(s). 
 Rho1p is the most probable target because it has been shown to participate in multiple 
pathways of cell polarization and integrity (see Introduction).  It is possible that Cdc24-
PB1Δp, without its PB1 domain to interact with Bem1p and Cdc42p, is free to promote 
Rho1p-GTP, which then hyper-activates its many downstream targets.  The non-suppression 
of tus1Δ rom2Δ synthetic lethality by the overexpression of Cdc24-PB1Δp does not 
necessarily reject this model, because it is possible that Cdc24-PB1Δp simply cannot act as 
the main or sole GEF to promote the normal essential functions of Rho1p.  To verify this 
model, one test is to see if Cdc24-PB1Δp has GEF activity for Rho1p via in vitro assay.  It is 
also possible to test if overexpressing Cdc24-PB1Δp can suppress the iqg1Δ growth defect 
when Rho1p is partially compromised (using a hypomorphic rho1 allele).  Rho2p is also a 
possible target, but because overexpressing Cdc24-PB1Δp could still suppress the iqg1Δ 
defect even without Rho2p, it cannot be the only target.  One possibility is that Cdc24-
PB1Δp can activate both Rho1p and Rho2p, which then both activate their downstream 
  89 
targets.  One test is to see if Cdc24-PB1Δp has GEF activity for Rho2p via in vitro assay.  
Rho5p is another possible candidate, but its reported role as a negative regulator (Schmitz et 
al., 2002) of the Rho1p-cell-integrity pathway is discordant with the model that Cdc24-
PB1Δp may activate downstream cell-integrity pathways to construct a better septum.  As 
Rho2p, Rho5p was not required for the suppression of the iqg1Δ defect by overexpressing 
Cdc24-PB1Δp.  Furthermore, the suppression of the iqg1Δ defect by overexpressing Rho5p 
appeared to be milder than the suppression by Rho1p, Rho2p, or Cdc24-PB1Δp, and is also 
discordant with the isolation of Rgd2p (GAP for Rho5p; Roumanie et al., 2001) as a dosage 
suppressor of the myo1Δ cyk3Δ growth defect.  Again, one test is to see if Cdc24-PB1Δp has 
GEF activity for Rho5p via in vitro assay.  The possible unknown factor(s) may either be an 
unidentified Rho-type GTPase in S. cerevisiae or a protein that is activated by Cdc24-PB1Δp 
independently of the GEF activity.  If the latter case is true, then the two mutations in the DH 
domain of Cdc24-DH8p probably cause defects in addition to GEF inactivation.  In that case, 
wild-type Cdc24p may have a minor GEF-independent role, which becomes dominant in the 
absence of the PB1 domain. 
 Finally, the suppression of the iqg1Δ growth defect by overexpressing Cdc24-PB1Δp 
requires the PB1 domain to be absent, because overexpressing wild-type Cdc24p could not 
suppress the same defect.  However, Cdc24p without its PB1 domain has been reported 
previously (Shimada et al., 2004) to be nonfunctional and likely degraded.  Consistent with 
this result, when the 299 amino acids (from the YEp13 vector) of Cdc24-PB1Δp were 
replaced with a stop codon, the resulting construct could no longer suppress the iqg1Δ spore 
inviability on YPD (data not shown), suggesting that the 299 amino acids might act a 
stabilizer that protects Cdc24-PB1Δp from degradation.  One experiment is to test if Cdc24-
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PB1Δp, with the 299 amino acids replaced by a GFP or 3HA epitope, can still suppress the 
iqg1Δ spore inviability. 
Suppressions by Overexpressing Egt2p or Other Dosage Suppressors 
The suppression of the iqg1Δ and chs2Δ growth defects by overexpressing Egt2p appears to 
be independent of primary-septum formation.  One possibility is that overexpressing an 
endoglucanase like Egt2p can help mutant cells with thick septa to conduct a more efficient 
hydrolysis of cell-wall materials during cell separation.  More efficient cell separations lead 
to fewer multi-cell clusters, and cells not in clusters can probably progress into the next cell 
cycle faster, because there is less limitation on its cell surface area.  An alternative 
explanation is that Egt2p may have a glucanase-independent function(s) that promotes the 
construction of a better thick septum.  Finally, the investigation of other isolated dosage 
suppressors, especially NAB6 and RPL30, are in progress. 
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FIGURE LEGENDS (1 to 8) 
Figure 3.1.  Dosage suppression of the myo1Δ cyk3Δ or myo1Δ hof1Δ synthetic growth 
defect.  (A) Strain RNY598 (myo1Δ::kanMX6 cyk3Δ::TRP1 [URA3 MYO1 plasmid])  was 
transformed with plasmid YEp13 or suppressor plasmids.  Strains KO725, KO1206, 
KO1207, KO1208, KO1209, KO1210, KO1211, KO1212, and KO1213 were grown to 
exponential phase (OD600 ≈ 0.4) in SC-Ura-Leu medium, and 5-µl aliquots of a dilution 
series (undiluted, 2x, 4x, 8x, and 80x diluted) were spotted onto SC-Ura-Leu and SC-Leu+5-
FOA plates and grown at 30˚C for 4 days.  (B) Strain RNY757 (myo1Δ::kanMX6 
hof1Δ::TRP1 [URA3 MYO1 plasmid])  was transformed with plasmid YEp13 or suppressor 
plasmids.  Strains KO723, KO1214, KO1215, and KO1216 were grown to exponential phase 
and dilution series were performed as described in A. 
 
Figure 3.2.  Suppression of the iqg1Δ or chs2Δ spore inviability and vegetative growth 
defect.  (A) Suppression of the spore inviability on YPD.  Tetrads were dissected on YPD 
from strains heterozygous for iqg1Δ::His3MX6 (top four rows) or chs2Δ::His3MX6 (bottom 
four rows) and carrying either plasmid YEp13 (KO836 or KO1190) or cdc24-PB1Δ (KO939 
or KO997), ECM33 (KO840 or KO995), or EGT2 (KO839 or KO993) plasmid.  With 
YEp13, no viable iqg1Δ or chs2Δ segregants were observed in more than 24 tetrads dissected 
for each strain.  With the cdc24-PB1Δ or ECM33 plasmid, all viable iqg1Δ and chs2Δ 
segregants (scored by growth on SC-His) also carried the corresponding plasmids (scored by 
growth on SC-Leu).  With the EGT2 plasmid, only viable iqg1Δ (carrying the plasmid) and 
no chs2Δ segregrants were isolated.  The numbers of viable segregants and tetrads dissected 
are described in Table 3.3.  (B) Suppression of the inability of vegetative iqg1Δ or chs2Δ 
cells to lose an IQG1 or CHS2 plasmid.  Strains RNY970 (top row) and RNY1419 (bottom 
row) were transformed with either plasmid YEp13 or cdc24-PB1Δ, ECM33, or EGT2 
plasmid.  Strains KO1130, KO1134, KO1132, KO1138, KO1095, KO1142, KO1140, and 
KO1097 were streaked onto SC-Ura-Leu and SC-Leu+5-FOA plates and grown for 5 days. 
 
Figure 3.3.  Suppression of the iqg1Δ or chs2Δ spore inviability by glycerol and slow-growth 
phenotype.  (A) iqg1Δ and chs2Δ spores are viable on YP+glycerol plates.  Tetrads were 
dissected on YP+glycerol from strains heterozygous for iqg1Δ::His3MX6 (RNY704) or 
chs2Δ::His3MX6 (ICY29).  After 14 days, all viable spore colonies were relocated onto 
YPD, grown for three more days, and then replicated onto SC-His to identify the iqg1Δ or 
chs2Δ segregants.  (B) Suppression of the slow-growth phenotype.  Strains scored were KO4, 
KO1243, KO1271, KO967, KO883, KO887, KO1016, KO1014, and KO1274.  Strains were 
grown in SC or SC-Leu (to select for plasmid) medium, and the doubling times shown are 
the averages of two measurements made as described in Materials and Methods. 
 
Figure 3.4.  Formation of primary-septum-like structures in iqg1Δ cells overexpressing 
Cdc24-PB1Δp or Ecm33p.  Strains KO4, KO969, KO967, KO883, and KO887 were grown 
to exponential phase in YM-P, SC-His, or SC-Leu medium and then collected for EM 
analysis as described in Materials and Methods.  At least 500 cytokinetic cells were observed 
for each strain. 
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Figure 3.5.  Formation of primary-septum-like structures in chs2Δ cells overexpressing 
Ecm33p.  Strains KO1255, KO1016, KO1014, and KO1105 were grown to exponential 
phase in SC-His or SC-Leu medium and then collected for EM analysis as described in 
Materials and Methods.  At least 500 cytokinetic cells were observed for each strain. 
 
Figure 3.6.  WGA labeling of iqg1Δ cells overexpressing Cdc24-PB1Δp or Ecm33p and 
chs2Δ cells overexpressing Ecm33p.  Strains KO883, KO967, and KO1014 were grown to 
exponential phase in SC-Leu medium and then collected for WGA labeling and EM analysis 
as described in Materials and Methods.  WGA (black dots; labels chitin) stained the primary-
septum-like structures (sharp-white stripes) of iqg1Δ cells overexpressing Cdc24-PB1Δp or 
Ecm33p, but seemed not to stain those of chs2Δ cells overexpressing Ecm33p.  At least 300 
chs2Δ cytokinetic cells with WGA-labeling were examined. 
 
Figure 3.7.  Single deletion of ECM33 and double deletions of ECM33 and PST1 may cause 
cytokinetic defects at 37˚C.  (A) ecm33Δ and ecm33Δ pst1Δ cells grow slightly slower than 
wild-type cells at 37˚C.  Strains scored were KO4, KO819, KO975, and KO981.  Strains 
were grown in YM-P medium, and the doubling times shown are the averages of two 
measurements made as described in Materials and Methods.  (B) Presence of multi-cell 
clusters in an ecm33Δ or ecm33Δ pst1Δ strain at 37˚C.  Strains KO819, KO975, and KO981 
were grown overnight in YM-P medium at 37˚C, collected by centrifugation, resuspended in 
water, and observed by DIC microscopy.  (C) Strains KO608, KO61, KO819, KO975, 
KO981, KO875, KO1056, and KO982 were grown to exponential phase (OD600 ≈ 0.4) in 
YM-P medium, and 5-µl aliquots of a dilution series (undiluted, 10x, 100x, 1000x, and 
10000x diluted) were spotted onto YPD plates and grown at the indicated temperatures for 4 
days. 
 
Figure 3.8.  The suppression by Cdc24-PB1Δp may involve Rho1p, Rho2p, Rho5p, and/or 
an unknown factor(s), but not Cdc42p.  (A) The inserts of the relevant plasmids.  The PB1 
domain (which is absent in the cdc24-PB1Δ plasmid) of wild-type Cdc24p is from amino 
acids 781-855.  (B) Cdc24-PB1Δp cannot function as wild-type Cdc24p.  Strain YEF313 
(cdc24-4) was transformed with the indicated plasmids, streaked onto SC-Leu plates, and 
grown for 3 days at the indicated temperatures.  (C) The suppression of the iqg1Δ spore 
inviability in the absence of Rho2p and/or Rho5p.  Tetrads were dissected on YPD from a 
strain (KO1445) carrying the cdc24-PB1Δ plasmid and heterozygous for iqg1Δ::His3MX6, 
rho2Δ::TRP1, and rho5Δ::kanMX6.  In 32 tetrads dissected, five iqg1Δ, eight iqg1Δ rho2Δ, 
12 iqg1Δ rho5Δ, and four iqg1Δ rho2Δ rho5Δ viable segregants carrying the plasmid were 
recovered.  (D) The overexpression of Cdc24-PB1Δp does not suppress the synthetic lethality 
of tus1Δ rom2Δ.  Tetrads were dissected on YPD from strains (KO1391 and KO1392) 
heterozygous for tus1Δ::His3MX6 and rom2Δ::TRP1.  In 44 tetrads dissected, no viable 
tus1Δ rom2Δ segregants were recovered. 
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Table 3.1.  Strain List of Chapter 3 
___________________________________________________________________________ 
 
Strain a Genotype       Source 
___________________________________________________________________________ 
 
YEF473 a/α his3-Δ200/his3-Δ200 leu2-Δ1/leu2-Δ1 lys2-801/ Bi and 
lys2-801 trp1-Δ63/trp1-Δ63 ura3-52/ura3-52  Pringle, 1996 
YEF473A a his3-Δ200 leu2-Δ1 lys2-801 trp1-Δ63 ura3-52  Segregant 
          from YEF473  
YEF473B α his3-Δ200 leu2-Δ1 lys2-801 trp1-Δ63 ura3-52  Segregant 
          from YEF473 
YEF313 as YEF473A except cdc24-4     Shimada et al. 
          2004 
ICY29  as YEF473 except chs2Δ::His3MX6/+   This study b 
RNY598 as YEF473A except myo1Δ::kanMX6 cyk3Δ::TRP1  Nishihama et 
  [pRS316-MYO1]      al., 2007 
RNY704 as YEF473 except iqg1Δ::His3MX6/+   Nishihama et  
          al., 2007 
RNY757 as YEF473A except myo1Δ::kanMX6 hof1Δ::TRP1  This study c 
  [pRS316-MYO1] 
RNY970 as YEF473A except iqg1Δ::His3MX6 [p1868]  Nishihama et  
          al., 2007 
RNY1232 as YEF473 except iqg1Δ::kanMX6/+   This study b 
RNY1233 as YEF473 except iqg1Δ::kanMX6/+   This study b 
RNY1419 as YEF473A except chs2Δ::kanMX6 [pJC328]   Nishihama et 
        al., 20007  
KO4  as YEF473A       This study 
KO61  as YEF473A except hof1Δ::TRP1    This study d 
KO608 as YEF473A except myo1Δ::kanMX6   see Chapter 2 
KO723  as YEF473A except myo1Δ::kanMX6 hof1Δ::TRP1  This study c 
  [pRS316-MYO1] [YEp13] 
KO725  as YEF473A except myo1Δ::kanMX6 cyk3Δ::TRP1  This study c 
  [pRS316-MYO1] [YEp13] 
KO819 as YEF473A except ecm33Δ::His3MX6   This study d 
KO836  as YEF473 except iqg1Δ::His3MX6/+ [YEp13]  This study e 
KO838 as YEF473 except iqg1Δ::His3MX6/+ [YEp13-YJL055W] This study e 
KO839  as YEF473 except iqg1Δ::His3MX6/+ [YEp13-EGT2] This study e 
KO840  as YEF473 except iqg1Δ::His3MX6/+ [YEp13-ECM33] This study e 
KO853 as YEF473 except iqg1Δ::His3MX6/+ [YEp13-YJL055W] This study e 
KO854  as YEF473 except iqg1Δ::His3MX6/+ [YEp13-ECM33] This study e 
KO855  as YEF473 except iqg1Δ::His3MX6/+ [YEp13-EGT2] This study e 
KO875  as YEF473B except hof1Δ::TRP1 ecm33Δ::His3MX6 This study d 
KO883  as YEF473A except iqg1Δ::His3MX6 [YEp13-ECM33] Segregant 
          from KO840 
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KO887  as YEF473B except iqg1Δ::His3MX6 [YEp13-EGT2] Segregant 
          from KO839 
KO933 as YEF473 except iqg1Δ::His3MX6/+ [YEp13-RGD2] This study e 
KO934 as YEF473 except iqg1Δ::His3MX6/+ [YEp13-RGD2] This study e 
KO935 as YEF473 except iqg1Δ::His3MX6/+ [YEp13-RHO1] This study e 
KO936 as YEF473 except iqg1Δ::His3MX6/+ [YEp13-RHO1] This study e 
KO937 as YEF473 except iqg1Δ::His3MX6/+ [YEp13-RPL30] This study e 
KO938 as YEF473 except iqg1Δ::His3MX6/+ [YEp13-RPL30] This study e 
KO939  as YEF473 except iqg1Δ::His3MX6/+   This study e 
  [YEp13-cdc24-PB1Δ] 
KO940 as YEF473 except iqg1Δ::His3MX6/+   This study e 
  [YEp13-cdc24-PB1Δ] 
KO941 as YEF473 except iqg1Δ::His3MX6/+ [YEp13-MNN9] This study e 
KO942 as YEF473 except iqg1Δ::His3MX6/+ [YEp13-MNN9] This study e 
KO964 as YEF473 except iqg1Δ::His3MX6/+ [YEp13-NAB6] This study e 
KO965 as YEF473 except iqg1Δ::His3MX6/+ [YEp13-NAB6] This study e 
KO967  as YEF473A except iqg1Δ::His3MX6   Segregant 
  [YEp13-cdc24-PB1Δ]      from KO939  
KO969 as YEF473B except iqg1Δ::His3MX6    This study f 
KO975  as YEF473B except pst1Δ::TRP1    This study d 
KO981 as YEF473A except ecm33Δ::His3MX6 pst1Δ::TRP1 This study d 
KO982  as YEF473A except myo1Δ::kanMX6 ecm33Δ::His3MX6 This study d 
  pst1Δ::TRP1 
KO993  as YEF473 except chs2Δ::His3MX6/+ [YEp13-EGT2] This study e 
KO994  as YEF473 except chs2Δ::His3MX6/+ [YEp13-EGT2] This study e 
KO995 as YEF473 except chs2Δ::His3MX6/+ [YEp13-ECM33] This study e 
KO996 as YEF473 except chs2Δ::His3MX6/+ [YEp13-ECM33] This study e 
KO997 as YEF473 except chs2Δ::His3MX6/+   This study e 
  [YEp13-cdc24-PB1Δ] 
KO998 as YEF473 except chs2Δ::His3MX6/+   This study e 
  [YEp13-cdc24-PB1Δ] 
KO1014 as YEF473B except chs2Δ::His3MX6 [YEp13-ECM33] Segregant  
          from KO995 
KO1016 as YEF473A except chs2Δ::His3MX6   Segregant 
  [YEp13-cdc24-PB1Δ]      from KO997 
KO1040 as YEF473 except iqg1Δ::His3MX6/+   This study e 
 [pGAL-6xHIS-CDC42] 
KO1041 as YEF473 except iqg1Δ::His3MX6/+   This study e 
 [pGAL-6xHIS-CDC42] 
KO1042 as YEF473 except iqg1Δ::His3MX6/+ [YEp51(42)]  This study e 
KO1043 as YEF473 except iqg1Δ::His3MX6/+ [YEp51(42)]  This study e 
KO1056 as YEF473A except hof1Δ::TRP1 ecm33Δ::His3MX6 This study d 
  pst1Δ::kanMX6 
KO1095 as YEF473A except chs2Δ::kanMX6  [pJC328] [YEp13] This study e 
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KO1097 as YEF473A except chs2Δ::kanMX6 [pJC328]  This study e 
 [YEp13-EGT2] 
KO1105 as YEF473A except chs2Δ::kanMX6 [YEp13-EGT2] This study g 
KO1130 as YEF473A except iqg1Δ::His3MX6 [p1868] [YEp13] This study e 
KO1132 as YEF473A except iqg1Δ::His3MX6 [p1868]  This study e 
[YEp13-ECM33] 
KO1134 as YEF473A except iqg1Δ::His3MX6 [p1868]  This study e 
[YEp13-cdc24-PB1Δ] 
KO1138 as YEF473A except iqg1Δ::His3MX6 [p1868]  This study e 
[YEp13-EGT2] 
KO1140 as YEF473A except chs2Δ::kanMX6 [pJC328]  This study e 
 [YEp13-ECM33] 
KO1142 as YEF473A except chs2Δ::kanMX6 [pJC328]  This study e 
 [YEp13-cdc24-PB1Δ] 
KO1190 as YEF473 except chs2Δ::His3MX6/+ [YEp13]  This study e 
KO1206 as YEF473A except myo1Δ::kanMX6 cyk3Δ::TRP1  This study c 
  [pRS316-MYO1] [YEp13-ECM33] 
KO1207 as YEF473A except myo1Δ::kanMX6 cyk3Δ::TRP1  This study c 
  [pRS316-MYO1] [YEp13-EGT2] 
KO1208 as YEF473A except myo1Δ::kanMX6 cyk3Δ::TRP1  This study c 
  [pRS316-MYO1] [YEp13-cdc24-PB1Δ] 
KO1209 as YEF473A except myo1Δ::kanMX6 cyk3Δ::TRP1  This study c 
  [pRS316-MYO1] [YEp13-RHO1] 
KO1210 as YEF473A except myo1Δ::kanMX6 cyk3Δ::TRP1  This study c 
  [pRS316-MYO1] [YEp13-RGD2] 
KO1211 as YEF473A except myo1Δ::kanMX6 cyk3Δ::TRP1  This study c 
  [pRS316-MYO1] [YEp13-RPL30] 
KO1212 as YEF473A except myo1Δ::kanMX6 cyk3Δ::TRP1  This study c 
  [pRS316-MYO1] [YEp13-NAB6] 
KO1213 as YEF473A except myo1Δ::kanMX6 cyk3Δ::TRP1  This study c 
  [pRS316-MYO1] [YEp13-MNN9] 
KO1214 as YEF473A except myo1Δ::kanMX6 hof1Δ::TRP1  This study c 
  [pRS316-MYO1] [YEp13-ECM33] 
KO1215 as YEF473A except myo1Δ::kanMX6 hof1Δ::TRP1  This study c 
  [pRS316-MYO1] [YEp13-EGT2] 
KO1216 as YEF473A except myo1Δ::kanMX6 hof1Δ::TRP1  This study c 
  [pRS316-MYO1] [YEp13-YJL055W] 
KO1243  as YEF473A except iqg1Δ::His3MX6 [YEp13]  This study f 
KO1255 as YEF473A except chs2Δ::His3MX6   This study f 
KO1271  as YEF473A except chs2Δ::His3MX6 [YEp13]  This study f 
KO1274 as YEF473A except chs2Δ::kanMX6 [YEp13-EGT2] This study g 
KO1324 as YEF473A except cdc24-4 [YEp13-CDC24]  This study h 
KO1332 as YEF473A except cdc24-4 [YEp13]   This study h 
KO1340 as YEF473 except iqg1Δ::kanMX6/+ [YEp13-CDC24] This study e 
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KO1341 as YEF473 except iqg1Δ::kanMX6/+ [YEp13-CDC24] This study e 
KO1342 as YEF473 except iqg1Δ::kanMX6/+ [YEp13-CDC24] This study e 
KO1343 as YEF473 except iqg1Δ::kanMX6/+ [YEp13-CDC24] This study e 
KO1344 as YEF473 except iqg1Δ::kanMX6/+ [YEp13-CDC24] This study e 
KO1345 as YEF473 except iqg1Δ::kanMX6/+ [YEp13-CDC24] This study e 
KO1346 as YEF473 except iqg1Δ::kanMX6/+ [YEp13-cdc24-DH8] This study e 
KO1348 as YEF473 except iqg1Δ::kanMX6/+ [YEp13-cdc24-DH8] This study e 
KO1350 as YEF473 except iqg1Δ::kanMX6/+ [YEp13-cdc24-DH8] This study e 
KO1368 as YEF473 except iqg1Δ::kanMX6/+ [pGAL-RHO5] This study e 
KO1369 as YEF473 except iqg1Δ::kanMX6/+ [pGAL-RHO5] This study e 
KO1381 as YEF473 except iqg1Δ::kanMX6/+ [pGAL-RHO1] This study e 
KO1382 as YEF473 except iqg1Δ::kanMX6/+ [pGAL-RHO1] This study e 
KO1383 as YEF473 except iqg1Δ::kanMX6/+ [pGAL-RHO2] This study e 
KO1384 as YEF473 except iqg1Δ::kanMX6/+ [pGAL-RHO2] This study e 
KO1385 as YEF473 except iqg1Δ::kanMX6/+ [pGAL-RHO3] This study e 
KO1386 as YEF473 except iqg1Δ::kanMX6/+ [pGAL-RHO3] This study e 
KO1387 as YEF473 except iqg1Δ::kanMX6/+ [pGAL-RHO4] This study e 
KO1388 as YEF473 except iqg1Δ::kanMX6/+ [pGAL-RHO4] This study e 
KO1391 as YEF473 except tus1Δ::His3MX6/+ rom2Δ::TRP1/+ This study i 
  [YEp13-cdc24-PB1Δ]] 
KO1392 as YEF473 except tus1Δ::His3MX6/+ rom2Δ::TRP1/+ This study i 
  [YEp13-cdc24-PB1Δ]] 
KO1445 as YEF473 except iqg1Δ::His3MX6/+ rho2Δ::TRP1/+ This study j 
  rho5Δ::kanMX6/+ [YEp13-cdc24-PB1Δ] 
KO1462 as YEF473A except cdc24-4 [YEp13-cdc24-PB1Δ]  This study h 
KO1466 as YEF473A except cdc24-4 [pRS315-CDC24]  This study h 
___________________________________________________________________________ 
a Denotes strains of the S288C genetic background (Mortimer and Johnson, 1986) 
b Strain YEF473 was transformed with an iqg1Δ::kanMX6 or chs2Δ::His3MX6 deletion 
cassette. 
c Tetrads were dissected on YPD from two strains (carrying pRS316-MYO1) doubly 
heterozygous either for myo1Δ::kanMX6 and cyk3Δ::TRP1 or myo1Δ::kanMX6 and 
hof1Δ::TRP1.  Viable double mutant segregants carrying the plasmid were isolated and 
transformed with either plasmid YEp13 or a high-copy YEp13-based genomic library. 
d Tetrads were dissected on YPD from a strain either heterozygous for hof1Δ::TRP1, doubly 
heterozygous for ecm33Δ::His3MX6 and hof1Δ::TRP1, triply heterozygous for 
ecm33Δ::His3MX6, hof1Δ::TRP1, and pst1Δ::kanMX6, or triply heterozygous for 
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ecm33Δ::His3MX6, myo1Δ::kanMX6, and pst1Δ::TRP1.  Viable single, double, and triple 
mutant segregants were isolated. 
e RNY704, RNY1232, RNY1233, ICY29, RNY970, and RNY1419 were transformed with 
the indicated plasmids.  
f Tetrads were dissected on YP+glycerol plates from four strains carrying either no plasmid 
or plasmid YEp13 and heterozygous either for iqg1Δ::His3MX6 or chs2Δ::His3MX6.  After 
2 weeks at 23˚C, viable single mutant segregants carrying either no plasmid or YEp13 were 
isolated. 
g Strain KO1097 was streaked onto SC-Leu+5-FOA for single colonies.  Viable 
chs2Δ colonies carrying only YEp13-EGT2 were isolated. 
h Strain YEF313 was transformed with the indicated plasmids. 
i A strain heterozygous for tus1Δ::His3MX6 and rom2Δ::TRP1 was transformed with 
YEp13-cdc24-PB1Δ. 
j Strain KO939 was transformed with a rho2Δ::TRP1 and rho5Δ::kanMX6 deletion cassettes.
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Table 3.2.  Plasmid List of Chapter 3 
___________________________________________________________________________ 
 
Plasmid     Description     Source 
___________________________________________________________________________ 
 
YEp13      2µ, LEU2 (high copy)   Broach et al., 1979 
pRS316-MYO1    CEN6 URA3 MYO1 (low copy)  Nishihama et al., 2007 
pJC328     CEN6 URA3 CHS2myc (low copy)  Chuang and Schekman, 
         1996 
p1868      CEN6 URA3 IQG1 (low copy)  Korinek et al., 2000 
YEp13-ECM33    ECM33 in YEp13    See text 
YEp13-EGT2     EGT2 in YEp13    See text 
YEp13-cdc24-PB1Δ    cdc24-PB1Δ in YEp13   See text 
YEp13-CDC24    CDC24 in YEp13    See text 
pRS315-CDC24    CEN6 LEU2 CDC24 (low copy)  See text 
YEp13-cdc24-DH8    cdc24-DH8 in YEp13   See text 
pGAL-6xHIS-CDC42    CEN4 LEU2 PGAL-CDC42 (low copy) See text 
YEp51(42)     2µ, LEU2 PGAL-CDC42 (high copy) Johnson and Pringle,  
         1990 
pGAL-RHO1     CEN4 LEU2 PGAL-RHO1 (low copy) See text 
pGAL-RHO2     CEN4 LEU2 PGAL-RHO2 (low copy) See text 
pGAL-RHO3     CEN4 LEU2 PGAL-RHO3 (low copy) See text 
pGAL-RHO4     CEN4 LEU2 PGAL-RHO4 (low copy) See text 
pGAL-RHO5     CEN4 LEU2 PGAL-RHO5 (low copy) See text 
YEp13-RHO1     RHO1 in YEp13    See text 
YEp13-RGD2     RGD2 in YEp13    See text 
YEp13-RPL30    RPL30 in YEp13    See text 
YEp13-NAB6     NAB6 in YEp13    See text 
YEp13-MNN9    MNN9 in YEp13    See text 
YEp13-YJL055W    YJL055W in YEp13    See text 
___________________________________________________________________________ 
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Table 3.3.  Suppression of the iqg1Δ or chs2Δ spore inviability 
___________________________________________________________________________ 
 
Dosage Suppressor           Tetrads     Total viable    iqg1Δ or chs2Δ     Carrying  
             dissected    spores    spores          plasmid 
___________________________________________________________________________ 
 
A ECM33    33  75  12  52 
C ECM33    22  49  5  35 
A EGT2    33  39  2  20 
C EGT2    22  40  0  22 
A cdc24-PB1Δ    22  65  20  62 
C cdc24-PB1Δ    21  62  18  57 
A CDC24    66  131  0  96 
A cdc24-DH8    31  58  0  45 
B CDC42    43  85  0  59  
A RHO1    22  42  0  36 
B RHO1    22  50  12  30  
B RHO2    22  61  17  41  
B RHO3    22  42  0  27  
B RHO4    22  38  0  28  
B RHO5    22  51  6  37  
A RGD2    20  40  0  34 
A RPL30    22  42  0  11 
A NAB6    43  85  0  30 
A MNN9    21  34  0  18 
A YJL055W    11  21  0  16 
___________________________________________________________________________ 
A A strain heterozygous for iqg1Δ was transformed with a high-copy plasmid overexpressing 
an indicated dosage-suppressor gene, tetrads were then dissected on YPD from two 
genetically identical diploid transformants [except for CDC24 (six identical) and cdc24-DH8 
(three identical)], and spore colonies were allowed to grow for at least 7 days before 
replicating to selective plates. 
B A strain heterozygous for iqg1Δ was transformed with a low-copy plasmid overexpressing 
an indicated dosage-suppressor gene from a GAL promoter, tetrads were then dissected on 
YPGal/Raff from two genetically identical diploid transformants, and spore colonies were 
allowed to grow for at least 14 days before replicating to selective plates.  In the case for 
CDC42, a low-copy and a high-copy plasmid (both overexpressing from a GAL promoter) 
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were used, and tetrads were dissected from four transformants. 
C A strain heterozygous for chs2Δ was transformed with a high-copy plasmid overexpressing 
an indicated dosage-suppressor gene, tetrads were dissected on YPD from two genetically 
identical diploid transformants, and spore colonies were allowed to grow for at least 7 days 
before replicating to selective plates. 
  109 
Table 3.4.  Primer List of Chapter 3 a 
___________________________________________________________________________ 
 
Primer a Purpose   Sequence 
___________________________________________________________________________ 
 
5'TTEF Internal check primer  5'-TATTTTTTTTCGCCTCGACATCATC 
of the His3MX6 or  TGCCC-3' 
kanMX6 marker 
 
3'PTEF Internal check primer  5'-GTATGGGCTAAATGTACGGGCGAC 
of the His3MX6 or   AGTCAC-3' 
kanMX6 marker 
 
5'TRP1 Internal check primer  5'-TAAAAGACTCTAACAAAATAGCAA 
  of the TRP1 marker  ATTTCG-3' 
 
3'TRP1 Internal check primer  5'-GTGCTTAATCACGTATACTCACGTG 
  of the TRP1 marker   CTCAA-3' 
 
ML176 5' primer to construct  5'-CATATAGACCCAAATAAAAACCAA 
  chs2Δ::His3MX6  AGAACCACATATAGAACGGATCCCC 
      GGGTTAATTAA-3' 
 
ML177 3' primer to construct  5'-AAAGAGGGAATGACGAGAAATTAG 
  chs2Δ::His3MX6  CTGAAAAATACTGGCAGAATTCGAGC 
      TCGTTTAAAC-3' 
 
CHS2-5'-656 Upstream check primer 5'-ACTCGATCGAGCCTTCTCGCACT-3' 
  for chs2Δ::His3MX6  
 
CHS2-3' Downstream check primer 5'-ACTAGTTCTAGCGACACGTCCT-3' 
-3370  for chs2Δ::His3MX6 
 
ECM33dF 5' primer to construct  5'-CTTTTAAAGATCTAGTTTTAATTTT 
  ecm33Δ   ACTATTATTCCGCACGGATCCCCGGG 
      TTAATTA-3' 
     
ECM33dR 3' primer to construct  5'-ACAATAAGAAATAAAAGAGATATT 
  ecm33Δ   AACGACACTAAAATTGAATTCGAGCT 
      CGTTTAAAC-3' 
 
ECM33dK Upstream check primer 5'-AGGTTGATTACTGCTTTATTTTCCT 
  for ecm33Δ   TTCTT-3' 
 
ECM33dC Downstream check primer 5'-CCAGCTACTCCAGCAACCCCAGCA 
  for ecm33Δ   ACCCCA-3 
 
PST1dF 5' primer to construct  5'-AGAGAGAAGCAAAAAAAAAAAGC 
  pst1Δ    TCGCTATAAAAATATCCGGATCCCCG 
      GGTTAATTA-3'    
      
PST1dR 3' primer to construct  5'-GTACTAGTTATCAAAAATGAAGAA 
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  pst1Δ    TATTTCTTCATTCCAGAATTCGAGCTC 
      GTTTAAAC-3' 
 
PST1dK Upstream check primer 5'-CTCCTTTGGACTGAACCCGCATTA 
  for pst1Δ   GTAATT-3' 
 
PST1dC Downstream check primer 5'-AACAACCGTTAATATACAGGATGT 
  for pst1Δ   TGAAGT-3 
 
HOF1-F1 5' primer to construct  5'-TTGGAAAGTGTACTACTAATATTCA 
  hof1Δ    GAAAAAGGTGAAAGACGGATCCCCG 
      GGTTAATTA-3' 
 
HOF1-R1 3' primer to construct  5'-CTTTTATCAGAAAACTAGTAAAATT 
  hof1Δ    GATATACATCGAGAGAATTCGAGCTC 
      GTTTAAAC-3' 
   
HOF1/-500F Upstream check primer 5'-GTGTAATCGTCAGAGTGCACTATTT 
  for hof1Δ   -3' 
 
HOF1/3510R Downstream check primer 5'-TCCTGCCTAAATGGAGCCATATTCA 
  for hof1Δ   -3' 
 
RHO2dF 5' primer to construct  5'-TGAAACGTTCTGCTTTGGTTGTGCT 
  rho2Δ    TTTGATCCCGTACTCGGATCCCCGG 
      GTTAATTA-3'    
          
RHO2dR 3' primer to construct  5'-TGCTAAAAAGATAATGTATCATTT 
  rho2Δ    CAGTGTAAGTTTTTTGAATTCGAGCT 
      CGTTTAAAC-3' 
 
RHO2dK Upstream check primer 5'-TAGGACTTAACTTGGATTACTCGA 
  for rho2Δ   CGTTTA-3' 
 
RHO2dC Downstream check primer 5'-TTTTTAAGATATGTTCCAGTTGAGA 
  for rho2Δ   AATTT-3 
 
RHO5dF 5' primer to construct  5'-AATATTTATTAAATACAATATAGTA 
  rho5Δ    TACTAATAAGTCTGCGGATCCCCGGG 
      TTAATTA-3' 
         
RHO5dR 3' primer to construct  5'-ATATGTAATTATTTATTTACTTTTT 
  rho5Δ    CTGCCTCCTTGATAGAATTCGAGCTC 
      GTTTAAAC-3' 
 
RHO5dK Upstream check primer 5'-ATACTAAAGCTGCAGTGAGAGTAA 
  for rho5Δ   ACCGGA-3' 
 
RHO5dC Downstream check primer 5'-GTTTTTCGCAAGCAGCAAGCTACA 
  for rho5Δ   ATTGGG-3 
 
ROM2-F1 5' primer to construct  5'-TGCTGACTTAATTGGACAATTCATC 
  rom2Δ    TCTTTTCCTGCGGTTCGGATCCCCGG 
      GTTAATTAA-3' 
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ROM2-R1 3' primer to construct  5'-ATTCTAAAGAAAATAAGGAAAGTC 
  rom2Δ    TATATACGTTGCTATCGAATTCGAGC 
      TCGTTTAAAC-3' 
 
ROM2/-501F Upstream check primer 5'-AGTGTTAGGATCTACAGGGAAAGT 
  for rom2Δ   -C3' 
 
ROM2/4590R Downstream check primer 5'-GAAGTAAGCTTGAAGCGAGTGAAG 
  for rom2Δ   -A3' 
 
TUS1-F1 5' primer to construct  5'-AACATTAAAACAAAAAACTTATTG 
  tus1Δ    AGTGCAGCAAGTTAACCGGATCCCCG 
      GGTTAATTAA-3'    
 
TUS1-R1 3' primer to construct  5'-TTACAACGATATTTACCATTAAAAG 
  tus1Δ    TGTCTATATCTTATAGAATTCGAGCT 
      CGTTTAAAC-3' 
 
TUS1/-481F Upstream check primer 5'-AACCAGTCATGCAAAGGAAATGCG 
  for tus1Δ   -T3' 
 
TUS1/4430R Downstream check primer 5'-GGTCGGGACAGGTCGCCTGGAAGA 
  for tus1Δ   -G3' 
     
CDC24P3 5' primer to construct  5'-ATATCATATAATAACAACTCTAATA 
  YEp13-CDC24  ATACCTCTAGTAGCG-3' 
 
CDC24P4 3' primer to construct  5'-TAGGTTGAGGCCGTTGAGCACCGC 
  YEp13-CDC24  CGCCGCAAGGAATGGTTTTTTTCTTTT 
      TGTTTTCACAGGACTCATT-3' 
 
CDC24P7 5' primer to construct  5'-ACAGCAAATCATGAACGCAGAAAA 
  YEp13-cdc24-DH8  CCAACACCGACATCAG-3' 
 
CDC24P8 3' primer to construct  5'-GCTGCCATTGTTGTCCGTTATGTTC 
  YEp13-cdc24-DH8  -3' 
 
pQErev 5' primer to construct  5'-AAGCTCAGCTAATTAAGC-3' 
  pGAL-6xHIS-CDC42 
 
SalI-HIS 3' primer to construct  5'-ACGCGTCGACATGAGAGGATCGCA 
  pGAL-6xHIS-CDC42  TCAC-3' 
  
T3  5' primer to construct  5'-ATTAACCTCACTAAAGGGA-3' 
  pQE-6xHIS-CDC42 
 
BamHI 3' primer to construct  5'-CGGGATCCATGCAAACGCTAAAGT 
-CDC42 pQE-6xHIS-CDC42  GTGT-3' 
 
GAL-RHO1 5' primer to construct  5'-TACCTCTATACTTTAACGTCAAGGA 
  pGAL-RHO1   GAAAAAACTATAATGTCACAACAAG 
      TTGGTAA-3' 
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3'IF-RHO1 3' primer to construct  5'-CCCCGGGCTGCAGGAATTCGATAT 
  pGAL-RHO1   CAAGCTTATCGATACCAATAGATGAT 
      AATACTTACT-3' 
 
GAL-RHO2 5' primer to construct  5'-TACCTCTATACTTTAACGTCAAGGA 
  pGAL-RHO2   GAAAAAACTATAATGTCTGAAAAGG 
      CCGTTAG-3' 
 
3'IF-RHO2 3' primer to construct  5'-CCCCGGGCTGCAGGAATTCGATAT 
  pGAL-RHO2   CAAGCTTATCGATACCTCCGTCGGAA 
      ATTTTGCTTC-3' 
 
GAL-RHO3 5' primer to construct  5'-TACCTCTATACTTTAACGTCAAGGA 
  pGAL-RHO3   GAAAAAACTATAATGTCATTTCTATG 
      TGGGTC-3' 
 
3'IF-RHO3 3' primer to construct  5'-CCCCGGGCTGCAGGAATTCGATAT 
  pGAL-RHO3   CAAGCTTATCGATACCTCGAGCACAT 
      GCTGGAGGGG-3'  
 
GAL-RHO4 5' primer to construct  5'-TACCTCTATACTTTAACGTCAAGGA 
  pGAL-RHO4   GAAAAAACTATAATGAATACACTATT 
      ATTTAA-3' 
 
3'IF-RHO4 3' primer to construct  5'-CCCCGGGCTGCAGGAATTCGATAT 
  pGAL-RHO4   CAAGCTTATCGATACCTGAATTATTA 
      TGATAAAATT-3' 
 
GAL1-seq 5' primer to construct  5'-AACAAAAAATTGTTAATATACC-3' 
  pGAL-RHO5    
 
3'IF-RHO5 3' primer to construct  5'-GGCTGCAGGAATTCGATATCAAGC 
  pGAL-RHO5   TTATCGATACCACTATTTGATAATAC 
      GGAAAGAGAT-3' 
___________________________________________________________________________ 
a Primers that were used to construct iqg1Δ, chs2Δ::kanMX6, and cyk3Δ strains are listed in 
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CONTROL OF 5-FOA RESISTANCE BY SACCHAROMYCES CEREVISIAE YJL055W 
 
ABSTRACT 
In a URA3/5-FOA-based dosage-suppressor screen, we isolated a plasmid containing the 
little-characterized ORF YJL055W.  Further analysis showed that this gene did not suppress 
the mutation of interest.  Instead, overexpression of Yjl055Wp directly suppresses the 
inviability of URA3+ cells in the presence of 5-FOA.  However, deletion of YJL055W has no 
detectable effect on 5-FOA resistance.  Based on these observations and a previous report 
that a yjl055wΔ mutant has increased sensitivity to purine-analog mutagens, we suggest that 
Yjl055Wp may function in one of several pathways for the detoxification of base analogs.  
However, its precise mechanism of action remains unknown
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INTRODUCTION 
In Saccharomyces cerevisiae, 5-fluoroorotic acid (5-FOA) has long been used in various 
genetic screens to select against URA3+ cells (Boeke et al., 1984; Rothstein, 1991; Sikorski 
and Boeke, 1991).  URA3 encodes orotidine-5'-phosphate decarboxylase, an enzyme in the 
uracil biosynthetic pathway that can convert 5-FOA into 5-fluorouracil (5-FU).  5-FU is a 
pyrimidine analog that can be mis-incorporated into RNA and DNA in place of uracil or 
thymine, leading to interference with RNA and DNA processing and function and thus to cell 
death.  ura3 mutants require exogenous uracil for growth and are viable in medium 
containing 5-FOA.  The presence of a URA3-marked plasmid makes ura3 cells sensitive to 5-
FOA, but they can survive on medium containing 5-FOA and uracil by spontaneously losing 
the plasmid.  Thus, dosage-suppressor screens can be conducted by transforming a genomic 
or cDNA library in a vector with a non-URA3 marker into a strain that harbors both a lethal 
mutation and a URA3-marked plasmid that contains a wild-type copy of the mutated gene.  
The original strain is inviable on 5-FOA medium, but the presence of a library plasmid that 
carries either a wild-type copy of the mutated gene or a dosage suppressor allows cells to lose 
the URA3 plasmid and thus survive in the presence of 5-FOA.  A potential problem with such 
a screen is that a gene might be isolated not because it suppresses the lethal mutation of 
interest but because it directly suppresses the lethality caused by 5-FOA in URA3+ cells.  We 
report here that the largely uncharacterized ORF YJL055W is such a gene. 
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MATERIALS AND METHODS 
Strains, Growth Conditions, Growth-Rate Measurements, and Genetic Methods 
The S. cerevisiae strains used in this study were RNY757 (MATa his3-Δ200 leu2-Δ1 lys2-
801 trp1-Δ63 ura3-52 myo1Δ::kanMX6 hof1Δ::TRP1 [pRS316-MYO1]) (see Chapter 3), 
DC-5 (MATa leu2-3,112 his3 canR URA3+) (Broach et al., 1979), and KO1468 (as DC-5 
except yjl055wΔ::His3MX6).  To construct KO1468, the entire coding region of YJL055W in 
strain DC-5 was deleted using the PCR method (Baudin et al., 1993; Longtine et al., 1998) 
and the primers indicated in Table 4.1.  The success of the deletion was confirmed by two 
PCR tests that used check primers that were upstream and downstream of the deleted region 
together with primers internal to the selectable marker (Longtine et al., 1998; Table 4.1).  
Yeast were grown on YP rich medium, synthetic complete (SC) medium, or SC medium 
lacking specific nutrients as needed to select plasmids or transformants (Guthrie and Fink, 
1991).  2% glucose was used as carbon source.  Liquid cultures were grown at 23˚C, and 
plates were incubated at 30˚C.  5-FOA (Research Products International, Mt. Prospect, IL) 
was used at 1 mg/ml (except as indicated) to select against URA3+ cells.  To determine 
growth rates, exponential-phase cultures (OD600 ≈ 0.4) in SC-Ura medium were diluted two-
fold with fresh SC-Ura, incubation was continued, and the times needed to return to the 
original OD600 were recorded as the doubling times.  Standard procedures were used for 
growth of Escherichia coli, genetic manipulations, polymerase chain reaction (PCR), and 
other molecular biological procedures (Sambrook et al., 1989; Guthrie and Fink, 1991; 
Ausubel et al., 1995). 
Plasmids 
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Plasmid pRS316-MYO1 contains the MYO1 gene in the low-copy, URA3-marked vector 
pRS316 (Sikorski and Hieter, 1989; Nishihama et al., 2007).  Plasmid p757-8-2 (see Figure 
4.1A) was isolated in a dosage-suppressor screen using strain RNY757 and a genomic-DNA 
library (DeMarini et al., 1997) constructed by cloning Sau3A fragments into the BamHI site 
of plasmid YEp13 (high-copy, LEU2; Broach et al., 1979).  Plasmid p757-8-2-ΔYJL055W 
(see Figure 4.1A) was constructed using the PCR method (Baudin et al., 1993).  Cells of a 
leu2Δ his3Δ strain containing p757-8-2 were transformed with a PCR fragment obtained 
using plasmid pFA6a-His3MX6 (Longtine et al., 1998) as template and primers YEp13sp168 
and YJL55dsr2 (Table 4.1).  This was expected to replace the region from nucleotide +258 
relative to the start site of YJL055W to nucleotide +10 relative to the BamHI cloning site of 
YEp13 with the His3MX6 marker, and the success of the construction was confirmed by two 
PCR tests that used the isolated plasmid as template and check primers that were upstream 
and downstream of the deleted region together with primers internal to the selectable marker 
(Table 4.1).  Plasmid YEp13-YJL055Wsub (see Figure 4.1A) was constructed in two steps.  
First, a fragment containing nucleotides from -621 relative to the start site of YJL055W to 
+521 relative to its stop codon was PCR-amplified using p757-8-2 as template and primers 
YJL055WF and YJL055WR (Table 4.1).  YJL055WF contained nucleotides -49 to -11 
relative to the BamHI site of YEp13 plus nucleotides -621 to -601 relative to the start site of 
YJL055W, whereas YJL055WR contained nucleotides +49 to +11 relative to the BamHI site 
of YEp13 plus nucleotides +521 to +501 relative to the stop codon of YJL055W.  In the 
second step, the PCR product from the first step was purified and transformed together with 
BamHI-cut YEp13 into leu2Δ yeast cells, and transformants (containing plasmids resulting 
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from homologous recombination) were selected on SC-Leu plates.  Several independent 
plasmids were isolated and gave identical results in subsequent tests. 
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RESULTS AND DISCUSSION 
To identify additional proteins involved in cytokinesis, we used a high-copy, LEU2-marked 
genomic library to screen for dosage suppressors of the 5-FOA-induced lethality of a myo1Δ 
hof1Δ [URA3 MYO1 plasmid] strain (see Chapter 3, Materials and Methods).  Among the 
several plasmids isolated, p757-8-2 displayed the strongest suppression (data not shown); it 
proved to contain the complete YJL055W ORF plus truncated copies of the neighboring 
genes (Figure 4.1A).  We then asked if p757-8-2 could suppress a deletion of IQG1 (whose 
product, like Myo1p and Hof1p, is involved in cytokinesis).  p757-8-2 strongly suppressed 
the 5-FOA-induced lethality of an iqg1Δ [URA3 IQG1 plasmid] strain, but it could not 
suppress the lethality of iqg1Δ spores on YP plates (data not shown).  These discordant 
results suggested that p757-8-2 might not suppress the myo1Δ hof1Δ and iqg1Δ defects but 
instead interfere with the action of 5-FOA.  Indeed, when we transformed plasmids p757-8-2 
and YEp13-YJL055Wsub (which contains YJL055W plus small fragments of the neighboring 
genes; Figure 4.1A) into a strain that was wild type at the URA3 chromosomal locus, the 
transformants were viable in the presence of 5-FOA (Figure 4.1B).  In contrast, a plasmid in 
which most of YJL055W had been deleted could not rescue the same strain on a 5-FOA plate 
(Figure 4.1, A and B).  We next tested if deletion of YJL055W would lead to an increased 
sensitivity to 5-FOA.  yjl055wΔ cells appeared to grow slightly less well than wild-type 
URA3+ cells in the presence of low concentrations of 5-FOA (Figure 4.1C, top four rows).  
However, this slight growth difference appeared to be independent of 5-FOA (Figure 4.1C, 
bottom row; also, in liquid SC-Ura medium, doubling times of 100 and 166 min were 
observed for wild-type and yjl055wΔ cells, respectively).  Thus, although overexpression of 
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Yjl055Wp can suppress the inviability of URA3+ cells in the presence of 5-FOA, deletion of 
YJL055W has little or no effect on 5-FOA resistance. 
 There has been little information available previously about the function of 
Yjl055Wp.  BLASTP searches reveal homologs in Archaea, Eubacteria, fungi, and plants 
(but, interestingly, apparently not in animals), suggesting that at least some aspects of 
Yjl055Wp function are ancient in origin and have been conserved.  Some of these homologs 
have been annotated as "possible lysine decarboxylases", based on a PGGxGTxxE motif that 
is shared with Yjl055Wp but whose association with lysine decarboxylase activity does not 
actually seem very clear, given that several bona fide enzymes of this type lack the motif 
(Kikuchi et al., 1997).  Most of the Yjl055Wp homologs also share with Yjl055Wp a 
Rossmann-fold motif (Gx1-2GxxG) that is indicative of possible nucleotide-binding activity 
(Kleiger and Eisenberg, 2002; Kukimoto-Niino et al., 2004).  In the only previously 
published report on Yjl055Wp itself, Stepchenkova et al. (2005) showed that yjl055w∆ 
strains have modestly elevated sensitivities to the purine-analog mutagens 6-
hydroxylaminopurine (HAP) and 2-amino-6-hydroxylaminopurine (AHA), which function 
by misincorporation into DNA (Pavlov et al., 1991; de Serres, 1991). 
 Because Yjl055Wp can protect cells from both pyrimidine and purine analogs and 
presumably from effects at the levels of both DNA and RNA, it seems unlikely that it 
functions by affecting the transport of analogs into cells, the levels of normal nucleotide 
pools, or DNA repair.  Instead, it seems most likely to function through the metabolic 
detoxification of the base analogs.  Because there are probably multiple pathways for such 
detoxification, it is not really surprising that the effects of deleting YJL055W are modest 
(HAP and AHA) or undetectable (5-FOA) despite the strong effect of YJL055W 
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overexpression on 5-FOA sensitivity.  Because yjl055w∆ cells grow significantly more 
slowly than congenic wild-type cells even in the absence of added base analogs, we speculate 
that Yjl055Wp functions in the detoxification of base analogs that accumulate in the course 
of normal metabolism (e.g., see Simandan et al., 1998) and/or that its detoxification ability is 
a by-product of another metabolic activity.  However, further studies will clearly be 
necessary to define the molecular details of Yjl055Wp function. 
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FIGURES (1) 
 
Figure 4.1.  Figure 1 of Chapter 4 
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FIGURE LEGENDS (1) 
Figure 4.1.  Effects on 5-FOA-induced lethality of overexpression or deletion of YJL055W.  
(A) The inserts of the relevant plasmids.  Plasmid p757-8-2 contains an N-terminal fragment 
of the 2643-nucleotide ZAP1 ORF, the complete YJL055W ORF, and an N-terminal fragment 
of the 1437-nucleotide TIM54 ORF.  Plasmid p757-8-2-ΔYJL055W contains the same N-
terminal ZAP1 fragment, a 257-nucleotide N-terminal YJL055W fragment, and a His3MX6 
marker (the arrow indicates the direction of transcription).  Plasmid YEp13-YJL055Wsub 
contains a 336-nucleotide N-terminal ZAP1 fragment, the complete YJL055W ORF, and a 
349-nucleotide N-terminal TIM54 fragment.  (B) Viability in the presence of 5-FOA of 
URA3+ cells overexpressing Yjl055Wp.  Strain DC-5 was transformed with the indicated 
plasmids and grown on SC-Ura-Leu (2 days) and SC-Leu+5-FOA (6 days) plates.  Only the 
plasmids harboring the complete YJL055W ORF could confer 5-FOA resistance to the 
URA3+ cells.  (C) Similar sensitivities of wild-type and yjl055wΔ cells to 5-FOA.  Strain DC-
5 and its yjl055wΔ derivative KO1468 were grown to exponential phase (OD600 ≈ 0.4), and 
10-µl aliquots of a dilution series (undiluted and 4x, 10x, 100x, and 1000x diluted) were 
spotted onto YP plates (bottom row) or SC plates containing 5-FOA at the indicated 
concentrations (top four rows) and grown for 4 days. 
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Table 4.1.  Primer List of Chapter 4 
___________________________________________________________________________ 
 
Primer  Purpose   Sequence 
___________________________________________________________________________ 
 
YJL55dF 5' primer to construct  5'-TAGAGTAAATCGCAGGCAATCCAG 
  yjl055wΔ   TACTAAGAAACGGCGCGGATCCCCG 
      GGTTAATTA-3' 
 
YJL55dR 3' primer to construct   5'-TACAGATCGTTTAAACTAGATACAT 
  yjl055wΔ   GACTTACGTTTCTAGAATTCGAGCTC 
      GTTTAAAC-3' 
 
YJL55dK Upstream check primer 5'-TGCAAAAGAATGATTATTAGAATT 
  for yjl055wΔ   ATACGT-3' 
 
YJL55dC Downstream check primer  5'-GCCCATCCGTCGATGCCAATATTTC 
  for yjl055wΔ   CTTTC-3' 
 
3'PTEF Internal check primer  5'-GTATGGGCTAAATGTACGGGCGAC 
of the His3MX6 marker AGTCAC-3' 
 
5'TTEF Internal check primer  5'-TATTTTTTTTCGCCTCGACATCATC 
of the His3MX6 marker TGCCC-3' 
 
YEp13sp168 5' primer to construct  5'-CTTGGAGCCACTATCGACTACGCG 
  p757-8-2-ΔYJL055W  ATCATGGCGACCACACGGATCCCCGG 
      GTTAATTA-3' 
 
YJL55dsr2 3' primer to construct  5'-CTGATTTAAGCGGACAGGTTCACG 
  p757-8-2-ΔYJL055W  GTATCATTCCAAATGGAATTCGAGCT 
      CGTTTAAAC-3' 
 
YEp13cp168 Upstream check primer  5'-GCATAGTACCGAGAAACTAGTGCG 
  for p757-8-2-ΔYJL055W  AAGTAG-3' 
 
YEp13cp169 Downstream check primer 5'-CTGTCCCTGATGGTCGTCATCTACC 
  for p757-8-2-ΔYJL055W  TGCCT-3' 
 
YJL055WF 5' primer to construct  5'-CTTGGAGCCACTATCGACTACGCG 
  YEp13-YJL055Wsub  ATCATGGCGACCACAACTCGAAATGT 
      TGGCAGTCG-3' 
 
YJL055WR 3' primer to construct  5'-ACCGCACCTGTGGCGCCGGTGATG 
  YEp13-YJL055Wsub  CCGGCCACGATGCGTGCATAATACAG 
      TACAGGCTT-3' 
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Various fungi are excellent model systems for the study of cytokinesis, because fungal 
cytokinesis shares similarities with both animal and plant cytokinesis.  Specifically, both 
animal and fungal cells divide by utilizing a contractile actomyosin ring, and both plant and 
fungal cells form a dividing structure made of cell-wall materials during cytokinesis.  The 
central aim of this work is to investigate septin-dependent, actomyosin-ring-independent 
cytokinesis in the budding yeast Saccharomyces cerevisiae. 
 Synthetic-lethal and dosage-suppressor screens starting with septin and myo1Δ 
mutants have found that deletion of genes encoding nonessential subunits of the anaphase-
promoting complex or cyclosome (APC/C) and overexpression of Iqg1p or Cyk3p can 
suppress the growth defects of myo1Δ cells.  Furthermore, Iqg1p has been identified as a 
novel APC/C substrate, and the elevated levels of Iqg1p in APC/C mutants account for the 
suppression of the myo1Δ growth defects.  In addition, dosage-suppressor screens starting 
with myo1Δ cyk3Δ and myo1Δ hof1Δ double mutants have found that overexpression of 
either Ecm33p or a truncated Cdc24p lacking its PB1 domain can promote the formation of 
primary-septum-like structures and possibly more organized thick septa in the absence of the 
actomyosin ring.  Finally, unrelated to cytokinesis, dosage-suppressor screens have 
unexpectedly found that overexpression of Yjl055Wp can suppress the 5-FOA-induced 
lethality of URA3+ cells.  These results are described in details in Chapters 2-4.
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 As with any work of this magnitude, there are a number of unresolved issues that 
need to be addressed.  The following sections represent some of these issues. 
myo1Δ  Phenotypes in the S288C and W303 Strain Backgrounds 
One unresolved issue is the difference between the myo1Δ phenotypes in the S288C and 
W303 strain backgrounds (Bi et al., 1998; Tolliday et al., 2003; see Chapter 2).  One possible 
explanation is that the actomyosin ring is essential in S. cerevisiae, and thus the viability 
observed in most genetic backgrounds, including S288C, is the result of some unidentified 
suppressor mutation(s).  This explanation is not plausible because the viable myo1Δ spore 
colonies were isolated by tetrad dissections of several heterozygous myo1Δ diploid strains.  
Thus, it is doubtful that each of the heterozygous myo1Δ mutants or the myo1Δ spore 
colonies independently acquired a suppressor mutation.  An alternative explanation is that the 
actomyosin ring is nonessential in S. cerevisiae, and thus the inviability observed in the 
W303 strain background is the result of some unidentified synthetic-lethal mutation(s), 
accumulated through polymorphisms.  Consistent with this model, previous studies have 
shown that no actomyosin ring can be detected in viable myo1Δ cells, indicating that there 
must be an actomyosin-ring-independent mechanism to complete cytokinesis (Bi et al., 
1998).  Our recent studies have shown that Iqg1p and Cyk3p are involved in such 
mechanism, but sequence analysis of both genes in the W303 background has revealed no 
mutation (Nishihama et al., 2007).  Thus, the unknown synthetic-lethal mutation(s) may be 
located within some other gene(s) involved in cytokinesis.  Currently, a dosage-suppressor 
screen, using myo1Δ mutant in the W303 strain background, is being conducted to identify 
this gene(s).  
Delay in Mitotic Exit and myo1Δ  Phenotypes 
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This study has shown that myo1Δ and net1Δ are synthetic lethal, suggesting that the 
mechanism of suppression of the myo1Δ phenotypes by the APC/C mutations may involve a 
simple delay in mitotic exit, which gives mutant cells more time to build the partially 
functional septum.  However, delaying mitotic exit by overexpressing a nondegradable 
mitotic cyclin does not suppress the same phenotypes.  One explanation for this 
inconsistency is that the overexpression of a nondegradable mitotic cyclin causes a severe 
delay in mitotic exit, which may induce cytokinetic defects by itself.  Conversely, mutation 
in a nonessential APC/C subunit causes only a slight delay, which gives myo1Δ cells enough 
extra time to carry out the inefficient cytokinesis without causing any additional cytokinetic 
defects.  One problem with this explanation is that unlike a deletion of other nonessential 
APC/C subunits, mnd2Δ appears to have no detectable effect on cell-cycle progression in 
mitotic cells (Oelschlaegel et al., 2005; Page et al., 2005), suggesting that the suppression of 
the myo1Δ phenotypes by mnd2Δ is likely to be independent of mitotic exit.  An alternative 
explanation for the inconsistency is that net1Δ prematurely activates the APC/C-mediated 
degradation of Iqg1p.  Premature degradation of Iqg1p compromises the actomyosin-ring-
independent mechanism of cytokinesis, which is lethal in combination with the absence of 
the actomyosin ring.  Consistent with this explanation, net1Δ single mutant cells appear have 
cytokinetic defects (data not shown).  Finally, another explanation for the inconsistency is 
that net1Δ can cause Iqg1p-independent growth defects and that the synthetic lethality 
between myo1Δ and net1Δ is merely the result of two unrelated growth defects being too 
damaging for the mutant cells to overcome. 
The Novel APC/C-Recognition Motif in Iqg1p 
This study has demonstrated that the absence of a novel N-terminal recognition motif makes 
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Iqg1p nondegradable by the APC/C.  Surprisingly, the two previously potential destruction-
box (DB) sequences found in Iqg1p turned out to be unnecessary for the degradation of 
Iqg1p, demonstrating that the existence of DB sequence is often not a good indicator for 
identifying bona fide APC/C targets.  As for the novel recognition motif, although it does not 
follow exactly the conserved sequence of a DB or KEN-box, it does contain similar 
conserved amino acids (arginine, lysine, and asparagine).  Important tests are to see whether 
the other amino acids within this motif are required for the recognition and to determine the 
exact mechanism (as a DB, KEN-box, or something entirely different) by which this novel 
motif functions. 
Significance of Timely APC/C-mediated Degradation of Iqg1p 
Another issue that needs to be addressed is the significance of the APC/C-dependent 
proteolysis of Iqg1p.  In other words, why does Iqg1p have to be degraded after cytokinesis?  
Recent studies have shown that S. cerevisiae cells are significantly sensitive to the cellular 
level of Mlc1p, which is the essential light chain for Iqg1p, Myo1p, and type V myosin 
Myo2p, and that the Mlc1p-Myo2p interaction is important for septum formation, cell 
separation, and new bud formation (Luo et al., 2004).  Thus, heterozygous mlc1Δ diploid 
cells display haploinsufficiency that can be suppressed by reduced copy of MYO2 (Stevens 
and Davis, 1998), and the overexpression of a Myo1p C-terminal tail (containing the Mlc1p-
binding IQ motifs) leads to cytokinetic defects that can be alleviated by overexpression of 
Mlc1p (Tolliday et al., 2003).  Furthermore, our recent studies have shown that 
overexpression of wild-type Iqg1p can cause minor cytokinetic defects (Nishihama et al., 
2007) and that overexpression of the nondegradable Iqg1p from a GAL promoter causes 
severe cytokinetic defects.  Taken together, these results suggest that the timely degradation 
  136 
of Iqg1p may be important for providing Mlc1p to interact with Myo2p, that the association 
of Mlc1p with each binding partner may need to be fine-tuned temporally, and that the 
APC/C-dependent proteolysis of Iqg1p may contribute to this fine-tuning. 
Possible Nuclear Localization of Iqg1p 
Another unresolved issue is the exact location of the APC/C-Iqg1p interaction.  In S. 
cerevisiae, the localization of the APC/C or the primary site of its activity is nuclear 
(Sikorski et al., 1993; Jaquenoud et al., 2002; Huh et al., 2003; Melloy and Holloway, 2004).  
Thus, in order to be properly ubiquitinated, many of the known APC/C substrates require 
transport into the nucleus.  For examples, both Kip1p and Cin8p contain a nuclear 
localization sequence (NLS) (Gordon and Roof, 2001; Hildebrandt and Hoyt, 2001), and the 
proper degradation of Pds1p seems to require a certain nuclear transport protein (Bäumer et 
al., 2000).  Another APC/C target, Hsl1p, has been shown to localize to the bud neck.  Thus, 
Hsl1p is either transported into the nucleus or ubiquitinated as the nucleus passes through the 
bud neck during nuclear migration (Burton and Solomon, 2000; Burton and Solomon, 2001).  
Iqg1p has been shown to localize to the bud neck as a ring (Epp and Chant, 1997; Shannon 
and Li, 1999; Nishihama et al., 2007; see Chapter 2), and because Iqg1p appears to be fully 
functional until after cytokinesis, it is unlikely to be ubiquitinated as early as nuclear 
migration.  Thus, Iqg1p is probably shuttled into the nucleus, either through its own possible 
NLS or by binding to another nuclear localizing protein, to be ubiquitinated after cytokinesis. 
Possible Conserved Regulation of IQGAPs by the APC/C 
Iqg1p is the only known member of the conserved IQGAP family in S. cerevisiae (Brown 
and Sacks, 2006), and because the APC/C is also a conserved complex, it is possible that 
IQGAPs in other organisms are also regulated by the APC/C, and these regulations are 
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evolutionarily conserved.  This hypothesis is especially possible for Rng2p in S. pombe and 
IQGAP1 in mammalian cells, because they have also been shown to be involved in 
cytokinesis.  Specifically, IQGAP1 was one of the proteins identified in midbodies isolated 
from Chinese Hamster Ovary cells, and it appears to be required for completion of meiotic 
and mitotic divisions as well as germline formation in Caenorhabditis elegans, based on 
RNAi studies (Skop et al., 2004).  Furthermore, Rng2p has been indicated to be essential for 
actomyosin-ring formation and cytokinesis in S. pombe cells (Eng et al., 1998; Wu et al., 
2003).  Logical experiments are to determine if the overall protein level of Rng2p is cell-
cycle-regulated and if this possible regulation is APC/C-dependent.  Similar questions should 
be answered for IQGAP1 and any other IQGAPs that might play a role in cytokinesis. 
 Although it is possible that Rng2p and/or IQGAP1 are regulated by the APC/C and 
that each protein has a single DB consensus sequence, neither protein appears to contain any 
obvious sequence similar to the novel APC/C-recognition motif identified in Iqg1p.  
BLASTP searches with Iqg1p sequence has revealed that in two other yeast species, Candida 
glabrata and Kluyveromyces lactis, there are uncharacterized proteins (XP_446838.1 and 
XP_453638.1, NCBI protein database) that contain N-terminal sequences (a.a. 25-34 and a.a. 
33-42, respectively) similar to the novel APC/C-recognition motif.  Although these two 
uncharacterized proteins have yet to be verified functionally as IQGAPs, they appear to 
contain some of the other known domains of IQGAP.  If they are indeed bona fide IQGAPs 
and their homologous N-terminal sequences are real APC/C-recognition motifs, then the 
regulation of IQGAPs by the APC/C appears to be conserved, at least among some yeast 
organisms.  This potential finding would suggest that Rng2p and IQGAP1, without the novel 
recognition motif, might not be APC/C targets. 
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Suppressions of iqg1Δ  and chs2Δ  Defects by Overexpressing Ecm33p or Cdc24-PB1Δp 
 
Another unresolved issue is the exact mechanism by which overexpression of Ecm33p or 
Cdc24-PB1Δp suppresses the iqg1Δ and chs2Δ growth defects.  Studies with electron 
microscopy (EM) have shown that instead of a trilaminar-septum structure, iqg1Δ and chs2Δ 
single mutant cells can only form thick septa (Schmidt et al., 2002; Nishihama et al., 2007; 
see Chapter 3).  Thus, the primary-septum-like structures in iqg1Δ and chs2Δ cells 
overexpressing Ecm33p probably help mutant cells to grow better by providing a more 
efficient method of cell separation.  Ecm33p has been suggested to play a role in the N-
linked glycosylation and cell-wall anchoring of mannoproteins (Pardo et al., 2004).  Thus, it 
is possible that Ecm33p participates in an actomyosin-ring-independent and Iqg1p-Cyk3p-
involved pathway of primary-septum construction by regulating mannoproteins and other 
cell-wall materials.  Because the observed primary-septum-like structures do not appear very 
frequently, the overexpression of Ecm33p probably also suppresses the iqg1Δ and chs2Δ 
growth defects via another mechanism(s).  One possibility is that overexpressing Ecm33p 
may help mutant cells defective in cytokinesis to construct more stable and stronger thick 
septa, which may prevent cell lysis, especially during cell separation.  Because the deletion 
of ECM33 does not cause any detectable cytokinetic defect at 23˚C and only causes minimal 
multi-cell clustering at 37˚C, it is likely that Ecm33p only plays a minor role in normal 
cytokinesis.  
 The formation of primary-septum-like structures in iqg1Δ cells, but not in chs2Δ 
cells, overexpressing Cdc24-PB1Δp suggests that the suppression may involve more than one 
mechanism.  Perhaps the overexpression of Cdc24-PB1Δp can help mutant cells to produce 
primary-septum-like structures (only in the presence of chitin made by Chs2p), build more 
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stable thick septa (by over-activating the cell-integrity pathways), and/or conduct more 
efficient hydrolysis of cell-wall materials during cell separation.  Furthermore, the 
suppression is likely to be independent of Cdc42p but dependent of the GEF activity of 
Cdc24-PB1Δp, which may function through another Rho-type GTPase(s) and/or an unknown 
factor(s).  To verify this model, it is possible to test the GEF activity of Cdc24-PB1Δp for 
Rho1p, Rho2p, and/or Rho5p via in vitro assays. 
Roles of Iqg1p and Cyk3p in Actomyosin-Ring-Independent Cytokinesis 
A central goal of our investigation of actomyosin-ring-independent cytokinesis is to 
understand the cytokinetic roles of Iqg1p and its possible downstream targets, including 
Cyk3p.  Based on EM analysis, myo1Δ cells can form both thick septa and disorganized 
primary-septa-like structures, which can be increased in number by the overexpression of 
Iqg1p or Cyk3p (Schmidt et al., 2002; Nishihama et al., 2007).  The overexpression of 
Cyk3p can also induce the formation of primary-septa-like structures in iqg1Δ cells, and 
cyk3Δ cells appear to synthesize primary and secondary septa simultaneously, suggesting that 
there may be a delay in the construction of primary septum (Nishihama et al., 2007).  Taken 
together, these results suggest that the formation of the actomyosin ring and the stimulation 
of the Cyk3p pathway are two functions of Iqg1p.  Furthermore, Cyk3p may function in the 
construction of primary septum by controlling targeted vesicle secretion and membrane 
invagination at the bud neck and/or the synthesis of cell-wall chitin (Nishihama et al., 2007).  
Thus, even in the absence of the actomyosin ring, Cyk3p can complete primary-septum 
construction, albeit less efficiently.  In other words, the actomyosin-ring contraction and the 
Cyk3p pathway are two mechanisms involved in the construction of primary septum.  
Perhaps because the mother-bud necks of S. cerevisiae cells are quite narrow, neither 
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mechanism by itself is essential for primary-septum formation, thus both myo1Δ and cyk3Δ 
single mutant cells can synthesize some primary septa or primary-septum-like structures.   
However, when both mechanisms are compromised, such as in myo1Δ cyk3Δ double and 
iqg1Δ single mutants, cells can only form thick septa, which often lead to severe growth 
defects. 
Possible Detoxification of Nucleotide Analogs by Yjl055Wp 
Yjl055Wp was identified as a dosage-suppressor of the inviability of URA3+ cells in the 
presence of 5-FOA.  Because this little-known protein can protect cells from both pyrimidine 
and purine analogs and presumably from effects at the levels of both DNA and RNA, it 
seems unlikely that it functions by affecting the transport of analogs into cells, the levels of 
normal nucleotide pools, or DNA repair.  Instead, it seems most likely to function through 
the metabolic detoxification of the nucleotide analogs.  However, further studies will clearly 
be necessary to define the molecular details of Yjl055Wp function. 
 
Final Remarks 
In conclusion, the results described in this work, suggest that Iqg1p, a novel APC/C target, 
may stimulate Cyk3p and other proteins (such as those involved in targeted membrane 
addition and/or cell-wall synthesis/integrity) in a cell-cycle-regulated manner to promote the 
construction of a more normal septum through the actomyosin-ring-independent mechanism 
of cytokinesis in S. cerevisiae.  However, many of the pathways and components of 
actomyosin-ring-independent cytokinesis remain to be identified, and the precise molecular 
roles that Iqg1p and Cyk3p play in actomyosin-ring-independent cytokinesis remain to be 
elucidated. 
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